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1
1. GENERAL INTRODUCTION
1.1 History and prevalence of Usher Syndrome
Usher syndrome is a devastating genetic condition characterized by hearing impairment 
and a progressive loss of visual function as a consequence of retinitis pigmentosa 
(RP). The combination of hearing loss and visual impairment was first reported by 
the German ophthalmologist Albrecht von Graefe in 1858, when he described three 
affected brothers who had been studied by his own cousin, Alfred Graefe 1. As these 
cases were relatives, a hereditary defect was suspected. The German ophthalmologist 
Richard Liebreich recognized the condition in the hearing impaired population of Berlin 
2, and in 1880 Arthur Hartmann, a German otologist, introduced a recessive pattern of 
inheritance for the combination of deafness and RP 3. The first descriptions of combined 
deaf-blindness in the Dutch population were by De Wilde in 1919. Finally, 77 years after 
the first description, the syndrome was named after the Scottisch ophthalmologist 
Charles Howard Usher in 1935 4.  Although Usher syndrome is the most common cause 
of hereditary deaf-blindness in man, it is still classified as a rare disease. The prevalence 
of Usher syndrome is estimated to range from 4.4 to 6.2 per 100,000 inhabitants, with a 
variable distribution in different populations and between the different clinical types of 
Usher syndrome 5,6. 
1.2 Clinical classification of Usher syndrome
Currently, three clinical types of Usher syndrome are distinguished based on the severity 
and progression of the hearing impairment, the presence of vestibular dysfunction and 
the age at which RP is diagnosed (Table 1) 7,8. The initial sign of visual dysfunction in 
Usher syndrome patients is often night blindness, which is followed by a progressive 
loss of peripheral vision that generally results in legal blindness in the sixth or seventh 
decade of life 9. In addition, atypical forms of Usher syndrome, such as congenital 
severe-to-profound hearing loss combined with late onset or subclinical RP, have been 
reported 10-12. It has been postulated that environmental factors or modifier genes might 
influence the observed clinical outcome in patients with atypical Usher syndrome. 
Usher syndrome type 1 is the most severe form of Usher syndrome characterized by 
congenital severe to profound hearing loss, vestibular dysfunction and a pre-pubertal 
onset of the retinal degeneration. Usher syndrome type 2 is the most common type 
of Usher syndrome (>50% of the patients). As shown in Table 1, patients with Usher 
syndrome type 2 have an intact vestibular function, congenital hearing impairment 
and a progressive loss of visual function, as a consequence of RP 13. The RP is generally 
diagnosed during or after puberty. Usher syndrome type 3 is the most variable form of 
Usher syndrome with stable, progressive or profound hearing loss, variable vestibular 
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function, and progressive vision loss. Other symptoms noticed in Usher syndrome 
patients are reduced fertility, mental deficiencies, cerebral atrophy, ataxia, bronchiectasis 
and immotile nasal cilia 14-21. Further research is needed to determine whether or not 
these symptoms are also part of the clinical spectrum of Usher syndrome. 
Hearing impairment
Usher syndrome type 1  
Usher syndrome type 2 
Usher syndrome type 3  
Visual impairment Vestibular function
Congenital; severe to 
profound
Congenital; moderate 
to severe
Variable age of onset; 
progressive
Onset of RP before 
puberty; progressive
Onset of RP around 
puberty; progressive
Variable age of onset 
of RP; progressive
Absent
Intact
Variable
USH type
Table 1. Clinical classification of Usher syndrome
2. HEARING AND HEARING REHABILITATION IN USHER 
SYNDROME PATIENTS
2.1  The ear: organ for hearing and balance
Sound is an important aspect of communication. The (inner) ear is the organ for hearing 
and balance. Sound waves are captured by the ear and converted into electrical signals 
that lead to the perception of sound by the brain. Besides that, the inner ear also 
contains the vestibular system or balance organ 22. 
2.2  Anatomy of the human ear
 The ear consists of three main parts: the outer, middle and inner ear (Figure 1). Sound 
waves are captured by the pinna and travel to the tympanic membrane via the external 
auditory canal. The three auditory ossicles in the middle ear; the malleus, incus and 
stapes, transmit these vibrations to the inner ear. The inner ear consists of the cochlea 
and the vestibular system. The increase in pressure in the cochlear fluid caused by 
inward movement of the stapes also displaces fluid in the inner ear. As a consequence, 
the basilar membrane moves in vertical direction resulting in an increased pressure 
within the scala tympani. The enhanced pressure results in displacement of cochlear 
fluid in the scala media and finally in displacement of the sensory epithelium in the 
organ of Corti. The sensory epithelium contains approximately 16,000 hair cells that 
convert mechanical stimuli into electrical signals. Inner hair cells convert the amplified 
mechanical signal into electrical responses, whereas the outer hair cells receive and 
amplify sound-evoked vibrations of the sensory epithelium. At the apical part of the hair 
cells, 10 to 50 actin based protrusions are present, the stereocilia, which are anchored 
General introduction | 15
1
in the cuticular plate. Stereocilia are organized in a staircase-like pattern and connected 
to each other by fibrous links. Every hair bundle contains one true, microtubule-based, 
cilium that is known as the kinocilium. In mammals, the kinocilium is required for proper 
hair bundle formation and orientation and disappears at the end of hair cell development 
in the cochlea. Finally, action potentials are transmitted via the auditory nerve to the 
primary auditory cortex. In general, healthy young individuals are capable of hearing 
frequencies between 20 and 20,000 Hertz (Hz). Sound of different frequencies can be 
distinguished because of difference in shape of the basilar membrane, the organ of Corti 
and the tectorial membrane from base to apex. High frequency sounds are optimally 
detected in the more basal part of the cochlea, and sounds with low frequencies in the 
more apical part of the cochlea. 
2.3  Vestibular system
The vestibulum or balance organ, is part of the inner ear and consists of semicircular 
canals and the otolith organs (the utricle and saccule) (Figure 1). The semicircular 
canals register rotational movements and the otoliths register linear accelerations. 
The ear stones (otoconia) ballast the otolith membrane, making it heavier than the 
surrounding endolymph. When the head rotates, the force on the hair cell-containing 
sensory epithelium changes which leads to a deflection of stereocilia. As a result, 
mechanotransduction channels are opened, resulting in the depolarization of the cell 
and neurotransmitter release onto the vestibular nerve.  
2.4 Hearing impairment in Usher syndrome patients and rehabilitation
Hearing impairment is defined as the loss in the ability of hearing sounds of more 
than 26 decibels (dB) for an average of four frequencies (0.5, 1, 2 and 4kHz) (www.
who.int). Patients with Usher syndrome type 1 have a severe to profound hearing loss 
from birth with occasionally only residual hearing at the lower frequencies 23,24. For 
these patients, cochlear implantation is so far the only effective treatment. A cochlear 
implant is an electronic device that replaces the function of the damaged inner ear 
sensory epithelium. Bilateral cochlear implantation can also improve identification 
of the direction of sound. Detection of sound can be achieved with implantation late 
in life, but speech recognition appears only possible in patients that had a previous 
stimulation of the auditory system, since it depends on the development of hearing 
skills and the maturation of the auditory pathways 25. Although, the level of hearing 
rehabilitation after implantation varies significantly among patients. 
Typical for Usher syndrome type 2 is congenital moderate-to-severe bilateral hearing 
impairment, with the high frequencies being most severely affected 24,26-29. Patients with 
Usher syndrome type 3 present with an onset of progressive hearing loss mainly in the 
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first and second decade of life. Rapid progression in the first two decades (≥ 25 dB per 
decade) is followed by a period of relative stability 30. For both Usher syndrome type 2 
and type 3 patients, bilateral hearing aids are provided from birth or at first detection 
of hearing loss. Hearing aids can amplify the signal, however they are incapable of truly 
correcting hearing loss. Modern devices use sophisticated digital signal processing to 
try and improve speech recognition. However, further research, especially on sound 
localization and speech intelligibility in noise, is necessary to improve hearing aids and 
hearing aid fitting 31. In some patients with Usher syndrome type 2 and 3 the severe 
progression of hearing impairment leads to insufficient speech intelligibility with 
hearing aids. These patients are often provided with a cochlear implant 31-33.
Ear drum
Cochlea
Incus
Malleus Stapes
Vestibular System
INNER EARMIDDLE EAROUTER EAR
Figure 1. Schematic representation of the outer, middle and inner ear. The inner ear is pointed out 
with the square. The vestibular system, the balance organ, is part of the inner ear. 
© Adobe Stock.
3. VISION AND VISUAL IMPAIRMENT IN  
USHER SYNDROME PATIENTS
3.1  Human visual perception
Visual perception is the ability to interpret the world around us using light in the visible 
spectrum reflected by the objects in the environment. The most primitive eyes originate 
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from 550 million years ago and are described as patches of photoreceptor proteins in 
unicellular organisms 34. Throughout evolution, the human eye developed into a highly 
specialized and sophisticated system that is responsible for our vision. 
3.2  Anatomy of the human eye
The human eye is composed of three main layers: the outer layer, the middle layer 
and the inner layer (Figure 2). The outer layer is made up of the sclera and the cornea. 
The sclera is the outermost layer of the eye that maintains the shape of the eye and 
serves as protector of the inner parts of the eye from bacterial invasions. The cornea 
functions as a window that controls the entry of light into the eye. The middle layer is 
formed by the choroid, ciliary body and iris. The choroid has a dark pigment, melanin 
that facilitates the absorption of light whereas the ciliary body is responsible for 
controlling the shape of the lens and the production of aqueous humor. The choroid 
is mainly composed of blood vessels and therefore this layer is also referred to as uvea 
or vascular tunic. The inner layer, the retina, contains the sensory epithelium. Based on 
its cellular components, the retina can be divided in three nuclear layers separated by 
two synaptic layers (Figure 3). The ganglion cell layer (GCL) contains the cell bodies of 
the retinal ganglion cells. At the inner plexiform layer (IPL) the synaptic connections 
between ganglion cells and secondary neurons (horizontal, amacrine and bipolar 
cells) are made. The inner nuclear layer (INL) contains the nuclei and part of the cell 
bodies of these three secondary neurons and the cell bodies of the Müller glia cells. In 
the outer plexiform layer (OPL) the synaptic connections between the photoreceptor 
cells and the secondary neurons are situated. The outer nuclear layer (ONL) contains 
the nuclei and part of the cell bodies of the light-sensitive photoreceptor cells. In the 
human retina, two types of photoreceptor cells can be distinguished: the rods and the 
cones (Figure 3). A human eye approximately contains 6.4 million cones and 110-125 
million rods. The density of cones is the highest in the fovea situated near the center of 
the macula. Cones are conically-shaped cells that are responsible for color vision and 
enable us to see during daytime. Humans have a trichromatic visual system consisting 
of three different type of cones varying in spectral sensitivity: the L-cones (red), M-cones 
(green) and S-cones (blue). In contrast, rods are cylindrically-shaped cells that enable us 
to see during night. Rods contain more visual pigment than cones, and multiple rods 
are connected to a single bipolar cell. Therefore, rods are able to amplify light signals 
much stronger than cones in dim light situations. Both types of photoreceptors have 
the same basic structure (Figure 3). In both rods and cones, the conversion of light into 
electrical signals (phototransduction), takes place in the outer segments (Figure 3) 35. 
The outer segment is regarded to be a highly specialized non-motile primary cilium with 
the connecting cilium as the ciliary transition zone. Proteins involved in outer segment 
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formation and function, such as proteins involved in the phototransduction cascade, 
are synthesized in the inner segment and actively transported to the outer segment via 
the connecting cilium. The outer segments of the photoreceptor cells are embedded 
in the multifunctional Retinal Pigment Epithelium (RPE). The RPE off ers protection, 
reduces the refl ection of light, and is involved in phagocytation of photoreceptor outer 
segment membranes 36.  
3.3  Retinal degeneration in Usher syndrome patients 
Progressive blindness caused by RP is considered to be a rare disorder (www.nei.nih.
gov). The term “retinitis” suggests an infl ammatory process, however this is misleading 
as RP is not an infl ammation, but an inherited, slow-paced degeneration of the retina. 
The term “pigmentosa” refers to the characteristic pigmentary deposits in the retina. 
In the early stages of RP, rods are more severely aff ected than cones. Function of rods 
gradually deteriorates and vision in dim light becomes more diffi  cult. During later stages 
of RP, the visual fi eld starts to narrow down. Only a small area of central vision remains, 
along with slight peripheral vision. The visual fi eld decrease results in tunnel vision 
and fi nally leads to total blindness. The pathophysiology underlying Usher syndrome-
associated photoreceptor degeneration is still largely unknown. Unfortunately, no 
treatment options are currently available for the progressive retinal degeneration in 
Usher syndrome patients. 
Retina
Inner retina:Outer retina:
Middle retina:
Vitreous humor
Optic nerve
Fovea
Optic disc
(Blind Spot)
Choroid
Cilliary body
Iris
Lens
Pupil
Cornea
Sclera
Figure 2. Anatomy of the human eye. 
© Adobe Stock.
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1Rods
Bipolar cells
Amacrine cells
Ganglion cells
Nerve fiber layer
RPE
Horizontal cells
Retina
Muller 
cells
Rods
Light
Cones
Ribbons
Nuclei
Inner segments
Outer segments
Calyceal
Processes
Ribbons
Calyceal
Processes
Connecting Cilium
Basal Body
Connecting Cilium
Basal Body
Nuclei
Inner segments
Outer segments
Cones
Figure 3. Schematic representation of the retina and light-sensitive photoreceptor cells. 
The light enters the eye via the lens and reaches the photoreceptor cells after passing the diff erent layers of 
the retina. 
4. GENES AND PROTEINS INVOLVED IN USHER SYNDROME
Usher syndrome is inherited as an autosomal recessive trait and is not only clinically but 
also genetically heterogeneous (Table 2). So far, nine genetic loci and six diff erent genes 
(MYO7A, USH1C, CDH23, PCDH15, USH1G and CIB2) have been identifi ed to be involved 
in Usher syndrome type 1. Mutations in USH2A, ADGRV1 and WHRN result in Usher 
syndrome type 2, and defects in USH3A lead to Usher syndrome type 3. In addition, 
mutations in PDZD7 can act as a modifi er of RP in Usher syndrome type 2a patients and 
together with ADGRV1 mutations contribute to digenic Usher syndrome 37. Mutations in 
HARS are associated with Usher syndrome type 3b 38, and a combination of mutations in 
CEP250 and C2ORF71 are associated with atypical Usher syndrome 39. 
4.1  Mutations in USH2A are the most frequent cause of Usher syndrome 
Usher syndrome type 2 is the most common type of Usher syndrome and has been 
reported to represent around two-thirds of Usher syndrome cases 40, of whom 57-85% 
can be explained by mutations in USH2A (ENSG00000042781) 41,42. Also, mutations in 
USH2A are the most frequent cause of autosomal recessively inherited nonsyndromic 
RP (arRP), accounting for 7-23% of arRP cases 42. 
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USH2A encodes usherin and to date, two diff erent isoforms have been identifi ed 
(Figure 4). The originally identifi ed human USH2A transcript is composed of 21 exons 
and encodes a presumably secreted protein of 1,551 amino acids (usherinisoA) 43. In 
2004, van Wijk et al. identifi ed 51 additional exons of USH2A that altogether encode a 
transmembrane protein of 5,202 amino acids (usherinisoB) 44. In addition to the domains 
present in usherinisoA (an N-terminal signal peptide, a Lam-G like domain, a LamNT 
domain, 10 EGF-lam domains and 4 FN3 domains), usherinisoB contains two laminin G 
domains (LamG), 28 FN3 domains, a transmembrane domain and a short intracellular 
region with a C-terminal class I PDZ-binding motif (Figure 4). In 2005, a novel inner ear-
specifi c exon was identifi ed, adding 24 additional amino acids to the intracellular region 
of the protein 45. In mouse retina, usherinisoB is reported to be the most prevalent isoform 
which is mainly located at the photoreceptor periciliary membrane and the synaptic 
region of photoreceptor cells 46-49. At the periciliary region, usherin is thought to be part 
of a protein complex that is involved in transport and docking of vesicles from the inner 
to the outer segment of photoreceptor cells 50. 
Usherin
S
Isoform B
S
Isoform A Signal sequence (S)
Laminin G-like domain (LamGL)
Laminin N-terminal domain (LamNT)
Laminin-type EGF-like domain (EGF Lam)
Fibronectin type 3 domain (FN3)
Laminin G domain (LamG)
Transmembrane domain (TM)
PDZ-binding motif (PBM)
S
Figure 4. Schematic representation of usherin protein isoform A and isoform B visualizing the 
diff erent domains.
4.2 Usher proteins function in highly dynamic protein networks
Usher proteins are members of protein families with very diverse functions 22. Despite 
the predicted variety in protein function, the clinical similarities in patients suggest that 
the associated proteins play a role in the same processes or pathways. Indeed, Usher 
proteins have been shown to interact and to function in highly dynamic multiprotein 
networks (Figure 5) 22. These protein networks function in diff erent compositions 
at diff erent subcellular locations during diff erent stages of inner ear and retinal 
development and thereafter 47,51. 
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In photoreceptor cells, Usher proteins predominantly localize in the region of the 
connecting cilium, more specifically at the basal body, the accessory centriole, the 
calyceal processes and the periciliary membrane (Figure 6) 22,50,52. It has been postulated 
that in this region Usher proteins are important for providing structural support. 
Besides that, evidence is accumulating for a major role of these proteins in the transport 
and docking of vesicles that contain essential proteins for outer segment formation, 
maintenance and function 47,53,54. Another important subcellular location where Usher 
proteins have been identified, is in the synaptic regions of both photoreceptors and 
inner ear hair cells (Figure 6) 50. Multiple studies have elucidated an important role for 
the Usher protein network in inner ear hair cell and photoreceptor synapse formation 
and function 49,52,55,56. Finally, Usher mouse mutants exhibit severe defects in the inner ear 
hair bundle morphology (Table 2) and Usher proteins have been detected in the hair 
bundle, indicating an essential role in hair bundle development and maintenance 50. 
However, despite all suggested and indicated functions, more research is needed to 
unravel the full function of the Usher proteins and the associated network(s) in both 
inner ear and retina. 
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Figure 5. The Usher protein network.
Identified protein-protein interactions are indicated. The red and green boxes represent Usher syndrome-
associated proteins. Black boxes indicate association with isolated deafness and orange boxes represent 
modifiers for Usher syndrome (Adapted with permission from thesis E. van Wijk). 
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Figure 6. Localization of USH proteins in the photoreceptor 
(Figure adapted with permission 50).
5. CELLULAR AND ANIMAL MODELS FOR USHER SYNDROME
Suitable cellular or animal models are essential to gain more insight into the molecular 
mechanisms underlying photoreceptor and hair cell dysfunction in Usher syndrome 
patients and to evaluate the therapeutic strategies that are currently under development. 
Here, we describe an overview of existing models for Usher syndrome (Table 2).
5.1 Human cellular models
The accessibility of human material for studying Usher protein function is limited since 
these proteins are mostly expressed in retina, brain and inner ear. However, human 
nasal epithelium or hair roots also express Usher proteins and can be collected from 
Usher patients semi-invasively 57,58. In addition, patient-specific induced pluripotent 
stem cell (iPSC)-derived otic and retinal progenitor cells may be useful in unraveling the 
mechanisms underlying the disease 59-61. iPSCs can be generated directly from fibroblasts 
or keratinocytes. Otic progenitors derived from iPSCs were used to study the function 
of MYO7A. Compound heterozygous mutations in MYO7A led to mechanotransduction 
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channel dysfunction, and abnormal electrophysiological activity of iPSC-derived hair 
cell-like cells 62. The lack of photoreceptor outer segments and RPE in cultured iPSC-
derived photoreceptor precursor cells and the impossibility to measure visual acuity 
in cell models remain a challenge at this moment. Therefore, animal models are crucial 
to gain insight into the pathophysiological effects of a mutated gene and to assess the 
efficacy of novel potential therapies at the level of visual function. 
5.2 Fruit fly (Drosophila melanogaster)
For more than 100 years,  studies in fruit flies yielded new and exciting insights in the 
field of genetics 63. The Drosophila compound eye consists of a retina and four optic 
ganglia. It is a highly organized and stereotypic organ in which it is easy to detect 
phenotypes that disrupt this regular pattern of organization 64. However, the retina 
comprises approximately 700-800 ommatidia, or facets. Each ommatidium contains 
eight photoreceptor cells that are associated with a rhabdomere. Fruit fly mutants for 
the orthologues Usher genes MYO7A, PCDH15, USH1G, CDH23 and USH1C have been 
generated (Table 2). Although some defects in the auditory Johnston’s organ were 
reported, no defects in visual function were observed. 
5.3 Mouse (Mus Musculus)
Mutant mouse models are commonly used to study inherited retinal dystrophies, 
including RP 65. Mice are more closely related to humans than fruit flies and have a 
greater genetic complexity. However, the available Usher knock-out models do not fully 
recapitulate the phenotype of Usher syndrome patients (Table 2). Hearing impairment 
and vestibular dysfunction is observed in the majority of knock-out models for Usher 
genes, whereas the retinal degeneration as observed in Usher syndrome patients is 
only sporadically seen as shown in Table 2. Compared to human photoreceptors, 
mouse photoreceptors have no calyceal processes and an underdeveloped periciliary 
membrane 66. These anatomical differences could possibly explain the observed 
discrepancy in phenotype, since the calyceal processes and the periciliary membrane 
are the most prominent subcellular locations in photoreceptor cells where USH1 and 
USH2 proteins have been found 47,66-68.
5.4  Zebrafish (Danio Rerio)
5.4.1 Using the zebrafish as model to study retinal degeneration 
Zebrafish, Danio Rerio, are tropical freshwater fish native to the Southern part of Asia, 
where they live in shallow, slow-flowing water. The vertebrate zebrafish are teleosts 
and belong to the family of Cyprinidae and class of Actinopterygii. In the 1970s the 
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American molecular biologist George Streisinger and his colleagues at the University of 
Oregon introduced the zebrafish as a laboratory animal 69. The zebrafish has emerged 
as an eminent model organism in scientific research thanks to numerous advantageous 
characteristics like their small size, ease of maintenance and genetic manipulation, 
high fecundity, rapid ex vivo development and transparency during embryogenesis 70 
(Figure 7). Challenges in using the zebrafish as a model organism for human retinal 
disorders are their largely duplicated genome, the absence of a macula, the distribution 
of rods and cones and their ability to regenerate retinal cells upon injury.  
Functional vision is crucial for the survival of zebrafish larvae, soon after hatching the 
larvae must be able to search for food and to avoid predators. Using the behavioral 
optokinetic response (OKR) assay and the electrophysiological electroretinogram (ERG), 
retinal function can be assessed in zebrafish larvae from 5 dpf onwards 71. 
Figure 7. Life cycle and development of the zebrafish. 
In total, 4 stages can be distinguished: embryonic stage (up to 3 days post fertilization), larval stage (3-27 days 
post fertilization), juvenile stage (approximately 27-60 days post fertilization) and adult stage (> 90 days post 
fertilization). 
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A dedicated online database containing information on zebrafish genetics and 
development is available (Zebrafish Information Network (ZFIN) (www.zfin.org)). 
The Zebrafish International Resource Center (ZIRC) is a resource from where more 
than 34,000 different mutant and transgenic zebrafish lines can be purchased (www.
zebrafish.org).
5.4.2 Zebrafish Usher knockdown and knock-out models             
In contrast to the existing mouse models for Usher genes, several morphant and mutant 
zebrafish models for Usher syndrome display early-onset retinal dysfunction (Table 2) 72. 
Due to an ancient genome duplication in teleost fish, orthologs of approximately ~30% of 
the mammalian genes are present in two copies. For instance, zebrafish have two copies 
of the MYO7A gene, myo7aa and myo7ab. Myo7aa is expressed in the sensory hair cells 
of the inner ear, the neuromasts, and in photoreceptors 73-75. Recently, impaired visual 
function and photoreceptor degeneration have been observed in myo7aa mutants 73. 
Similar to what has been observed in Myo7a mouse mutants, opsins like rhodopsin and 
blue cone opsin are not correctly localized in photoreceptors of myo7aa mutants. In 5 
day old ush1c mutants, maturation of the photoreceptor ribbon synapse is abnormal, 
leading to a decrease in synaptic transmission and, as a consequence, to an impaired 
visual function 76,77. Cdh23 (USH1d) was shown to be expressed in GABAergic amacrine 
cells but not in photoreceptors of larval zebrafish eyes 78. Auditory and vestibular 
defects were detected 79, although no defects in visual function were reported for the 
existing cdh23 mutant alleles 78,80. Zebrafish also have two PCDH15 (USH1f) orthologs, 
pcdh15a and pcdh15b. Pcdh15a is expressed in mechanosensory hair cells and brain, 
whereas pcdh15b is expressed in photoreceptors, the brain and weakly in the inner 
ear and neuromasts 81. The pcdh15a mutant orbiter shows vestibular dysfunction but 
intact visual function. In contrast, vestibular function is normal in pcdh15b, whereas 
visual function is impaired. For Usher syndrome type 3a, the conserved role of USH3A 
in hearing and balance is demonstrated in clrn1 morphants and mutants 82,83. Although 
clarin1 is described to be present in larval and adult eyes, no analysis of retinal function 
was performed 84. For USH2 genes no knock-out models have been generated and 
characterized yet. However, ush2a or adgrv1 (USH2c) morphants exhibit signs of early 
photoreceptor death 37,72,85. In contrast with USH1 and USH3 models 86-89, so far no 
vestibular defects were described for the USH2 models. Taken together, the observed 
photoreceptor defects in ush2a morphants and ush1 mutants suggest that the zebrafish 
could be a suitable model to study USH2A-associated RP (Chapter 4). 
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6. OUTLINE AND AIM OF THIS THESIS
The main purpose of the research in this thesis is to obtain a better understanding of 
the pathophysiology underlying USH2A-associated retinal degeneration, and to design, 
develop and evaluate therapeutic strategies for the future treatment of this condition. 
In chapter 2, the retinal function of ninein-like protein (NINL), a key interaction partner 
of usherinisoB is studied. With the use of proteomics, Double Zinc Ribbon and Ankyrin 
Repeat domains 1 (DZANK1) has been identified as a novel interaction partner of 
NINL (chapter 2A). Furthermore, we show that NINL and DZANK1 co-function in the 
cytoplasmic dynein1-mediated transport of Trans-Golgi network (TGN)-derived vesicles 
in zebrafish photoreceptor cells. In chapter 2B the physical and genetic interaction 
between CC2D2A and NINL is described. The association of NINL with both the 
cytoplasmic dynein 1-dynactin motor complex (chapter 2A) and MICAL3 supports 
a role for NINL in the initial transport of trans-Golgi network-derived RAB8A-MICAL3 
coated vesicles towards the base of the photoreceptor cilium, while the association of 
NINL with CC2D2A provides a docking point for these incoming vesicles at the entrance 
of the ciliary compartment (chapter 2B).  
To evaluate future therapeutic strategies that could potentially halt the progression of 
the devastating Usher syndrome, an animal model that mimics the human phenotype 
is needed. In chapter 3A we describe the generation and characterization of two ush2a 
knock-out zebrafish models. In contrast with Ush2a knock-out mouse models, the 
zebrafish models display an early-onset retinal phenotype. In addition, in chapter 3B 
we investigate the sensitivity of different behavioral assays to detect retinal dysfunction 
in zebrafish larvae. We have optimized the semi high-throughput visual motor response 
(VMR) assay and propose a new workflow to analyze visual performance in zebrafish 
larvae. 
Chapter 4 highlights our efforts in the development of therapeutic strategies for USH2A-
associated RP. For this purpose, we have generated two different Tol2-based transgenic 
zebrafish lines that express human miniUSH2A genes in the ush2armc1 background. We 
demonstrate that expression of either miniUSH2A gene results in significant rescue 
of the retinal phenotype observed in ush2armc1 larvae. Finally, chapter 5 provides the 
general discussion of this thesis, and implications for future research on this topic.  
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ABSTRACT
Ciliopathies are Mendelian disorders caused by dysfunction of cilia, ubiquitous 
organelles involved in fluid propulsion (motile cilia) or signal transduction (primary 
cilia). Retinal dystrophy is a common phenotypic characteristic of ciliopathies since 
photoreceptor outer segments are specialized primary cilia. These ciliary structures 
heavily rely on intracellular minus-end directed transport of cargo, mediated at least 
in part by the cytoplasmic dynein 1 motor complex, for their formation, maintenance 
and function. Ninein-like protein (NINL) is known to associate with this motor complex 
and is an important interaction partner of the ciliopathy-associated proteins lebercilin, 
USH2A and CC2D2A. Here, we scrutinize the function of NINL with combined proteomic 
and zebrafish in vivo approaches. We identify Double Zinc Ribbon and Ankyrin Repeat 
domains 1 (DZANK1) as a novel interaction partner of NINL and show that loss of Ninl, 
Dzank1 or both synergistically leads to dysmorphic photoreceptor outer segments, 
accumulation of trans-Golgi-derived vesicles and mislocalization of Rhodopsin and 
Ush2a in zebrafish. In addition, retrograde melanosome transport is severely impaired 
in zebrafish lacking Ninl or Dzank1. We further demonstrate that NINL and DZANK1 are 
essential for intracellular dynein-based transport by associating with complementary 
subunits of the cytoplasmic dynein 1 motor complex, thus shedding light on the 
structure and stoichiometry of this important motor complex. Altogether, our results 
support a model in which the NINL-DZANK1 protein module is involved in the proper 
assembly and folding of the cytoplasmic dynein 1 motor complex in photoreceptor 
cells, a process essential for outer segment formation and function. 
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1.  INTRODUCTION
Dysfunction of cilia is the underlying defect in a growing group of pleiotropic genetic 
disorders, the ciliopathies. Cilia are ubiquitous microtubule-based organelles involved 
in fluid propulsion (motile cilia) or signal transduction (primary cilia) and ciliopathy-
associated proteins localize to various ciliary sub-compartments. Retinal dystrophy is 
a common clinical feature of ciliopathies where the primary affected retinal cell type 
is the photoreceptor, which contains a highly specialized primary cilium, consisting 
of the connecting cilium and axoneme serving as a backbone to the outer segment. 
For propagation of visual excitation, outer segments are composed of stacks of 
membranous discs, which are densely packed with the light-sensitive transmembrane 
receptor rhodopsin and its associated photo-transduction machinery. The membranous 
discs are organized around the axoneme that is continuous with the connecting cilium. 
The entire outer segment can thus be regarded as a highly specialized primary cilia 
compartment. The connecting cilium literally connects the outer segment to the inner 
segment of the photoreceptor and is the equivalent of a canonical ciliary transition 
zone. This proximal region of the cilium ensures a tight control of protein access into 
the ciliary compartment [1–5] through a gate-keeper function, involving several 
ciliopathy-associated proteins such as NPHP’s [4] and Meckel and Joubert syndrome 
proteins [6], importins and Ran GTPases [7, 8]. Given the daily renewal of about 10% 
of the total length of the outer segments in humans [9], photoreceptor cells require 
intense intracellular trafficking to build their outer segments and to replenish the shed 
discs. Transmembrane proteins, such as rhodopsin and Usherin are synthesized in the 
inner segment and subsequently moved from the trans-Golgi network (TGN) towards 
the base of the ciliary compartment via microtubule-based vesicular transport [10]. 
This transport involves motor proteins such as the ATPases kinesin and dynein [11, 12]. 
Specifically, the cytoplasmic dynein 1 motor complex, which consists of two 530 kDa 
heavy chains, responsible for force production, a group of 74 kDa intermediate chains, 
53 to 57 kDa light intermediate chains, and 8 to 21 kDa light chains [13], has been 
implicated in minus-end directed transport of post-Golgi-derived rhodopsin-containing 
vesicles [14]. During its transport, the carboxy-terminal domain of rhodopsin binds 
to the dynein light chain Tctex-type DYNLT1 [14]. In the absence of rhodopsin, small 
rudimentary photoreceptor outer segments are formed during the first few postnatal 
weeks. After this period the outer segments vanish and photoreceptors die rapidly. As 
a consequence, photo-transduction is impaired leading to defects in visual function 
[15, 16]. A similar defect in photoreceptor morphology and function is observed in 
the zebrafish cannonball mutant, in which the cytoplasmic dynein motor complex 1 is 
dysfunctional due to a mutation in the dynein cytoplasmic 1 heavy chain 1 (dync1h1) 
gene [17]. These findings emphasize the importance of the cytoplasmic dynein motor 
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complex 1 for intracellular trafficking which is essential for photoreceptor development 
and function. However, the structure of this complex has not been fully elucidated to 
date. Previously, we described a retinal ciliopathy-associated protein module consisting 
of Usherin, Lebercilin (Leber’s congenital amaurosis type 5) and NINLisoB (ninein-like 
protein isoform B) present at the base of the connecting cilium [18]. In addition, we now 
identified a physical interaction between NINLisoB and the ciliopathy protein CC2D2A, 
involved in Joubert and Meckel syndrome, two important ciliopathies (Bachmann-
Gagescu, et al co-submission). Furthermore, NINL was found to associate with several 
members of the cytoplasmic dynein 1-dynactin motor complex and polo-like kinase 1 
and was found to function in microtubule nucleation by recruitment of gamma-tubulin 
ring complexes [19]. However, the function of NINL in photoreceptors is still elusive.
In the current study, we investigate the role of NINL and its associated protein complex 
in the retina using a combination of proteomics and in vivo studies in zebrafish. We 
identify a central role for NINL and its novel interaction partner DZANK1 in vesicle 
transport towards the photoreceptor outer segments. Knockdown in zebrafish larvae 
of either ninl or dzank1 or synergistically at sub-phenotypic doses, leads to abnormal 
outer segment morphology, mislocalization of rhodopsin, accumulation of vesicular 
structures and consequently, loss of visual function. We further demonstrate that NINL 
and DZANK1 associate with complementary subunits of the cytoplasmic dynein 1 motor 
complex, which is essential for proper transport of vesicle-bound proteins towards the 
base of the photoreceptor connecting cilium and, as a consequence, photoreceptor 
development in zebrafish. Together, our findings shed light onto the assembly and 
structure of the cytoplasmic dynein 1 motor complex and link it to several ciliopathy 
proteins located at the entrance to the ciliary compartment. 
2.  RESULTS
2.1  DZANK1 interacts with NINLisoB in the retina
Previously, NINLisoB was identified as a key connector of three large retinal ciliopathies 
[18] (Bachmann-Gagescu et al, co-submission). Its function within the retina, however, 
has not yet been deciphered. To get insight into the function of NINL, we screened 
a random-primed bovine retina cDNA library to identify interaction partners for 
the previously predicted intermediate filament (IF) domain (538-825aa) of NINLisoB 
[18]. Approximately 70% of the positive clones (> 1,000 clones), could be identified 
as DZANK1 (double zinc ribbon and ankyrin repeat domains 1), a protein with a yet 
unknown function. To elaborate on this finding, three overlapping cDNA fragments 
were cloned: one encoding full length DZANK1 (752aa) and two different deletion 
constructs, encoding either the zinc finger domains as found in Ran binding proteins 
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(ZNF_RBZ, SMART accession number SM00547, 244-317aa) or the ankyrin repeats 
known to be involved in protein-protein interactions (ANK, SMART accession number 
SM00248, 595-681aa) (SMART database; http://smart.embl-heidelberg.de) (Fig 1a). To 
test whether the interactions of DZANK1 with NINL are isoform-specific, both isoforms 
of NINL were tested. The transcript encoding NINLisoB lacks exon17 of the originally 
described NINL gene (encoding NINLisoA), resulting in the in-frame skipping of 349 
amino acids after residue 734 [18]. Using dedicated binary yeast two-hybrid assays, we 
were able to pinpoint the interaction to the ZNF_RBZ domains of DZANK1 and both 
isoforms of NINL (Fig 1b). Since NINLisoB was originally found in the yeast-two hybrid 
screen, we continued with this isoform for further confirmations. We performed several 
in vitro and in vivo binding assays to conclusively validate the interaction between 
DZANK1 and NINLisoB. In a glutathione S-transferase (GST) pull-down assay, we identified 
that full-length Strep/FLAG-tagged DZANK1 was pulled down from HEK293T cell 
lysates by GST-fused NINLisoB_538-825aa and not by GST alone (Fig 1c). To confirm this 
interaction in cellulo, HEK293T cells were co-transfected with plasmids encoding full 
length HA-tagged NINLisoB and Strep/FLAG-tagged DZANK1 for immunoprecipitation 
(IP) assays. With anti-HA antibodies, NINLisoB consistently co-immunoprecipitated 
with full length DZANK1, but not with the control protein LRRK2 (Fig 1d). Reciprocal 
IP experiments with anti-FLAG antibodies for IP confirmed these results (Fig 1d’). In 
addition we performed GST pull-down assays from biologically relevant bovine retinal 
extracts followed by mass spectrometry (LC-MS/MS) analysis. In total, 445 different 
proteins were identified of which 59 passed the stringent filtering criteria. GST-fused 
human NINLisoB_aa538-825 was able to consistently pull-down endogenous bovine 
DZANK1 (in 4 out of 4 assays) whereas unfused GST (in 0 out of 3 assays) was not, which 
further confirmed the interaction (S1 Table). Further confirmation of the interaction was 
obtained through co-localization of eGFP- and mRFP-tagged DZANK1 and NINLisoB in 
hTERT-RPE1 cells. In singly transfected cells, NINLisoB and DZANK1 were both present 
at the ciliary base, partially co-localizing with the basal body and the ciliary marker 
polyglutamylated tubulin (anti-GT335) (Fig 2a and 2b”). DZANK1 also localized along the 
microtubule network of the cells. Co-expression of NINLisoB and DZANK1 resulted in the 
co-localization of both proteins, thereby fully retaining the latter to the basal body (Fig 
2c”, yellow signal). Importantly, co-localization of endogenous NINL and DZANK1 was 
also observed by immunohistochemistry in rat retina where NINL was demonstrated 
at the region of the connecting cilium [18]. Using a specific anti-DZANK1 antibody we 
show that NINL and DZANK1 co-localize in this region (Fig 2d–2f’).
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Figure 1. Protein-protein interaction studies
(a) Schematic protein structure of DZANK1. Two different deletion constructs of DZANK1, one consisting 
of the ZNF_RBZ domains (244-317aa) and the other of the ANK domains (595-681aa), were used for co-
transformation in yeast. (b) Results of the cotransformation in yeast. Yeast transformants were selected on low 
(SD/-Trp/-Leu/-His) and high-stringency (SD/-Trp/-Leu/-His-/-Ade) medium with observed growth, indicating 
interaction of the tested bait and prey proteins. In addition, the β-galactosidase filter lift assay was performed. 
The USH2A_intracellular region was used as a positive control. Empty prey vector was used as a negative 
control. Yeast-two-hybrid analysis revealed a specific interaction between DZANK1 ZNF_RBZ domains and 
both NINLisoA/B. (c) GST pull-down assays, showing that Strep/FLAG-tagged DZANK1 was efficiently pulled 
down by GSTfused NINLisoB, but not by GST alone. The first lane shows 5% input of the protein lysate. (d) 
Co-immunoprecipitation of DZANK1 Full Length (FL) with NINLisoB, but not with LRRK2. The immunoblot (IB) 
in the top panel shows that HA-tagged NINL co-immunoprecipitated with Strep/FLAG-tagged DZANK1 (lane 
2), whereas unrelated FLAG-tagged LRRK2 (lane 3) did not. The anti-HA immunoprecipitates are shown in 
the middle panel; protein input is shown in the bottom panel. (d’) Reciprocal IP experiments using anti-FLAG 
antibodies confirmed the co-immunoprecipitation of HA-tagged NINLisoB with Strep/FLAGtagged DZANK1 
(lane 2) and not with LRRK2 (lane 3) shown in the top panel. The anti-FLAG immunoprecipitations are shown 
in the middle panel; protein input is shown in the bottom panel. ANK: ankyrin repeat domain; ZNF_RBZ: Zinc 
Finger domain like in Ran-binding proteins; aa: amino acids.
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Figure 2. NINL and DZANK1 co-localize at the base of cilia in RPE cells and rat retina. 
(a-c) Centrosomal co-localization of NINLisoB and DZANK1 in hTERT-RPE1 cells. When expressed alone, mRFP-
NINLisoB (red signal in, a-a” and c-c”) was localized to both centrioles at the base of the cilia marked with 
GT335 (green signal in a’-a” and red signal in b-b”), whereas eYFP–DZANK1 was localized to the basal body and 
to the microtubule network of the cell (green signal in b-b”). After co-expression of NINLisoB and DZANK1, 
both proteins were localized at the basal body of the cilia in the centrosome (cilia marked by GT335, cyanid 
signal), supporting an interaction between the two proteins (c-c”). Nuclei were stained with DAPI (blue signal). 
(d-f ) Co-localization of endogenous NINLisoB and DZANK1 in rat retina. (d-e) Co-immunostaining of NINL 
and DZANK1 in radial cryo-sections of adult (P20) rat retina with anti-NINL antibodies (green signal; d) and 
antiDZANK1 antibodies (red signal; e) showing co-localization (yellow signal: f ) in the inner segment (IS) and 
in the region of the connecting cilium (CC). (d’-f’) show details of the subcellular (co-) localization of NINL and 
DZANK1 in, respectively, d, e and f. Scale bars represent 10 μm (a-c”), 5 μm (f ) and 1 μm (f’).
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2.2  Ninl and dzank1 genetically interact in photoreceptor outer segment 
morphogenesis and function
To investigate the biological role of NINL and DZANK1 in the retina, we first addressed 
the suitability of zebrafish as an animal model. tBLASTn searches of the zebrafish 
genome, using the amino acid sequence of human NINL and DZANK1, revealed a single 
ortholog for both genes. Although extensive RT-PCR analyses were performed, we were 
not able to detect the transcript encoding zebrafish Ninl isoform A in RNA obtained 
from zebrafish larvae (5 days post fertilization (dpf )). Therefore we conclude that under 
the given conditions the  ninl  transcript that shows the highest degree of homology 
with the human NINLisoB  encoding transcript is the most prominent. The presence of 
shorter or alternative transcripts encoding additional zebrafish Ninl isoforms cannot 
be ruled out, as no 5’- and 3’-RACE experiments were performed. Subsequently, the 
effect of  ninl  and  dzank1  knockdown during zebrafish embryonic development was 
investigated, using gene-specific translation-blocking (atgMOs) and splice-blocking 
morpholinos (spMOs).
Control MO-injected larvae (10 ng/nl; n = 300 from 2 biological replicates) appeared 
morphologically normal, and could not be distinguished from uninjected larvae (WT) 
during the studied developmental period of 4 to 5 dpf (Fig 3a and 3d). In contrast, 
injection of ninl atgMO revealed a concentration-dependent spectrum of phenotypes 
(n>200/group from 2 biological replicates; Bachmann-Gagescu  et al., companion 
manuscript). Injection of the optimal concentration of 2 ng/nl ninl atgMO resulted in 
severe morphological defects including ventrally curved body axis, ventriculomegaly, 
pronephric cysts, expanded melanophores, small eyes and circling swimming behavior 
at 4 dpf (n = 300 from 2 biological replicates;  Fig 3b  and Bachmann-Gagescu  et al., 
companion manuscript). In addition, we observed significantly shorter photoreceptor 
outer segments (OS) on retinal cryosections from 4dpf ninl morphant larvae stained with 
boron-dipyrromethene (bodipy) to mark the outer segment membrane discs (mean OS 
length 1.6+/-0.26 μm in morphants compared to 3.9+/-0.32 μm in wild-type, p<0.0001, 
unpaired Student’s t-test, n>10 larvae from each group in each of 2 biological replicates) 
(Bachmann-Gagescu et al, companion manuscript). Co-injection of 150 pg/nl capped 
MO-resistant mRNA encoding human NINLisoB with 2 ng/nl of ninl atgMO rescued the 
observed body curvature phenotype (curved body shape in 71% of ninl atgMO injected 
larvae (n = 207) versus 36% in ninl atgMO + ninl mRNA injected larvae (n = 203), data 
pooled from 2 biological replicates, p<0.0001, two-tailed Fisher’s exact test) and the 
OS length (mean OS length in rescued larvae 3.8+/-0.25 μm, p<0.0001, Student’s t-test, 
n = 10 larvae) (Bachmann-Gagescu et al, co-submission). In addition, the specificity of 
the observed phenotypes is further confirmed by the fact that a second morpholino 
against ninl targeting the splice site at the intron14/exon15 junction causing aberrant 
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splicing led to similar phenotypes, including ventriculomegaly, expanded melanophores 
(4 ng/nl, n = 200) and shortened photoreceptor outer segments as compared to control 
MO-injected larvae. Finally, using an anti-ninl  antibody, we observed substantial 
decrease of Ninl protein on Western blots and on immuno-histochemistry of retinal 
cryosections for the ninl atgMO-injected larvae and milder decrease in both assays for 
the ninl ex15 spMO-injected larvae (Bachmann-Gagescu et al, companion manuscript).
Injection of increasing amounts of a splice-blocking morpholino targeting dzank1 exon8 
resulted in small eyes and severe pericardial edema at 4 dpf (S1a Fig, Fig 3c). In 
addition, dzank1 morphants showed impaired ambulatory activity as predicted before 
[20]. Based on the incidence of the observed phenotypes and non-quantitative RT-PCR 
analysis on RNA from morphant larvae (harvested at 2 and 4dpf; S1a and S1g Fig.) we 
determined that the optimal dose of the dzank1 ex8 spMO was 6 ng/nl. Co-injection of 
150 pg/nl capped MO-resistant mRNA encoding human DZANK1 with 6 ng/nl dzank1 ex8 
spMO rescued the observed ambulatory activity phenotype (n = 105, 2 biological 
replicates;  S1b and S1e Fig). This observed ambulatory activity phenotype could be 
fully recapitulated by a second splice blocking morpholino targeting dzank1 exon4 (6 
ng/nl, n = 162 out of 200 injected larvae from 2 biological replicates; S2 Fig), further 
indicating the specificity of the used morpholino. Subsequently, we evaluated the 
retinal morphology of  dzank1  ex8 spMO-treated larvae (4 dpf; n = 40). While retinal 
lamination was unaffected, significantly shortened photoreceptor outer segments 
(OS) were observed as compared to controls, as highlighted by boron-dipyrromethene 
(bodipy) staining of membranes (Fig 3a’-3c’ and 3h) (mean OS length 2.1+/-0.39 
μm in morphants compared to 4.9+/-0.27 μm in wild-type, p<0.0001, unpaired 
Student’s  t-test, n> 10 larvae from each group in each of 2 biological replicates). The 
observed photoreceptor outer segment defects fully coincided with the ambulatory 
activity defects observed in dzank1 ex8 spMO-treated larvae and could be rescued as 
well (mean OS length in rescued larvae 3.0+/-0.36 μm as compared to 1.9+/-0.25 μm 
in dzank1 morphants (P = 0.01, unpaired Student’s t-test, n = 13 larvae each group) and 
3.5+/-0.25 μm in uninjected larvae (P = 0.3 (NS), unpaired Student’s t-test, n = 12 larvae) 
(S1 Fig). These phenotypes could also be recapitulated by a second splice blocking MO 
targeting ninl ex15 or dzank1 ex4 (Bachmann-Gagescu et al., companion manuscript; S2 
Fig). These observations are indicative for an essential role of both Ninl and Dzank1 in 
OS formation and/or maintenance.
To investigate whether there is a functional relationship between Ninl and Dzank1 in 
this process, sub-effective doses of dzank1 ex8 spMO (1 ng/nl) and ninl atgMO (0.5 ng/
nl) were co-injected. While single injections with these sub-phenotypic amounts of MOs 
caused no discernible phenotypes (no body curvature defects or abnormal swimming 
behavior for ninl atgMO-injected larvae or no defects in ambulatory activity in dzank1 
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Figure 3. Morphological, functional and epistatic effects of ninl and dzank1 knockdown in 
zebrafish retina. 
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(a-c) Images of 4 dpf living zebrafish. Un-injected controls (WT) appear morphologically normal (a), while 
embryos injected with 2 ng of ninl atgMO display morphological defects, including ventrally curved body 
axis and small eyes (b). Embryos injected with 6 ng dzank1 ex8 spMO resulted in expanded melanophores, 
small eyes and severe pericardial edema (c) (a’-c’) Retinal histology of 4 dpf zebrafish morphants examined 
by cryosections, where bodipy highlights the OS (red) and nuclei are stained with DAPI (blue) in all panels. 
Outer segments were shortened and dysmorphic in ninl and dzank1 morphants compared to wildtype larvae. 
(d-g) Ninl interacts genetically with dzank1. Injection of sub-effective dzank1 (1 ng/nl) MO (e’) or ninl (0.5 ng/ 
nl) MO (f’) shows normal OS shape and length in morphologically normal appearing larvae, which could not 
be distinguished from un-injected embryos (WT) or control MO-injected larvae (d’). Combined injection of 
sub-effective concentrations of ninl (0.5 ng/nl) and dzank1 (1 ng/nl) MO together results in almost complete 
absence of OS (g’). (h) Quantification of Outer Segment length, shown as a scatter graph where each datapoint 
represents the mean OS length in one larva, revealed a significantly decreased length of outer segments in 
ninl (2ng/nl), dzank1 (6ng/nl) and ninl/dzank1 double morphants as compared to controls. Bars represent 
the mean value for each treatment group with the Standard error of the mean (SEM) ***P< 0.0001, ** P< 
0.001, unpaired Student’s t-test. (i) Analysis of the Opto Kinetic Response (OKR) showing severely decreased 
responses in larvae injected with 2 ng ninl atgMO or 6 ng dzank1 ex8 spMO (*** p< 0.0001, Student’s t-test). 
Scale bars represent 500 μm (a-c and e-h) and 15 μm (a’-c’ and e’-h’). RPE, retinal pigment epithelium; OS, 
Outer Segment; IS, Inner Segment; ONL, Outer Nuclear Layer; OPL, Outer Plexiform Layer.
ex8 spMO-injected larvae) (n = 200/group, 2 biological replicates;  Fig 3e and 3f )), co-
injection of both MOs resulted in a severely enhanced phenotype including defects in 
swimming behavior, small eyes and curved tails (Fig 3d–3g). Furthermore, photoreceptor 
outer segment length measurements on transverse sections of bodipy-stained retina 
demonstrated significantly impaired OS formation in double morphants (ninl atgMO 0.5 
ng/nl + dzank1 ex8 spMO 1ng/nl; mean OS length 1.6+/-0.3 μm, n = 6), as compared to 
low dose single  ninl  atgMO-injected (0.5 ng/nl;mean OS length 4.3+/-0.66 μm, n = 6) 
and dzank1 ex8 spMO-injected larvae (1ng/nl; mean OS length 5.2+/-0.76 μm, n = 5), 
and as to control MO-injected (mean OS length 4.2+/-0.26 μm, n = 10) and uninjected 
(WT) larvae (mean OS length 4.8+/-0.28 μm, n = 9) (Fig 3a’, 3d’, 3e’, 3f’, 3g’ and 3h; P<0.001, 
unpaired Student’s t-test for pairwise comparison between double morphants and each 
low dose single morphant). These retinal defects in double morphants were similar to 
those quantified in larvae injected with the optimal doses of  dzank1  spMO (6 ng/nl; 
2.1+/-0.39 μm, n = 10; Fig 3c’ and 3h) or ninl atgMO (2 ng/nl; 1.6+/-0.26 μm, n = 8; Fig 3b’ 
and 3h) alone. The functional impact of these morphological changes in the morphant 
retinas was confirmed by measurements of the optokinetic response (OKR) [21,  22], 
which tests the ability of zebrafish larvae to visually track rotating stripes [23]. At 4 
dpf, ninl and dzank1 morphant larvae displayed a grossly impaired OKR response (0–2 
saccades per minute), in contrast to the normal OKR response (5–15 saccades per minute) 
of control morphants and un-injected larvae from the same clutch (mean number of 
saccades per minute = 10.3 +/- 0.7 in uninjected wild-type, 10.1 +/- 0.6 in control oligo 
injected, 0.5 +/- 0.2 in dzank1 morphant and 0.9 +/- 0.2 in ninl morphant larvae, n = 
9/group; P<0.0001 for pairwise comparisons wildtype/control oligo vs each morphant, 
unpaired Student’s t-test) (Fig 3h). Since spontaneous eye movements in the absence of a 
stimulus were occasionally registered in all MO-injected larvae, the loss of OKR response 
is not due to a defect in ocular muscular contraction, but to impaired visual function.
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Figure 4. dzank1 and ninl knockdown leads to accumulation of vesicles and vacuoles in zebrafish 
photoreceptors.
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Transmission electron microscopy of control (a), ninl knockdown larvae (b,d) and dzank1 knockdown larvae 
(c,e). Ninl and dzank1 morphants (b-e) demonstrate absent or shortened and dysmorphic outer segments (OS), 
whereas connecting cilia (CC) are still intact (arrowheads in b-c,h), and accumulation of vesicular structures 
(v), highlighted in the boxed area in e (e’). Sub-effective concentration of ninl (f ) and dzank1 (g) MO-injection 
leads to a normal phenotype compared to control MO-injected larvae (a) and uninjected controls. Injection of 
combined sub-effective concentrations of dzank1 and ninl (h) MO leads to increased vesicle accumulation in 
OS (h’) and inner segment (h”). (i) Analysis of the presence of vesicles in inner segments of photoreceptor of 
cells (%). On the Y—axis the different classes are indicated (minimum of 6 eyes per group). (* P<0.01 and *** 
P<0.001 Student’s t-test). Larvae in all panels are 4 dpf. Scale bars represent 0.5 μm. OS: outer segment, CC: 
connecting cilium, m: mitochondria, n: nucleus, v: vesicular structures, G: Golgi system, L: lysosome.
2.3 Knockdown of  ninl  and  dzank1  leads to vesicle accumulation in 
photoreceptor cells
To obtain a more detailed insight into the role of Ninl and Dzank1 in OS morphogenesis, 
the retinal ultra-structure of  ninl,  dzank1  morphants and control larvae was studied 
by transmission electron microscopy (TEM) (for numbers see S5 Table). In control MO-
injected embryos (4 dpf ), the photoreceptor inner segments (IS) displayed compact 
ellipsoid regions with clustered mitochondria, a narrow myoid with a Golgi apparatus, 
while OS presented well-organized, nicely stacked disc structures (Fig 4a), as described 
for wild-type uninjected larvae [17, 24]. In contrast, in both ninl and dzank1 morphants, 
IS malformations were found including swollen Golgi complexes with enlarged 
and distended cisternae, accumulation of vesicle-like structures throughout the IS, 
large vacuoles and dispersed mitochondria. Occasionally, lysosomal structures were 
observed (Fig 4e’). OS were either absent, or disrupted. Ultra-structural characteristics 
of deviant OS were hampered elongation, accumulation of vesicles, polarization defects 
and deformed discs (Fig 4d and 4e’). Statistical analyses of these defects were based on 
quantification of the proportion of photoreceptor cells presenting with vesiculated inner 
segments in the different experimental groups (Fig 4i). No significant difference could 
be demonstrated between vesiculation in IS of larvae injected with sub-phenotypic 
doses of dzank1 (1 ng/nl) or ninl (0.5 ng/nl) MO (Fig 4f and 4g) as compared to control 
MO-injected (10 ng/nl) or wildtype (WT) zebrafish larvae. The percentage of IS in 
photoreceptors with vesicular structures and/or swollen Golgi complexes in dzank1 (6 
ng/nl MO), ninl (2 ng/nl MO) as well as combined (dzank1 1 ng/nl and ninl 0.5 ng/nl) 
MO-injected zebrafish groups was significantly increased compared to WT and control 
MO-injected larvae (P<0.01, Student’s  t-test). The most significant vesicular increase 
was observed in the combined MO-injected (dzank1 and ninl) group (Fig 4h and 4h”) 
(P<0.001, Student’s t-test).
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2.4  NINL and DZANK1 associate specifically with complementary 
subunits of the cytoplasmic dynein 1 motor complex
Mass spectrometry (MS)-based quantitative proteomics was employed to gain further 
insights into the molecular basis of the defects observed in ninl and dzank1 morphants. 
N-terminally fused Strep/FLAG-tagged NINLisoA/B  and DZANK1 together with their 
associated, native protein complexes were tandem-affinity-purified from HEK293T cells 
and the complex components identified by liquid chromatography coupled to tandem 
mass spectrometry (LC-MS/MS). Besides six actin-binding proteins (ARP1, ARP1B, 
ARP10, CAPZA1, CAPZA2 and CAPZB) and three subunits of Ca2+/calmodulin-dependent 
protein kinase II (CaMKII) (CAMK2A, CAMK2D, and CAMK2G), the NINL-associated 
interactome contained multiple subunits of the cytoplasmic dynein 1-dynactin motor 
complex (DYNC1H1, DYNC1LI1, DYNC1LI2, DYNCI2, DYNLRB1, DCTN1-4, and DCTN6), 
which is involved in minus end–directed, microtubule-associated transport (Fig 
5a, S2 Table). These results were confirmed by the GST pull-down from bovine retinal 
extracts in which DZANK1, several subunits of the cytoplasmic dynein 1-dynactin 
motor complex (DYNC1H1, DYNC1LI1, DCTN1, DCTN2 and DCTN4) and five dynactin-
associated actin-binding proteins (ARP1B, ARP10, CAPZA1, CAPZA2 and CAPZB) were 
found to associate with GST-fused NINLisoB_aa538-825 (S1 Table). We thus confirmed 
the previously described association of NINL with several subunits of the cytoplasmic 
dynein 1-dynactin motor complex [19]. Intriguingly, the DZANK1-associated protein 
complex exclusively contained the two cytoplasmic dynein 1 light chains, DYNLL1 and 
DYNLL2, which were absent from the NINL interactome. We confirmed the identified 
interaction between DZANK1 with DYNLL1 and DYNLL2 by reciprocal co-IP experiments 
in HEK293T cells. In addition, co-expression of mRFP-tagged DYNLL1 or DYNLL2 with 
eCFP-tagged DZANK1 in ciliated hTERT-RPE1 cells resulted in recruitment of the latter 
to the basal body and accessory centriole (S3 and S4 Figs). These results suggest that 
the cytoplasmic dynein 1 motor complex is composed of at least two sub-complexes: 
one DZANK1-associated sub-complex containing DYNLL1 and DYNLL2, and another 
NINL-associated sub-complex containing at least DYNC1H1, DYNC1LI1, DYNC1LI2, 
DYNCI2 and DYNLRB1. In order to better understand the orchestration and dynamics 
of the NINL-associated motor complex, we performed an elution profile analysis of 
SDS-induced sub-complexes by quantitative mass spectrometry (EPASIS) [25]. SF-TAP-
tagged NINLisoA/isoB was over-expressed in HEK293T cells and affinity-purified using the 
FLAG moiety of the fusion tag. The native protein complex was sequentially treated with 
increasing SDS-concentrations to destabilize the interactions and thereby induce the 
elution of sub-complexes. Besides the dynactin submodule, which showed the most 
stable association with the NINL complex (S5c Fig; complete elution at ≥ 0.005% SDS) a 
second sub-module consisting of proteins from the cytoplasmic dynein 1 motor complex 
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[26] was identified (S5c Fig c; elution between 0.001 and 0.01% SDS). This dynein sub-
module may dissociate in two additional sub-modules but this finding lacked statistical 
significance (S5–S8 Figs, S3 and S4 Tables). In addition, CLIP1 (= CLIP-170), PAFAH1B1 (= 
LIS1), ACAD11 and MRPS27 co-eluted with the dynein module, making them potentially 
novel candidate components of the dynein 1 motor complex.
2.5  Zebrafish Ninl and Dzank1 are required for intracellular dynein-
based transport
Dynein 1 heavy chain 1  (dync1h1), encoding a subunit of the cytoplasmic dynein 1 
motor complex which mediates minus-end-directed post-Golgi vesicle trafficking 
towards the basal body, is mutated in the zebrafish cannonball mutant [17]. Similar to 
our findings in ninl and dzank1 morphants, cannonball mutants form short rudimentary 
photoreceptor OS, show organelle positioning defects and display a severe accumulation 
of vesicles in the photoreceptor IS and OS and this phenotype could be recapitulated by 
a translation blocking morpholino against dync1h1 [17]. Sub-effective concentrations of 
this previously published dync1h1 MO (1 ng/nl) [17] in combination with the ninl atgMO 
(0.5 ng/nl) were co-injected and compared to single injected morphants, control MO-
injected larvae and uninjected controls (n = 300/group from 2 biological replicates). 
At 4 dpf, quantification of OS lengths in each group was performed on bodipy-stained 
cryosections and revealed significantly shortened OS in larvae in the dync1h1 (3 ng/nl; 
mean OS length 1.95+/-0.4 μm, n = 5; Fig 5d’, 5d” and 5h) and dync1h1/ninl morphant 
groups (1ng/nl + 0.5 ng/nl; mean OS length 1.413+/-0.2 μm, n = 13; Fig 5g’, 5g” and 5h) as 
compared to uninjected controls (mean OS length 4.8+/-0.27 μm, n = 9; Fig 5b’, 5b” and 5h), 
control MO-injected (10 ng/nl; mean OS length 4.2+/-0.26 μm, n = 10; Fig 5c’, 5c” and 5h) 
and to both low-dose single dync1h1 MO-injected (1 ng/nl; mean OS length 3.6+/-0.44 
μm, n = 13; Fig 5f’, 5f” and 5h) and ninl atgMO-injected (0.5 ng/nl; mean OS length 4.3+/-
0.66 μm, n = 6; Fig 5e’, 5e” and 5h) groups (P<0.001; two tailed, unpaired Student’s t-test 
on pairwise comparisons between double morphants and each of the single low-
dose morphants), demonstrating a genetic interaction between ninl and dync1h1 and 
supporting a role for Ninl in cytoplasmic dynein 1-driven intracellular vesicle transport. 
In addition, localization of rhodopsin, which should be restricted to the OS, was 
aberrantly observed in the photoreceptor cell body in both ninl and dzank1 morphants 
(S9 Fig and Bachmann-Gagescu et al. co-submission.). The observed mislocalization of 
rhodopsin in these morphants could be explained by defects in intracellular transport. 
However it could also be the result of defects in OS development and a consequence of 
the absence of this structure. Although the OS of ninl morphants are severely affected, 
the connecting cilium of photoreceptor cells in  ninl,  dzank1  and  ninl-dzank1  double 
morphants was found to be intact (arrow heads in  Fig 4b, 4c and 4h), providing the 
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Figure 5. NINL and DZANK1 associate specifically with complementary subunits of the cytoplasmic 
dynein 1 motor complex. 
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(a) Strep-SILAC and TAP experiments show that DZANK1 interacts specifically with DYNLL1 and DYNLL2 
(yellow). NINL associates with components of the dynactin complex (red) and with most components of the 
dynein 1 motor complex (blue), except for DYNLL1 and DYNLL2. The solid line between NINL and DZANK1 
symbolizes a direct interaction, whereas the dashed lines stand for interactions determined by immune 
and affinity purifications. (b-g”) Genetic interaction between ninl and dync1h1. MO-injection with a high 
concentration of dync1h1 (3 ng/nl) shows larvae with pericardial edema, small eyes and short OS (d-d”). MO-
injection of sub-effective concentrations of ninl (0.5 ng/nl) (e-e”) or dync1h1 (1 ng/nl) (f-f”) generates larvae 
with a normal phenotype and normal OS length, compared to wildtype larvae (b-b”) and control MO-injected 
larvae (c-c”). The combination of sub-effective MO concentrations of ninl (0.5 ng/nl) and dync1h1 (1 ng/nl) 
results in short larvae and virtual absence of outer segments (g-g”). All larvae are 4 dpf. Panels b’-d” and e’-g” 
are retinal cryo-sections stained with bodipy (red) to highlight the outer segments and DAPI to stain the nuclei. 
(h) Quantification of photoreceptor outer segment length revealed a significantly decreased length of outer 
segments in dync1h1 (3ng/nl) and dync1h1/ninl double morphants as compared to controls (*** P< 0.0001; 
two-tailed, unpaired Student’s t-test). Scale bars represent 500 μm (b-g), 50 μm (b’- g’) and 15 μm (b”-g”).
opportunity to test the localization of proteins to this ciliary compartment regardless of 
the presence of an outer segment. USH2A, a previously published interaction partner 
of NINL, is a transmembrane protein that is synthesized in the IS and subsequently 
transported in TGN-derived vesicles towards the base of the connecting cilium. USH2A 
was previously shown to localize in the peri-ciliary region, which should be independent 
of the presence of the OS [27]. Therefore, a defect in USH2A localization would likely 
be due to impaired post-Golgi dynein-based trafficking. Using a zebrafish-specific anti-
Ush2a antibody, we observed a strongly reduced immunofluorescent signal in  ninl 
and dzank1 morphants (4 dpf ), as compared to control MO-injected larvae (4 dpf ) (Fig 
6a’–6d’). The localization of centrin, which was used as a marker for the connecting 
cilium, was unaffected in both controls and morphants (Fig 6a”’–6d”’). Together, these 
data indicate a defect in the transport of vesicle-bound transmembrane proteins 
in ninl and dzank1 morphants.
To determine whether Ninl and/or Dzank1 are required for other dynein-based 
intracellular transport processes, we monitored dynein 1-mediated melanosome 
transport in zebrafish skin. Zebrafish alter their skin pigmentation by trafficking 
melanosomes within melanophores. The melanosome, a lysosome-related organelle, 
can be shuttled bi-directionally between the cell periphery and the peri-nuclear region 
by two microtubule-based molecular motors, kinesin ll (anterograde) and dynein 1 
(retrograde). Pigment aggregation (retrograde transport) can be stimulated within 
minutes upon treatment with epinephrine [28]. In the melanosome transport assay, 
5 dpf larvae are dark-adapted to display maximum melanophore dispersion (Fig 7a). 
After addition of epinephrine, the melanosomes rapidly contract and can be visually 
evaluated for reduction in pigment dispersion (Fig 7a’–7a”). The endpoint is apparent 
when pigmentation pattern reflects peri-nuclear accumulation of melanosomes (Fig 
7a’). A rapid melanosome contraction was seen in control MO-injected and un-injected 
larvae (Fig 7a–a” and 7d) (ΔT = 1.55 min and ΔT = 1.30 min respectively; n = 20/group), 
whereas  ninl  and  dzank1  morphants demonstrated significantly delayed dynein 
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1-mediated melanosome retraction (ΔT = 15.42 min and ΔT = 23.62, n = 20; P<0.001; 
Student’s t-test (two tailed, unpaired), Fig 7b–7c”’ and 7d), which is indicative for impaired 
dynein 1-mediated retrograde transport. Taken together, our findings suggest that the 
Ninl-Dzank1-cytoplasmic Dynein 1 complex is required for the intracellular transport 
of organelles and vesicles, and is essential for the photoreceptor’s OS formation, 
maintenance and function.
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Figure 6. Impaired Ush2a transport in dzank1 and ninl morphants. 
(a-d) Overview of Ninl and Ush2a localization in cryo-sections of 4 dpf zebrafish retina using anti-Ninl (red 
signal), anti-Ush2a (green signal) and the basal body marker anti-Centrin (cyanid signal). In all images the 
nuclei are counterstained with DAPI (blue signal). (a-a”“‘) Un-injected wildtype, (b-b”“‘) 10 ng/nl control MO-
injected, (c-c”“‘) 2 ng/nl ninl MO-injected and (d-d”“‘) 6 ng/nl dzank1 MO-injected zebrafish retinas. (a’-d’) Anti-
Ush2a staining (green signal) is strongly reduced in dzank1 and ninl morphants (c’-d’), while Ush2a is clearly 
present in wildtype and control MO-injected larvae. (a”-d”). Specific Ninl-immunofluorescence (red signal) was 
largely abolished in ninl morphants and reduced in dzank1 morphants. (a”‘-d”‘) Centrin (cyanide signal) was 
observed in wildtype, un-injected control and in both ninl and dzank1 morphants. (a”“-d”“) Co-localization 
of Ush2a and Ninl (yellow signal) was observed in wildtype and control MO-injected larvae. (a”“‘-d”“‘) Co-
localization of Ush2a and Centrin (yellow signal) was seen in all images (WT, Control Oligo, ninl and dzank1 
morphants), despite strong reduction of Ush2a immunofluorescence in ninl and dzank1 morphants. Scale 
bars represent 15 μm, except for (a-d) in which the scale bars represent 50 μm.
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Figure 7. ninl and dzank1 knockdown results in epinephrine-induced melanosome retraction 
delay. 
Control MO-injected larvae (10 ng/nl; n = 20) at 5 dpf (a-a”‘), ninl morphant (2 ng/nl; n = 20) (b-b”‘) and 
dzank1 morphant (6 ng/nl; n = 20) (c-c”‘). White Box denotes the area at higher magnification (40x) (a’-c”). 
(a-c’) Melanosome pattern of the different larvae before treatment, (a”-c”), 5 min after epinephrine addition 
and (a”‘- c”‘) 20 min after epinephrine addition, t represents time in minutes. (d) Graphical representation 
with error bars (standard deviation) demonstrating a significant delay of epinephrine-induced melanosome 
retrograde trafficking compared with wild-type and control MO-injected (10 ng/nl) larvae. Treatment (control, 
ninl- or dzank1-morphants) is noted on the x-axis and average response time in minutes is noted on the Y-axis. 
***: P<0.001 (two-tailed, unpaired Student’s t-test).
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3.  DISCUSSION
In this study, a central role for NINL and its novel interaction partner DZANK1 is identified 
in vesicle transport in photoreceptor cells. We demonstrate that NINL and DZANK1 
associate with complementary subunits of the cytoplasmic dynein 1 motor complex 
and that this complex consists of at least two submodules. In photoreceptor cells, this 
motor complex has been implicated in post-Golgi vesicle trafficking and organelle 
positioning [14, 17]. In line with this function, in vivo studies in the zebrafish demonstrate 
defects in post-Golgi trafficking as revealed by delayed cytoplasmic dynein 1-regulated 
melanosome transport, defective photoreceptor outer segment formation, abnormal 
vesicle accumulation within the photoreceptor inner segments and mislocalization of 
rhodopsin and Ush2a in both ninl and dzank1 morphants. 
Cytoplasmic dynein 1 is fundamentally important for embryonic development. Dynein 
1 heavy chains are essential for the formation of the motor complex and their absence 
leads to very early embryonic lethality in mice before E8.5 [29]. In contrast, larvae of 
the zebrafish cannonball (cnb) mutant lacking Dync1h1 undergo relatively normal early 
development and remain indistinguishable from wild-type siblings until approximately 
3.5 dpf. This remarkable difference between mouse and zebrafish mutants may be 
explained by the presence of wild-type maternally-derived (yolk-associated) mRNA in 
zebrafish embryos [30]. Cnb larvae eventually show a reduced eye size, present with small 
rudimentary photoreceptor outer segments and expanded skin melanophores, show 
severe organelle positioning defects and die between 6 and 8 dpf [17]. The phenotype 
of zebrafish depleted for Ninl is remarkably similar to that of the cnb mutant, with small 
eyes, mispositioned organelles, retinal dystrophy, and expanded melanophores. These 
overlapping phenotypic characteristics in combination with the observed genetic 
interaction in the retina between  ninl  and  dync1h1  suggest that the  ninl  morphant 
phenotype is caused by dysfunctional cytoplasmic dynein 1-mediated transport.
Mice lacking Dync1li1, a light-intermediate chain subunit of dynein 1, which is structurally 
less important than heavy chains, survive into adulthood [31]. Their photoreceptors do, 
however, lack outer segments due to blocked transport of TGN-derived vesicles towards 
the basal body. In contrast to the  ninl  morphants,  dzank1  morphants show a much 
milder phenotype and do not present curved bodies or major early developmental 
defects. DZANK1 associates specifically with two structurally less important dynein 
1 light chains, which might explain the less severe phenotype of  dzank1  morphant 
zebrafish larvae. Nonetheless, photoreceptor cells of both ninl and dzank1 morphant 
zebrafish larvae display severely shortened outer segments, disruption of mitochondria 
organisation and accumulation of vesicles within the inner segments. Given that 
photoreceptors have extremely high transport requirements due to the significant daily 
renewal of their outer segments, they are predicted to be more sensitive to defects in 
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intracellular transport, which could explain why loss of dzank1 results predominantly in 
a photoreceptor phenotype.
The physical position and role of NINL and DZANK1 in the cytoplasmic dynein 1 
motor complex remains unknown. Up to now, tandem affinity purification assays from 
HEK293T cells using different subunits of this motor complex as bait never identified 
peptides of NINL or DZANK1 (S2 Table). The most likely explanation for this is that NINL 
and DZANK1 are not expressed in these cells or are expressed only at very low levels. 
To get the first insights into the dynamics and orchestration of the NINL-associated 
dynein 1 motor complex, we performed an elution profile analysis of SDS-induced 
sub-complexes by quantitative mass spectrometry (EPASIS). Despite the fact that the 
dynein module shows a tendency of being built up of two distinct sub-modules, the 
statistical significance is lacking. CLIP1 (= CLIP-170), PAFAH1B1 (= LIS1), ACAD11 and 
MRPS27 co-eluted with the dynein module, making them potentially novel candidate 
components of the dynein 1 motor complex. LIS1 was previously found to interact 
with cytoplasmic dynein 1-dynactin [32] and CLIP1 [33] in order to keep dynein in a 
persistent microtubule-bound state [34]. The role of ACAD11 and MRPS27 in dynein 1 
function or dynamics needs to be determined. The dynactin complex was identified as a 
distinct sub-complex which was most strongly associated with NINL in the EPASIS essay. 
The lack of clear OS defects in zebrafish mok/dctn1a and dctn1b mutants [17, 35, 36] 
however, implies that dynein 1 functions independently of dynactin in outer segment 
morphogenesis. Indeed it was reported that the binding of dynactin1 to dynein 1 is 
non-essential for the ability of dynein 1 to bind stably to rhodopsin transport vesicles in 
vitro  [14]. Therefore it can be concluded that the ocular phenotypes observed in 
the ninl morphant are most likely caused by a non-functional dynein 1 complex rather 
than dysfunction of the dynactin complex. 
We previously described the association of NINLisoB with USH2A [18], a protein known to 
be essential for photoreceptor homeostasis in mice [27, 37]. The retinal defects observed 
in ninl morphants are more severe than those observed in the Ush2a knockout mouse 
model, which displays intact outer segments and late-onset mild photoreceptor 
degeneration [27]. This comparison suggests a transport function for NINLisoB upstream 
of USH2A towards the apical inner segment. The absence of Ush2a at the photoreceptor 
periciliary region of ninl morphants is in line with this hypothesis.
DZANK1 protein sequence analysis predicted the presence of two ZNF_RBZ domains 
and their interaction with RanGDP rather than their involvement in transcription. 
Ran is an abundant Ras-like GTPase, which plays a role in multiple cellular processes, 
including modulation of nucleo-cytoplasmic transport of macromolecules larger than 
~40 kDa across the nuclear envelope [38]. Further, it has been proposed that a similar 
complex, consisting of Ran, Ran-binding proteins and importins/exportins plays a role 
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in regulating import of cargo at the base of the cilium [39] and that RanBP2 is involved 
in processing or transport of opsin [40]. Since the ZNF domains of DZANK1 are highly 
homologous to the functional domains of RanBP2, DZANK1 might be involved in 
transport of opsin as well. The observed mislocalization of rhodopsin in photoreceptor 
cells of  dzank1  morphant zebrafish larvae is in line with this. Moreover, a role for 
DZANK1 in opsin transport and subsequent ciliary entry creates an attractive functional 
connection between DZANK1 and the Usher protein network, members of which have 
been suggested to act in opsin vesicle docking at the periciliary region and subsequent 
transport in the connecting cilium and calyceal processes [41, 42].
In summary, our study provides a deeper insight into the tissue-specific dynamics of the 
cytoplasmic dynein 1 motor complex, and supports an essential role for this complex in 
close connection to NINL and DZANK1 in post-Golgi vesicle transport of selective cargo 
in zebrafish photoreceptor cells.
4.  METHODS
4.1  Ethics statement
Animal experiments were conducted in accordance with the Dutch guidelines for the 
care and use of laboratory animals, with the approval of the Animal Experimentation 
Committee (Dier Experimenten Commissie [DEC]) of the Royal Netherlands Academy 
of Arts and Sciences (Koninklijke Nederlandse Akademie van Wetenschappen [KNAW] 
(Protocol # RU-DEC 2012–301).
4.2  Yeast two-hybrid interaction assay
To identify the interacting regions between DZANK1 and NINLisoA/B, a GAL4-based 
Y2H screen (HybriZAP, Stratagene, La Jolla, CA, USA) was used as previously described 
[43, 44]. Accession IDs: NINLisoA  (Q9Y2I6), NINLisoB  (XP_005260736), DZANK1 (Q9NVP4), 
DYNLL1 (NP_001032584), DYNLL2 (Q96FJ2). 
4.3  Localization studies in cells
The cellular (co)-localization of DZANK1, NINLisoB, DYNLL1 and DYNLL2 was determined by 
co-transfecting hTERT-RPE1 cells on glass slides, with pcDNA3-mRFP and pcDNA3-eCFP. 
DZANK1 FL, NINLisoB, DYNLL1 and DYNLL2 were transfected using Effectene Transfection 
Reagent (Qiagen, Netherlands) according to manufacturer’s instructions. After 48 hours 
transfection, cells were washed with PBS, fixed with 4% paraformaldehyde (PFA) and 
mounted with Vectashield containing DAPI (Vector Laboratories, Inc., UK). Images were 
taken with an Axioplan2 Imaging fluorescence microscope (Zeiss) and processed using 
Adobe Photoshop version 8.0 (Adobe Systems, USA).
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4.4  GST pull-down
The GST-fusion proteins were produced by transforming  Escherichia coli  BL21-DE3 
with plasmid pDEST15-NINL (538aa to 825aa), as previously described [43]. Strep/
FLAG-tagged DZANK1 or Strep/FLAG-tagged NINLisoB  were produced by transfecting 
HEK293T cells with plasmids encoding N-SF-TAP-hsDZANK1 or NINLisoB, respectively, 
using the transfection reagent (PEI; Polyethylenimine), according to the manufacturer’s 
instructions. The GST pull-down assay was performed as described previously [43]. For 
GST pull-down experiments from retinal extracts, retinas were dissected from fresh 
bovine eyes obtained from the local slaughter house. Retinas were homogenated by 
sonication on ice for two times 30 s in extraction buffer [10 mM HEPES (pH 7.9), 10 
mm NaCl, 3 mm MgCl2, freshly added 1 mm DTT, 1 mm Na3VO4], supplemented with 
complete protease inhibitor cocktail (Roche Diagnostic). Retinal extracts were incubated 
overnight at 4°C with the GST fusion proteins immobilized on glutathione sepharose 4B 
beads. GST fusion proteins were eluted from the glutathion sepharose 4B beads with 
100 mM reduced Glutathione (GSH) in 50mM TRIS-HCl (pH 8.0) overnight. Proteins were 
subsequently precipitated and analyzed by mass spectrometry analysis as described 
below.
4.5  Co-immunoprecipitation in HEK293T cells
HA-tagged NINL and DYNLL1 were expressed by using the mammalian expression 
vector pcDNA3-HA/DEST, the 3xHA-tagged DYNLL2 by using p3xHA_CMV/DEST, 
Strep/FLAG-tagged DZANK1 by using pSF-NTAP/DEST and LRRK2 by using p3xFLAG/
DEST from the Gateway cloning system (Invitrogen, USA). HEK293T cells were co-
transfected, using Effectene Transfection Reagent (Qiagen, USA) according to the 
manufacturer’s instructions. Twenty-four hours after transfection, the cells were washed 
with PBS and subsequently lysed in IP lysis buffer (50 mM Tris-HCL pH 7.5, 150 mM 
NaCl, 1% Triton-X-100 supplemented with complete protease inhibitor cocktail (Roche, 
Germany)) on ice. HA-tagged molecules were immune-precipitated from cleared lysates 
at 4°C overnight. Protein-antibody complexes were coupled to ProtA/G beads (Santa 
Cruz) for 2 hours at 4°C. After incubations, the beads were pelleted and washed three 
times with lysis buffer. Beads were boiled and proteins were resolved on SDS-PAGE. 
For western blotting, proteins were electrophoretically transferred into nitrocellulose 
membranes, blocked with 5% non-fat dry milk (Biorad) in PBS-T (PBS supplemented 
with 0.1% Tween) and analyzed with the appropriate primary and secondary antibodies 
in 0.5% non-fat dry milk in PBS-T. After 4 washes in lysis buffer, the protein complexes 
were analyzed on immunoblots using the Odyssey Infrared Imaging System (LI-COR, 
USA). As secondary antibodies, IRDye800 goat-anti-mouse IgG and Alexa Fluor 680 
goat-anti-rabbit IgG were used.
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4.6  Antibodies
The monoclonal antibodies directed against Centrin (1:100), Millipore, lot nr: 04–162 and 
the polyclonal antibodies directed against the cytoplasmic region of USH2AisoB (1:100), 
Novus Biological, lot nr: T00620A02 have been described previously [43,  45]. For the 
rhodopsin staining anti-rhodopsin, clone 4D2 Millipore lot nr: 2038649 (1:1000) was 
used.
For Western blot and immunohistochemical analyses, antibodies directed against 
human NINL (aa406-455) were purchased from LSBio, cat. No. LS-C201509 (1:100). 
Antibodies against the C-terminal region of zebrafish Ninl, which were raised in 
guinea pigs against a GST-fusion protein, encoding a peptide consisting of 403aa to 
591aa (Genbank NP_001268727) were used for immunohistochemical analyses. The 
cDNA, encoding this peptide was amplified by using the forward and reverse primers 
5’-GACCAAGCCTGTCAAGAGCG-3’ and 5’-GCCCTGAGACTTCAACAAC-3’, respectively. 
The secondary antibodies were goat anti-guinea pig Alexa Fluor 488 and Alexa Fluor 
568, goat anti-rabbit Alexa Fluor 488, goat anti-mouse Alexa Fluor 488, Alexa Fluor 568 
and Alexa Fluor 647; (all used at a dilution of 1:500, all from Molecular Probes-Invitrogen 
Carlsbad, CA, USA). The latter were diluted together with DAPI in block buffer (2% BSA 
and 10% Normal Goat serum in PBS).
4.7  Zebrafish
Experimental procedures were conducted in accordance with international and 
institutional guidelines. Wild type adult Tupfel Long fin (TLF) zebrafish were used. The 
zebrafish eggs were obtained from natural spawning of wild-type breeding fish. Larvae 
were maintained and raised by standard methods [46]. Translation-blocking ninl (5’-CAT
CCTCGTCCATCCCACCACATAC-3’), exon15 splice-blocking ninl (5’-CCCAACACTAAAGAGA
TACACCAAT-3’), exon4 splice-blocking dzank1 (5’-CGGCCATCACTGCATCACATTACAA-3’) 
exon8 splice-blocking dzank1 (5’- AGGACATCTTTAGAATGATAGACGT-3’) and translation 
blocking  dync1h1 (5’- CGCCGCTGTCAGACATTTCCTACAC-3’) morpholinos (MOs) were 
designed by Gene Tools Inc. (USA) and diluted to the appropriate concentration in 
deionized, sterile water, supplemented with 0.5% phenol red. To determine the most 
effective dose of the  ninl,  dzank1  and  dync1h1  MOs, 1 nl of diluted MO (containing 
2,4,6,8 and 10 ng) was injected into the yolk of one- to two-cell-stage embryos using a 
Pneumatic Picopump pv280 (World Precision Instruments). A minimum sample size of 50 
larvae was used for every condition. After injection, embryos were cultured in E3 embryo 
medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4, supplemented 
with 0.1% methylene blue) at 28°C and subsequently phenotyped at 4 dpf (days post 
fertilization). Injected embryos were classified into two classes of phenotypes based on 
the relative severity as compared to age-matched, standard control (5’-cctcttacctcagttaca
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atttatac-3’; Gene Tools Inc, USA) MO-injected (10 ng) embryos of the same clutch. Images 
were taken with an Axioplan2 Imaging fluorescence microscope (Zeiss, Germany) 
equipped with a DC350FX camera (Zeiss, Germany). To determine the efficiency of 
splice-blocking, RNA was isolated from 50 control MO injected and 50 dzank1- (and ninl-
) splice MO-injected embryos (2 dpf ) using the RNeasy mini kit (Qiagen) according to 
manufacturer’s instructions. Here, 500 ng of total RNA was used to produce first-strand 
cDNA. Reverse transcription was performed using the Superscript III cDNA synthesis 
kit (Life Technologies) according to the manufacturer’s instructions. Subsequently, 
PCR analysis was performed. Primers used for the analysis of ninl exon15 morphants 
are 5’-AAGTATGATGGCCTGGATGC-3’ and 5’-GAGATGTCCTTCCGCTCAAC-3’; primers 
used for the analysis of dzank1 exon4 morphants are 5’-GGCAGCACCTCAAATAATCC-3’ 
and 5’-CTGAAGGTCGATGGCTAAGG-3’; primers used for the analysis of  dzank1  exon8 
morphants are 5’-CTCGCTTGACAGCACAAAAC-3’ and 5’-AAAACAGGTCTGGCTTGTCG-3’. 
Obtained fragments were extracted from a 1% agarose gel using the Nucleospin gel 
extraction kit (Machery Nagel, USA) and Sanger sequenced. For histological analysis of 
zebrafish, larvae were fixed in 4% PFA in PBS at 4°C overnight. Embryos were rinsed 
with PBS and infiltrated in 10% sucrose solution in PBS for two hours. Embryos were 
positioned (ventral side downwards) in Tissue Tek (Sakura), rapidly frozen in melting 
isopropyl alcohol and sections (7 μm thickness along the lens/optic nerve axis) were 
made. Immunohistochemistry was performed using retina sections, derived from four-
to-six day old morphants and age-matched control oligo MO-injected zebrafish. The 
bodipy staining was performed on 5 day old larvae. The sections were washed twice in 
PBS for 5 minutes, permeabilized with 0.5% triton-x-100 in PBS for two times 10 minutes 
and followed by three washing steps with PBS for 5 minutes. Sections were then 
incubated for 10 minutes with bodipy (1:100), DAPI and phalloidin/actin (monoclonal 
Actin, Abcam lotnr: Ab328–500 (1:400)) diluted in PBS. Subsequent photoreceptor outer 
segment length measurements were performed blinded as to their injection status 
(using ImageJ). Equivalent single confocal sections through each eye were selected and 
the outer segments from 10 adajcent photoreceptors were measured and averaged for 
each larvae. P-values were calculated using Student’s t-test (two tailed, unpaired).
4.8  Affinity purifications of protein complexes
HEK293T cells were cultured as described previously [47]. For SILAC experiments, 
HEK293T cells were grown in SILAC DMEM (PAA), supplemented with 3 mM L-Glutamine 
(PAA), 10% dialyzed fetal bovine serum (PAA), 0.55 mM lysine and 0.4 mM arginine. 
Light SILAC medium was supplemented with  12C6, 
14N2  lysine and 
12C6, 
14N4  arginine. 
Heavy SILAC medium was supplemented with either 13C6 lysine and 
13C6, 
15N4 arginine 
or 13C6, 
15N2 lysine and 
13C6, 
15N4 arginine. 0.5 mM proline was added to all SILAC media to 
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prevent arginine to proline conversion. All amino acids were purchased from Silantes. For 
DNA transfections, HEK293T cells were seeded, grown overnight, and then transfected 
using PEI.
4.9  Tandem affinity purification
HEK293T (human embryonic kidney, ATCC) cells were transfected for 48 hours with 
either SF-TAP-NINL, SF-TAP-DZANK1, using polyethyleneimine (PEI, Polysciences) as a 
transfection reagent. Following transfection, cells were lysed in lysis buffer containing 
30 mM Tris–HCl (pH 7.4), 150 mM NaCl, 0.5% Nonidet-P40 (NP40), freshly supplemented 
with protease inhibitor cocktail (Roche), phosphatase inhibitor cocktail II and III (Sigma), 
for 20 minutes at 4°C. The Streptavidin- and FLAG-based tandem affinity purification 
steps were performed as previously described [47,  48]. 5% of the final eluate was 
evaluated by SDS-PAGE followed by silver staining, according to standard protocols, 
while the remaining 95% were subjected to protein precipitation with chloroform and 
methanol. Protein precipitates were subsequently subjected to mass spectrometry 
analysis and peptide identification as previously described [25].
4.10  One-step Strep affinity purification
For SILAC experiments, one step Strep purifications of SF-TAP-tagged proteins and 
associated protein complexes was performed as described earlier [49]. HEK293T cells, 
transiently expressing the SF-TAP-tagged constructs were lysed in lysis buffer, containing 
0.5% Nonidet-P40, protease inhibitor cocktail (Roche) and phosphatase inhibitor 
cocktails II and III (Sigma-Aldrich) in TBS (30 mM Tris-HCl (pH 7.4), 150 mM NaCl), for 20 
minutes at 4°C. After sedimentation of nuclei at 10,000 x g for 10 minutes, the protein 
concentration was determined by a Bradford assay, before equal amounts of each lysate 
were transferred to Strep-Tactin-Superflow beads (IBA) and were incubated for one hour 
at 4°C on an end-over-end shaker. Then, the resin was washed three times with wash 
buffer (TBS containing 0.1% NP-40, phosphatase inhibitor cocktail II and III). The protein 
complexes were eluted by incubation for 10 minutes in Strep-elution buffer (IBA). The 
eluted samples were concentrated using 10 kDa cut-off VivaSpin 500 centrifugal devices 
(Sartorius Stedim Biotech) and pre-fractionated using 1D-SDS-Page. Afterwards, the 
samples were subjected to in-gel tryptic cleavage as described elsewhere [50].
4.11  Protein complex destabilisation
For EPASIS, SF-TAP-tagged NINL was over-expressed in HEK293T cells as described 
above. After 48 hours, cells were lysed as described for SF-TAP analysis and the cleared 
lysates were incubated with anti-FLAG-M2 agarose resin for 1h. After three washes 
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with wash buffer (TBS containing 0.1% Tergitol-type NP-40 and phosphatase inhibitor 
cocktails II and III, Sigma-Aldrich), the resin was incubated at 4°C for three minutes with 
each concentration of SDS (0.001%, 0.005%, 0.01% and 0.02%) in SDS-elution buffer 
(TBS containing phosphatase inhibitor cocktails II and III). Afterwards, a final elution 
step with FLAG peptide (200 μg/ml; Sigma-Aldrich) in wash buffer was performed. After 
every elution step a single wash step was performed. The flow-through was collected 
and precipitated by methanol-chloroform, before being analyzed by LC-MS/MS.
4.12  Mass spectrometry and data analysis
LC-MS/MS analysis was performed on an Ultimate3000 nano RSLC system (Thermo 
Scientific) coupled to a LTQ Orbitrap Velos or to an LTQ OrbitrapXL mass spectrometer 
(Thermo Scientific) by a nano spray ion source. Tryptic peptide mixtures were 
automatically injected and loaded at a flow rate of 6 μl/min in 0.1% trifluoroacetic 
acid in HPLC-grade water onto a nano trap column (75 μm internal diameter (i.d.) × 2 
cm, packed with Acclaim PepMap100 C18, 3 μm, 100 Å; Thermo Scientific). After five 
minutes, peptides were eluted and separated on the analytical column (75 μm i.d. × 25 
cm, Acclaim PepMap RSLC C18, 2μm, 100 Å; Thermo Scientific) by a linear gradient from 
2% to 35% of buffer B (80% acteto-nitrile and 0.08% formic acid in HPLC-grade water) in 
buffer A (2% aceto-nitrile and 0.1% formic acid in HPLC-grade water) at a flow rate of 300 
nl/min over 33 minutes for EPASIS samples, respectively over 80 minutes for SF-TAP and 
SILAC samples. Remaining peptides were eluted by a short gradient from 35% to 95% 
buffer B in 5 minutes. The eluted peptides were analyzed by a LTQ Orbitrap Velos or a LTQ 
Orbitrap XL mass spectrometer. From the high resolution MS pre-scan with a mass range 
of 300 to 1500, the ten most intense peptide ions were selected for fragment analysis in 
the linear ion trap if they exceeded an intensity of at least 200 counts and if they were at 
least doubly charged. The normalized collision energy for CID was set to a value of 35% 
and the resulting fragments were detected with normal resolution in the linear ion trap. 
The lock mass option was activated; the background signal with a mass of 445.12002 
as lock mass. Every ion selected for fragmentation, was excluded for 20 seconds by 
dynamic exclusion. Non-quantitative MS/MS data were analyzed, using Mascot (version 
2.4, Matrix Science, Boston, MA, USA). Mascot was set up to search the human subset 
of the Swiss Prot database (Release 2013_12, 20274 entries), assuming trypsin as the 
digestion enzyme. Mascot was searched with a fragment ion mass tolerance of 0.5 Da 
and a parent ion tolerance of 10.0 PPM. Oxidation of methionine and was specified as 
variable modification, iodoacetamide derivative of cysteine as fixed. The Mascot results 
were loaded in Scaffold (version Scaffold_4, Proteome Software Inc., Portland, OR) to 
validate MS/MS based peptide and protein identifications. Peptide identifications were 
accepted if they could be established at greater than 95.0% probability as specified by 
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the Peptide Prophet algorithm [51]. Protein identifications were accepted if they could 
be established at greater than 99.0% probability and contained at least two identified 
peptides. Protein probabilities were assigned by the Protein Prophet algorithm [52]. 
Proteins, which contained similar peptides and could not be differentiated based on 
MS/MS analysis alone, were grouped to satisfy the principles of parsimony.
For SILAC experiments, all acquired spectra were processed and analyzed, using the 
MaxQuant software [53] (version 1.3.0.5) and the human subset of the human proteome 
reference set, provided by SwissProt (release 2012_01 534,242 entries) was used for 
peptide and protein identification. Cysteine carbamidomethylation was selected as 
fixed modification, methionine oxidation and protein acetylation were allowed as 
variable modifications. The peptide and protein false discovery rates were set to 1%. 
Contaminants like keratins were removed. Proteins, identified and quantified by at 
least two unique peptides were considered for further analysis. The significance values 
were determined by Perseus tool (part of MaxQuant), using significance A. Label-free 
quantification and statistical analysis of the EPASIS data were performed as previously 
described [25] using MaxQuant (version 1.3.0.5). The human subset of the human 
proteome reference set, provided by SwissProt (Release 2012_01 534,242 entries) 
was used for peptide and protein identification. Seven biological replicates with five 
fractions each were performed for the NINL experiment and three biological replicates 
for the control experiment, resulting in a total number of 50 individual samples being 
measured. Proteins had to be present in at least 4/7 (57%) repeated experiments to be 
considered for further analysis. The reproducibility of the experiments was analyzed 
as already described [25] and is shown in S6 and S7 Figs To assign the proteins to the 
pre-defined sub-complexes (S4 Table [26, 54]), the EPD threshold was determined by a 
stepwise parameter search (n = 1000), which resulted in a value of 0.089 (S8 Fig).
4.13  Transmission electron microscopy (TEM)
Zebrafish (4 dpf ) were fixed at 4°C overnight in a freshly prepared mixture of 2,5% 
glutaraldehyde and 2% PFA in 0.1 M sodium cacodylate buffer (pH 7.4). After rinsing 
in buffer, specimens were post-fixated in a freshly prepared mixture, containing 1% 
osmium tetroxide and 1% potassium ferrocyanide in 0.1 M sodium cacodylate buffer (pH 
7.4), at room temperature during 2 hours. After rinsing, tissues were dehydrated through 
a graded series of ethanol and embedded in epon. Ultrathin (rostrocaudally) sections 
(70 nm), comprising zebrafish eyes at the optic nerve level, were collected on Formvar 
coated grids, subsequently stained with 2% uranyl acetate and Reynold’s lead citrate, 
and examined with a Jeol1010 electron microscope. Using Adobe Photoshop version 
8.0, TEM images were adjusted for brightness and contrast. To compare the degree of 
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vesiculation in the inner segments of the various experimental groups, quantitative TEM 
analysis was accomplished. To this end, 8000x magnification images of the central retina 
(50% middle arc length) were acquired. For each zebrafish group, several eyes and fields 
of view in the retina were evaluated (S5 Table). For each field of view, the total number 
of photoreceptor cells was counted. Finally, each photoreceptor cell was evaluated for 
presence of vesicles. The statistical significance of differences between two groups was 
assessed using the independent samples Student’s t-test (SPSS 20.0). Morphant groups 
were analyzed and compared versus the wild type group, as well as versus the mock-
injected group. The statistical significance was set at p < 0.05. Data are presented as 
means ± SEM.
4.14  Zebrafish OKR assay
The OKR was measured by a previously described method [55]. Zebrafish larvae were 
mounted in an upright position in 3% methylcellulose in a small Petri dish. The Petri 
dish was placed on a platform surrounded by a rotating drum 8 cm in diameter. A 
pattern of alternating black and white vertical stripes was displayed on the drum 
interior (each stripe subtended an angle of 36°C). Larvae (4 dpf ) were visualized through 
a stereomicroscope positioned over the drum and illuminated with fiberoptic lights. 
Eye movements were recorded while larvae were optically stimulated by the rotating 
stripes. Larvae were subjected to a protocol of a 30 seconds counterclockwise rotation, 
a 10 seconds rest, and a 30 seconds clockwise rotation.
4.15  Melanosome transport assay
To induce melanosome retraction P5 larvae were exposed to epinephrine (Sigma 
E4375) at a final concentration of 500 μg/ml. Melanosome retraction was continuously 
monitored under the microscope and the endpoint was scored when all melanosomes 
in the head (and the trunk) were perinuclear [28].  P-values were obtained using 
Student’s t-test (two tailed, unpaired).
4.16  Statistical analyses
For all quantifications of zebrafish experiments, the Graphpad Prism6 software (http://
www.graphpad.com/scientific-software/prism/) was employed to generate scatter 
plots, calculate mean values and SEM values, and perform statistical tests. Continuous 
data was analyzed using two-tailed, unpaired Student’s t-test and categorical data was 
analyzed using Fisher’s exact test.
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S1 Fig. Specificity of the dzank1 ex8 spMO. 
Titration curve of the dzank1 ex8 spMO scored on ambulatory activity shows an increased incidence of 
the phenotype with an increasing dose (a). (b) Co-injection of 6 ng dzank1 ex8 spMO with 150 pg capped 
MO-resistant mRNA encoding human DZANK1 reduced the incidence of phenotypes including ambulatory 
activity, small eyes (c, d, e) (n>95/group, p<0.0001 (two-tailed Fisher’s exact test) and restored photoreceptor 
outer segment lengths (n = 13, P<0.001 (two-tailed, unpaired Student’s t-test), c’, d’, e’, f ). (f ) Quantification 
of photoreceptor outer segment lengths revealed a significant increase in length in the DZANK1 rescue 
group (3.0+/-0.4 μm) as compared to dzank1 morphants (6ng/nl; 1.9+/-0.25 μm) (P<0.001; two-tailed, 
unpaired Student’s t-test). Bars indicate mean OS length per group and Standard error of the mean (SEM) (g) 
Characterization of the effect of the dzank1 ex8 spMO at 2 and 4 dpf by RT-PCR analysis. Injection of various 
amounts of MO resulted in the (partial) retention of intron7, leading to a premature termination of translation. 
PCR fragments were analyzed by Sanger sequencing. Scale bars represent 500 μm (c-e) and 15 μm (c’-e’).
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S2 Fig. Recapitulation of the phenotype by a second dzank1 spMO targeting exon4. 
Injection of a dzank1 ex4 spMO-injected larvae completely recapitulates the phenotype observed in dzank1 
ex8 spMO-injected larvae, including pericardial edema, small eyes, defects in ambulatory activity (b) and 
shortened photoreceptor outer segments (b’) as compared to control MO-injected larvae from the same 
clutch (a,a’). (c) Characterization of the effect of the dzank1 ex4 s pMO at 2 dpf by non-quantitative RT-PCR 
analysis. Injection of various amounts of MO resulted in the (partial) skipping of exon4, leading to a premature 
termination of translation. PCR fragments were analyzed by Sanger sequencing. Scale bars represent 500 μm 
(a-b) and 15 μm (a’-b’).
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S3 Fig. DZANK1 co-localizes with DYNLL1 at the base of the cilia. 
(a-c) eCFP-DZANK1 (green signal) and mRFP-DYNLL1 (red signal) localized to both centrioles of the centrosome 
and to the basal body of the cilia marked by GT335 (Cyanid signal). After co-expression, both proteins localized 
at the basal body of the cilia at the centrosome. c; yellow signal). Nuclei are stained with DAPI (blue signal). 
(d) Co-immunoprecipitation of DZANK1 FL with DYNLL1, but not with LRRK2. The immunoblot (IB) in the 
top panel shows that HA-tagged DYNLL1 co-immunoprecipitated with Strep/FLAG-tagged DZANK1 (lane 2), 
whereas unrelated FLAG-tagged LRRK2 (lane 3) did not. The anti-HA immunoprecipitates are shown in the 
middle panel; protein input is shown in the bottom panel. (d’) Reciprocal IP experiments using anti-FLAG 
antibodies confirmed the co-immunoprecipitation of HA-tagged DYNLL1 with Strep/FLAG-tagged DZANK1 
(lane 2) and not with LRRK2 (lane 3) shown in the top panel. The anti-FLAG immunoprecipitates are shown in 
the middle panel; protein input is shown in the bottom panel. Scale bars represent 10 μm (a-c).
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S4 Fig. DZANK1 co-localizes with DYNLL2 at the base of the cilia. 
(a-c) eCFP DZANK1 (a; green signal) and mRFP-DYNLL2 (b; red signal) co-localizes at the basal body of the cilia 
in the centrosome (c; yellow signal). Nuclei were stained with DAPI (blue signal). (d-d’) Co-immunoprecipitation 
of DZANK1 FL with DYNLL2, but not with LRRK2. The immunoblot (IB) in the top panel shows that 3xHA-
tagged DYNLL2 co-immunoprecipitates with Strep/FLAG-tagged DZANK1 (lane 2), whereas unrelated FLAG-
tagged LRRK2 (lane 3) does not. The anti-HA immunoprecipitates are shown in the middle panel; protein 
input is shown in the bottom panel. (d’) Reciprocal IP experiments using anti-FLAG antibodies confirm the co-
immunoprecipitation of 3xHA-tagged DYNLL2 with Strep/FLAG-tagged DZANK1 (lane 2) but not with LRRK2 
(lane 3) shown in the top panel. The anti-FLAG immunoprecipitations are shown in the middle panel; protein 
input is shown in the bottom panel. Scale bars represent 10 μm (a-c).
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S5 Fig. EPASIS of the NINL protein complex. 
(a) Visualization of the elution profi les of the known consensus protein groups, dynactin (DCTN, red), 
cytoplasmic dynein 1 module (DYN, blue), after analysis by liquid chromatography coupled to tandem mass 
spectrometry (LC-MS/MS) and label-free quantifi cation. On the y-axis the cumulative relative abundance is 
plotted against the stepwise increasing SDS concentration on the x-axis. (b) Nonmetric multidimensional 
scaling ordination plot based on the Euclidean distances of elution profi les (stress 0.04). Data points (n = 
86) present the average of replicated data (n = 7). (c) Sub-module organization of the NINL interactome, 
showing its putative sub-structure as determined by EPASIS. The respective modules are highlighted by 
colored clouds, the known members of the sub-modules are shown in full color, the new members in grey. 
Additionally to the known members of the dynactin module, several, potentially new candidates could be 
assigned to the dynactin module (ACTR10, RBM14, BIRC6, SMC4, MARK2, DNAJA1, CEP170, ATAD3A and 
PRPF19) with an Elution Profi le Distance (EPD) ≤ 0.077. The second sub-module consists of proteins from the 
cytoplasmic dynein 1 motor complex and eluted between a SDS concentration of 0.001 and 0.01% from the 
NINL protein complex. Four further proteins were determined as potential new candidates to this module 
(MRPS27, ACAD11, PAFAH1B1 and CLIP1; EPD ≤ 0.015). Interestingly, the dynactin “pointed-end complex” 
protein DCTN5 was in our experiments clearly assigned to the dynein module. The distance of the modules 
from the bait, along the curved, dashed line, refl ects the resistance of the interaction to SDS and correlates 
with stability of association.
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S6 Fig. Reproducibility of the NINL EPASIS. 
Scatter plots of log2-transformed protein (n = 86) intensities from replicated experiments (experiment 1–7). 
Orthogonal regression lines are shown in red; Pearson correlation coefficients (r) and their 95% confidence 
intervals (ci) are shown.
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S7 Fig. Correlation matrix plot of the NINL EPASIS. 
Correlation matrix plot of log2-transformed protein (n = 86) intensities for all concentration steps. Correlation 
scores of Spearman’s test statistic are displayed and color-coded.
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S8 Fig. Threshold estimation for the elution profile distance (EPD) of the NINL EPASIS. 
For stepwise increasing thresholds (n = 1000), the specificity (black line) and sensitivity (blue line) to detect 
known consensus profile members are displayed. The grey line represents the selected threshold of 0.089 
leading to the selection of 13 candidate proteins and 13 reference group proteins.
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S9 Fig. Ninl or Dzank1 knockdown in zebrafish leads to mis-localization of rhodopsin. 
Immunofluorescence with anti-opsin antibody 4D2 demonstrated mislocalization of opsins (indicated by 
arrows) in the photoreceptor cell body in ninl (b-b’) and dzank1 (c-c’) morphants, compared to controls, where 
opsins are restricted to the outer segments (a-a’). (a’-c’) are the white boxed areas of (a-c). Larvae are 4 dpf. 
Scale bars represent 50 μm (a-c) and 15 μm (a’-c’).
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Zebrafish Group Eyes (n) Fields of view (n) Photoreceptor cells (n)
Wildtype 10 21 102
Control Oligo (10ng/nl) 8 18 111
Ninl (2ng/nl) 6 18 115
Ninl (0.5ng/nl) 8 11 80
Dzank1 (6ng/nl) 9 18 139
Dzank1 (1ng/nl) 8 12 134
Combi (dzank1 + ninl)  (1 ng/nl + 0.5ng/nl) 7 20 142
S1 Table. GST pull-down from retinal extracts. 
GST pull-down analysis from bovine retinal extracts with N-terminally GST-fused NINLisoB_aa538-825 (n = 
4) or GST alone (n = 3) as a control. Shown are the number of unique peptides that were identified for each 
protein detected by mass spectrometry. Proteins identified in less than three out of four experiments and/or 
in GST-control experiments were removed. https://doi.org/10.1371/journal.pgen.1005574.s010
S2 Table. TAP-data and SILAC data. 
SF-TAP analysis with over-expressed N-terminally SF-TAP-tagged proteins in HEK293T cells. Shown are the 
number of unique identified peptides as well as the sequence coverage for each protein detected by mass 
spectrometry. Proteins identified in the SF-TAP analysis of empty vector control experiments were removed. 
SILAC analysis with over-expressed N-terminally SF-TAP-tagged proteins in HEK293T cells. Shown are the 
ratios and significance value for WT/SF-control experiments. 
https://doi.org/10.1371/journal.pgen.1005574.s011
S3 Table. EPD-values for EPASIS of the NINL protein complex. 
EPD to consensus profiles were calculated for each protein displayed. Proteins with an EPD equal or less than 
0.089 were assigned to a consensus profile. DCTN: dynactin module, DCTN_cand: proteins with EPD-value in 
the range of DCTN, DYN: Cytoplasmic dynein 1 module, DYN_cand: proteins with EPD-value in the range of 
DYN, unknown: unassigned proteins.
https://doi.org/10.1371/journal.pgen.1005574.s012
S4 Table. Consensus protein groups NINL interactome for EPASIS. 
In the first column the corresponding sub-modules are depicted, the second column indicates the Uniprot 
accession number, in the third column the gene names are shown and the last column indicated the reference 
for the module association. The assignment to the different modules was done according to literature and by 
interpretation of the SF-TAP and SILAC data.
https://doi.org/10.1371/journal.pgen.1005574.s013
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Zebrafish Group Eyes (n) Fields of view (n) Photoreceptor cells (n)
Wildtype 10 21 102
Control Oligo (10ng/nl) 8 18 111
Ninl (2ng/nl) 6 18 115
Ninl (0.5ng/nl) 8 11 80
Dzank1 (6ng/nl) 9 18 139
Dzank1 (1ng/nl) 8 12 134
Combi (dzank1 + ninl) (1 ng/nl + 0.5ng/nl) 7 20 142
S5 Table. Specimens (central retina) analyzed for ultrastructural TEM analysis. 
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ABSTRACT
Ciliopathies are a group of human disorders caused by dysfunction of primary cilia, 
ubiquitous microtubule-based organelles involved in transduction of extra-cellular 
signals to the cell. This function requires the concentration of receptors and channels 
in the ciliary membrane, which is achieved by complex trafficking mechanisms, in part 
controlled by the small GTPase RAB8, and by sorting at the transition zone located at 
the entrance of the ciliary compartment. Mutations in the transition zone gene CC2D2A 
cause the related Joubert and Meckel syndromes, two typical ciliopathies characterized 
by central nervous system malformations, and result in loss of ciliary localization of 
multiple proteins in various models. The precise mechanisms by which CC2D2A and 
other transition zone proteins control protein entrance into the cilium and how they are 
linked to vesicular trafficking of incoming cargo remain largely unknown. In this work, 
we identify the centrosomal protein NINL as a physical interaction partner of CC2D2A. 
NINL partially co-localizes with CC2D2A at the base of cilia and ninl knockdown in 
zebrafish leads to photoreceptor outer segment loss, mislocalization of opsins and 
vesicle accumulation, similar to cc2d2a-/- phenotypes. Moreover, partial ninl knockdown 
in cc2d2a-/- embryos enhances the retinal phenotype of the mutants, indicating a 
genetic interaction in vivo, for which an illustration is found in patients from a Joubert 
Syndrome cohort. Similar to zebrafish cc2d2a mutants, ninl morphants display altered 
Rab8a localization. Further exploration of the NINL-associated interactome identifies 
MICAL3, a protein known to interact with Rab8 and to play an important role in vesicle 
docking and fusion. Together, these data support a model where CC2D2A associates 
with NINL to provide a docking point for cilia-directed cargo vesicles, suggesting a 
mechanism by which transition zone proteins can control the protein content of the 
ciliary compartment.
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1.  INTRODUCTION
Primary cilia are microtubule-based organelles protruding from the apical surface of 
most differentiated vertebrate cell types where they play a crucial role in transduction 
of extra-cellular signals to the cell [1]. Cilia achieve this function by concentrating and 
regulating receptors and channels that are required for sensing these signals in their 
membrane domain. Consequently, the ciliary membrane has a distinct composition from 
that of the adjacent plasma membrane, despite them being continuous with each other 
[2]. The tight regulation required to maintain the specificity of the ciliary membrane 
composition is achieved by complex trafficking and sorting mechanisms at the entry 
point to the ciliary compartment, as well as by a diffusion barrier present at the base of 
the cilium [3,4]. The transition zone, at the base of the ciliary axoneme, plays a crucial 
role in this sorting mechanism [5,6]. Indeed, dysfunction of proteins normally localized 
at the transition zone leads to both abnormal access to the ciliary compartment for 
proteins that should not localize there and loss of normal localization for ciliary proteins 
[5,7]. The actual mechanism, by which these transition zone proteins contribute to this 
sorting of ciliary proteins, remains however largely unknown.
Mutations in transition zone proteins in humans lead to several ciliopathies such as 
Joubert syndrome. Ciliopathies are a group of human disorders caused by dysfunction 
of primary cilia and characterized by overlapping genetics and phenotypes [8]. As cilia 
are present on most vertebrate cells, their dysfunction can manifest as a wide array of 
phenotypic features affecting most organs systems [9]. Retinal dystrophy is a common 
finding in ciliopathies given that retinal photoreceptor outer segments, which are the 
site of the phototransduction cascade, are highly specialized primary cilia [10]. Joubert 
syndrome (JBTS) (OMIM 213300) is a prototypical ciliopathy with a phenotypic spectrum 
that can encompass most of the typical ciliopathy phenotypes [11,12]. It is characterized 
by a specific hindbrain malformation termed the molar tooth sign (MTS), in addition 
to which affected individuals may have retinal dystrophy, tubulo-interstitial kidney 
disease, liver fibrosis, skeletal dysplasia and polydactyly [13–15]. To date, mutations in 
over 27 different genes have been reported as an underlying cause for JBTS [12,16–20]. 
Most of these genes encode proteins associated in multi-protein complexes localized at 
the transition zone of the primary cilium [7,21]. 
Mutations in CC2D2A (Coiled-coil and C2-domains containing protein 2A) are the second 
most common genetic cause for JBTS, accounting for almost 9% of affected individuals 
[22,12]. Moreover, mutations in CC2D2A can also result in the genetically related and 
more severe Meckel syndrome, which is a perinatal-lethal disorder characterized by 
encephalocele, polydactyly, cystic kidneys and liver fibrosis [23]. CC2D2A is part of 
one of the ciliary transition zone complexes with several other JBTS proteins [7,21]. 
Two Cc2d2a mouse mutants have been described, presenting with severe brain 
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malformation (holoprosencephaly), microphthalmia, curved body axis and randomized 
left-right axis, all typical ciliopathy-associated phenotypes [7,24]. Interestingly, mouse 
embryonic fibroblasts from one of the reported Cc2d2a-/- mice appear to lack cilia 
entirely [24] whereas disruption of CC2D2A function in the other reported mutant does 
not compromise ciliogenesis in mouse embryonic fibroblasts [7]. Instead, the ciliary 
localization of several proteins (including ARL13B, Adenylyl Cyclase III, Smoothened 
and Polycystin2) is lost, suggesting that presence of CC2D2A at the transition zone 
is required for appropriate targeting of proteins to the ciliary compartment [7]. The 
zebrafish cc2d2a mutant sentinel demonstrates a curved body axis, pronephric cysts and 
a striking retinal phenotype with short and dysmorphic photoreceptor outer segments 
[25]. In addition, the photoreceptors of cc2d2a mutants also show mislocalization of 
opsins in the cell body and cytoplasmic accumulation of vesicles in the apical portion 
of the cells and around the connecting cilium (equivalent of the transition zone in 
photoreceptors), suggesting a defect in opsin trafficking. Opsins are the photosensitive 
pigment molecules concentrated at high levels in the outer segments and required 
for sensing the light signal. Trafficking of opsins from the cell body towards the ciliary 
compartment is (at least in part) controlled by the small GTPase Rab8, which coats 
rhodopsin-carrier vesicles allowing their docking and fusion at the ciliary base [26]. 
Expression of a dominant-negative form of Rab8a leads to accumulation of rhodopsin-
containing vesicles in photoreceptors [27]. In addition, RAB8A is also involved in ciliary 
membrane biogenesis in other cell types and thus appears to play a general role in 
orchestrating trafficking towards the ciliary compartment [28,29]. The trafficking defect 
observed in cc2d2a-/- photoreceptors appears to be mediated by loss of normal Rab8 
localization [25] but the precise mechanism by which loss of this transition zone protein 
affects the localization of Rab8 and the trafficking of ciliary-directed opsins remains 
unclear. 
In the current work, we identify a chain of physical interactions linking CC2D2A to RAB8A 
through NINL and MICAL3. Using a zebrafish model, we demonstrate that loss of Ninl 
function leads to a similar retinal phenotype as loss of Cc2d2a, including short outer 
segments, mislocalization of opsins and accumulation of vesicles. Based on the physical 
and genetic interactions that we identify, we propose a model in which CC2D2A provides 
a docking point at the photoreceptor ciliary base, allowing RAB8A-positive vesicles to 
bind through a series of interactions involving CC2D2A-NINL-MICAL3-RAB8A. 
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2.  RESULTS
2.1  CC2D2A associates with NINL
In order to shed light on the function of CC2D2A we performed a dedicated ciliary yeast 
two-hybrid assay with different fragments of CC2D2A against a panel of 164 proteins, 
containing most of the ciliopathy-associated proteins [30]. A direct binary interaction 
between CC2D2A and both isoforms (A and B) of the centrosome- and basal body-
associated protein NINL (Ninein-like protein) was identified (Figure 1a). NINL isoforms 
A and B are distinguished by the fact that isoform B is 349 amino acids shorter due 
to skipping of the large exon 17 (Figure S1a). Both isoforms share predicted EF-hand 
domains in the N-terminal region as well as coiled-coil domains in the more C-terminal 
portion. Both isoforms display similar broad expression patterns, with the strongest 
expression patterns in cochlea, brain, testis, kidney and retina [31].
By generating deletion constructs for CC2D2A and subsequent evaluation of the 
interaction with NINL, we could pinpoint the interaction to the two predicted coiled-
coil domains (433-637aa) present in CC2D2A (Figure 1a). Since CC2D2A and NINL 
isoform B demonstrated the strongest interaction (Figure 1a), we focused on NINL 
isoform B (NINLisoB) for confirmation and further investigation of this interaction. Co-
immunoprecipitation assays performed using full-length tagged-constructs for NINLisoB 
and CC2D2A, showed co-precipitation of the two proteins. FLAG-tagged LRRK2 that 
was used as a negative control did not co-precipitate with HA-tagged NINLisoB, which 
confirmed the specificity of the interaction between NINLisoB and CC2D2A in this assay 
(Figure 1b). A reciprocal co-immunoprecipitation experiment confirmed the interaction 
between NINLisoB and CC2D2A (Figure 1c).
2.2  CC2D2A and NINL co-localize at the base of cilia independently of 
each other 
To further validate the interaction between CC2D2A and NINLisoB in ciliated mammalian 
cells, we transfected hTERT-RPE1 cells (human telomerase reverse transcriptase retinal 
pigment epithelium cells) with expression-constructs of wild-type mRFP-tagged 
NINLisoB, eCFP-tagged CC2D2A or a combination of both. When expressed alone, eCFP-
tagged CC2D2A localizes to the ciliary base (basal body, accessory centriole) and also 
(partly) to the ciliary transition zone, which was visualized using anti-RPGRIP1L as 
a marker (Figure 2a-b). mRFP-tagged NINL isoform B was localized at the ciliary base 
adjacent to the ciliary transition zone (Figure 2c-d). When co-expressed, NINLisoB and 
CC2D2A co-localized at the base of the primary cilium (Figure 2e-e’’). 
To investigate the localization and function of endogenous Ninl, we turned to the 
zebrafish model. The zebrafish genome harbors a single ninl orthologue (Genbank 
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(a) Yeast two-hybrid interaction assays were performed with different fragments of CC2D2A fused to the GAL4 
DNA binding domain (BD) and full length NINL isoform A and B, fused to the GAL4 activation domain (AD). 
Activation of the reporter genes, which indicates a physical interaction, was dependent on coiled-coil (CC) 
domains 1 and 2 of CC2D2A and either NINL isoform A or B. (b) The top panel of the immunoblot (IB) shows 
that FLAG-tagged CC2D2A, but not the FLAG-tagged LRRK2 that was included as a negative control, was 
co-precipitated with HA-tagged NINL isoform B using a rat monoclonal antibody directed against the HA-
epitope. Protein input is shown in the lower panel; anti-HA precipitates are shown in the middle panel. (c) 
In a reciprocal experiment, HA-tagged NINLisoB was co-precipitated with FLAG-tagged CC2D2A, but not with 
FLAG-tagged LRRK2. Protein input is shown in the lower panel; anti-FLAG precipitates are shown in the middle 
panel.
NP_001268727) that has 45% similarity with human NINL. Conserved domains include 
the predicted EF-hand domains and multiple coiled-coil domains. Cloning of zebrafish 
ninl from whole embryo mRNA at 5dpf revealed that all identified zebrafish transcripts 
lack the large exon 17 which is present only in human NINL isoform A but not in isoform 
B (Figure S1a). Therefore, zebrafish ninl is most similar to the shorter human NINL 
isoform B. RNA in situ hybridization with two different antisense probes derived from 
the 5’-end and the 3’-end of the zebrafish ninl transcript revealed broad expression at 
14-18 somites in neural tube, inner ear, developing eye and pronephros. Expression 
persists in the retina at least up to 6 dpf (days post fertilization; last developmental stage 
assessed) (Figure S1b). Antibody staining showed punctate localization of endogenous 
Ninl in zebrafish retina at the base of the cilium in 4dpf larvae (Figure 2g). While co-
staining with Cc2d2a antibodies was not possible due to different fixation conditions, 
co-staining of serial sections with anti-centrin and anti-Ninl or anti-Cc2d2a antibodies 
respectively revealed that both endogenous proteins partially co-localize at the base of 
the photoreceptor cilium of 4 dpf old zebrafish larvae (Figure 2f-g). We observed that 
Cc2d2a localizes slightly more apically with respect to Centrin than Ninl, consistent with 
Cc2d2a localization at the connecting cilium, while Ninl localization is overlapping more 
broadly with the basal body (Figure 2f-g, schematized in j).
In order to determine whether Cc2d2a localization is dependent on the presence of Ninl, 
we performed morpholino-induced knockdown studies in zebrafish. Injection of 2 ng/
nl of ninl translation-blocking morpholino (atgMO) led to efficient knockdown of Ninl, 
as demonstrated by substantially decreased antibody staining in cryosections through 
morphant retina (Figure S2a-b’’). On Western blots of whole 5dpf larval extracts, a single 
strong band of 80 kDa is present in wild-type fish (Figure S2d), which is consistent 
with results from immunoprecipitation from retinal bovine extracts with a previously 
published antibody against human NINL (Figure S2 [31]). This band is strongly reduced 
in ninl atgMO injected larvae (Figure S2d), supporting the specificity of the morpholino 
and of the antibody. 
Ninl knockdown led to typical ciliopathy-associated phenotypes, including curved body 
shape, enlarged brain ventricle and pronephric cysts (Figure S3a-g). The specificity of 
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(a, a’ and inset) When expressed alone, eCFP-tagged CC2D2A (green signal) localizes to the ciliary base 
(basal body, accessory centriole). The cilium is marked by anti-polyglutamylated tubulin (red signal, a’ and 
inset). eCFP-tagged CC2D2A (green signal; b) also (partly) localizes to the ciliary transition zone, which was 
visualized using anti-RPGRIP1L as a marker (red signal; b). (c, c’ and inset) mRFP-tagged NINL isoform B was 
localized at the ciliary base (cilium in green, c’ and inset). (d and inset) mRFP-tagged NINL isoform B (red 
signal) localizes adjacent to the ciliary transition zone (anti-RPGRIP1L; green signal). (e-e’’ and inset) Co-
expression of mRFP-tagged NINL isoform B (red signal) and eCFP-tagged CC2D2A showed co-localization of 
both proteins around the ciliary base (yellow signal). (f) In wild-type larval zebrafish retina (4 dpf ), Cc2d2a 
marked by anti-Cc2d2a antibodies (red signal) is localized apically to the photoreceptor basal body (marked 
by anti-centrin antibodies, green signal). (g) Ninl, stained with anti-Ninl antibodies, (red signal) is localized 
at the zebrafish photoreceptor ciliary base, partially overlapping with and apical to the green centrin signal. 
(h) Cc2d2a localization is unaffected by ninl knockdown and (i) Ninl localization is normal in cc2d2a-/- larvae. 
(j) Schematic representation of the localization of Ninl and Cc2d2a in zebrafish photoreceptor cells. (f-i) are 
immunostainings on cryosections from 4 dpf larvae. Nuclei were stained with DAPI (blue signal) in all panels. 
Scale bars are 10 µm in a-e, and 4 µm in f-i.
the observed phenotype was confirmed by rescue experiments, in which co-injection of 
2 ng/nl ninl MO with capped MO-resistant human NINL-mRNA reduced the prevalence 
of the curved body phenotype in a dose-dependent manner (curved body shape in 
71% of ninl atgMO injected larvae (n=207) versus 36% in ninl atgMO + ninl mRNA 
injected larvae (n=203), data pooled from 2 biological replicates, P<0.0001, two-tailed 
Fisher’s exact test; Figure S4a-d). Finally, the specificity of the observed phenotypes 
was further confirmed by a second morpholino against ninl targeting the splice site 
at the intron14/exon15 junction and thus causing aberrant splicing with premature 
truncation (Figure S5c). This splice morpholino led to similar phenotypes as the atgMO, 
including ventriculomegaly and abnormal photoreceptor outer segments (Figure 
S5a-b). The body curvature phenotype was absent in the splice morphants, which may 
be explained either by rescue of this early phenotype by maternal ninl mRNA, which 
remains unaffected by splice morpholinos (as seen in some ciliopathy zebrafish mutants 
such as talpid3 where only the maternal zygotic mutants have a curved body shape 
[32]), or by less efficient gene knockdown with this morpholino, as normal transcript 
persists in addition to the aberrant transcript (Figure S5c). Indeed, using the anti-
NINL antibody, we observed a milder decrease of Ninl protein on Western blots and 
on immuno-histochemistry of retinal cryosections at 5dpf for the ninl ex15 spMO as 
compared to the atgMO (Figure S2c-d).
Localization of Cc2d2a at the connecting cilium, shown by anti-Cc2d2a immunostaining, 
was unaffected by Ninl knockdown (Figure 2h). Conversely, immunostainings using 
anti-Ninl antibodies revealed no clear mislocalization of Ninl in the retina of cc2d2a-/- 
larvae (Figure 2i). Taken together, these data indicate that Cc2d2a and Ninl co-localize 
at the ciliary base independently of each other.
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2.3  NINL knockdown in zebrafish leads to outer segment loss, opsin 
mislocalization and vesicle accumulation
Since cc2d2a-/- zebrafish have prominent retinal abnormalities [25], we focused our 
phenotypic analysis on the retina of ninl morphants. Retinal lamination was unaffected 
in ninl morphants (Figure 3a-b). In contrast, photoreceptors demonstrated shortened 
axonemes and abnormal outer segments, as seen on retinal cryosections at 4 dpf 
stained with boron-dipyrromethene (bodipy) to mark the outer segment membrane 
discs (Figure 3c-d’) and anti-acetylated alpha-tubulin and anti-Ift88 antibodies to mark 
the axoneme (Figure 3e-f ). Measurement of outer segment (OS) length of early 4dpf 
larvae, performed in a blinded manner as to injection status, revealed a significant 
shortening (mean OS length 1.6 +/- 0.26 µm in ninl atgMO morphants compared to 
3.9 +/- 0.32 µm in wild-type, P<0.0001, unpaired Student’s t-test, n>10 larvae from 
each group in each of 2 biological replicates; Figure S4e). This retinal phenotype was 
observed with both the ninl translation-blocking and the splice-blocking morpholinos 
(Figure S5b’). Little to no photoreceptor cell death was observed with TUNEL assay on 
cryosections of 4dpf morphant larvae (Figure S3i-j) compared to ift88-/- retinas that are 
known to display prominent photoreceptor cell death at the same stage (and were thus 
used as positive controls; Figure S3k). In general, minimal cell death was observed at 
4dpf throughout the embryo, including in brain of larvae with overt ventriculomegaly 
(Figure S3l). Co-injection of 150pg of capped human NINL mRNA with 2ng/nl ninl atgMO 
restored normal outer segment length (mean OS length in rescued larvae 3.8 +/- 0.25 
µm, P<0.0001, unpaired Student’s t-test, n= 10 larvae; Figure S4 a’-c’ and e).
Immuno-staining with anti-opsin antibodies (4D2 antibody) demonstrated significant 
accumulation of opsins in the inner segment and throughout the cell body of ninl-
depleted photoreceptors (Figure 3g-i; mean intracellular fluorescence was significantly 
increased in ninl morphants compared to controls, P<0.0001, unpaired Student’s t-test, 
n=15 morphant larvae and 7 control larvae, 2 replicate experiments). At the ultra-
structural level, two types of abnormal membrane-bound structures were observed 
by transmission electron microscopy in ninl morphants: large vacuole-like structures 
were present in the cell body and small vesicular structures accumulated around the 
Golgi complex and below the connecting cilium (Figure 3j-m; vacuolar and/or vesicular 
structures were present in 45/112 photoreceptors from 6 morphant eyes compared to 
13/192 photoreceptors from 4 uninjected and 4 Control Oligo injected eyes; P<0.0001, 
Fisher’s exact test). These phenotypes are partially reminiscent of those observed in 
cc2d2a-/- embryos [25], supporting a common or coordinated function for Cc2d2a and 
Ninl in the process of vesicular trafficking towards the ciliary compartment.
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Figure 3. Zebrafish ninl knockdown causes loss of axonemes and outer segments, opsin 
mislocalization and vesicle/vacuole accumulation. 
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(a-b) Paraffin sections stained with Hematoxylin/Eosin of control (a) and ninl knockdown larvae (b) 
demonstrating shortened outer segments and grossly preserved retinal lamination in the morphants. (c-
d’) Bodipy-stained cryosections highlight the shortened (brackets c’-d’) and dysmorphic outer segments of 
ninl knockdown larvae (d and d’) compared to the long cone- or rod-shaped outer segments of controls 
(c and c’). (e-f) Axonemes and connecting cilia marked with anti-acetylated alpha-tubulin and anti-Ift88 
antibodies are severely shortened and reduced in numbers in ninl knockdown larvae (arrowhead in f ). (g-
h’) Immunofluorescence with anti-opsin antibody 4D2 demonstrates mislocalization of opsins within the 
cell body in ninl knockdown larvae (arrow in h’) compared to controls (g) where opsins are restricted to the 
outer segment. (i) Quantification of the intracellular opsin accumulation in ninl morphant photoreceptors 
compared to control: each single datapoint in the scatter graph displays the averaged mean grey value from 
one larva. The mean value and the Standard Error of the Mean (SEM) are displayed as bars. The difference is 
statistically significant (*** = p<0.0001, Student’s t-test). (j-l’) Transmission electron microscopy of control (j) 
and ninl knockdown larvae (k-l’) demonstrates absent or shortened and dysmorphic outer segments (OS) 
and accumulation of large vacuoles (v, arrow in l’) and smaller vesicular structures (bracket in k’’ and white 
arrowheads in l’) in morphants. Black arrowheads point to the connecting cilium in k and k’’. k’ and k’’ are the 
boxed areas in k and l’ is the boxed area in l. (m) Quantification of the % of photoreceptors displaying these 
phenotypes. Absolute numbers of photoreceptors are also indicated. Error bars indicate 95% Confidence 
Intervals. The differences between morphant (red bars) and controls (blue bars) are statistically significant (*** 
= p<0.0001, Fisher’s exact test). Larvae in all panels are 4 dpf old. Scale bars are 30 µm in a-b, 15 µm in c-d and 
g-h, 3 µm in c’-d’ and g’-h’, 4 µm in e-f , 0.5 µm in j-k and l and 150nm in k’-k’’ and l’. OS outer segment, CC 
connecting cilium, m mitochondria, n nucleus, v vacuole.
2.4  Ninl genetically interacts with cc2d2a and may act as a genetic 
modifier for CC2D2A-associated Joubert Syndrome
To further delineate the relationship between cc2d2a and ninl, we tested whether 
a synergistic effect was detectable between the two genes by using partial ninl 
knockdown in the cc2d2a mutant background. We observed that injection of a sub-
phenotypic dose of ninl MO (0.75 ng/nl), which causes no discernible phenotype in wild-
type larvae, significantly increased the penetrance and severity of pronephric cysts in 
cc2d2a mutants: 89% of ninlMO-cc2d2a-/- zebrafish developed cysts compared to 40% of 
uninjected cc2d2a-/- larvae (p<0.0001, Fisher’s exact test) and the size of these cysts was 
significantly increased (as measured by the area of the dilated glomerulus and proximal 
tubules: 0.044 +/-0.004 mm2 for cc2d2a-/- + ninlMO (n=16) as compared to 0.016 +/-
0.002 mm2 for uninjected cc2d2a-/- (n=8, P<0.0001, unpaired Student’s t-test) (Figure 
4a-d). Importantly, the cc2d2a+/- and cc2d2a+/+ siblings from the same injection clutch 
did not develop pronephric cysts at these sub-phenotypic ninl MO doses (Figure 4a 
and d). In the retina, the opsin mislocalization phenotype in cc2d2a-/- larvae (5 dpf ) was 
enhanced by the addition of the same sub-phenotypic dose of ninlMO (Figure 4 e-h; 
P<0.0001, Student’s t-test, n=19 cc2d2a-/- + ninlMO and n=16 cc2d2a-/- uninjected, 2 
replicates). These findings support a genetic interaction between cc2d2a and ninl and 
suggest that NINL could be a genetic modifier for CC2D2A-caused disorders or even 
contribute to the genetic spectrum underlying Joubert/Meckel syndrome. Following 
this rationale, we sequenced NINL in a cohort of 346 individuals with Joubert syndrome 
(from 291 families) using a molecular inversion probes (MIPs) capture method followed 
by next-generation sequencing [33] but did not identify any individuals carrying bi-allelic 
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rare deleterious NINL variants. We did however find 3 individuals with heterozygous 
NINL mutations predicted to be deleterious. Individual UW48-3 carried the homozygous 
missense CC2D2A mutation c. 3364C>T (p.P1122S), previously shown to be causal for 
Joubert syndrome, and a heterozygous NINL frameshift mutation leading to a stop 
codon after 43 amino acids (c.3020delC, p.P1007Lfs*43) (Figure 4i) (and no other rare 
deleterious variant in any of the known JS genes). Phenotypically, this subject had a 
severe form of JBTS with retinal dystrophy, hearing loss, ventriculomegaly in addition 
to the MTS and renal failure leading to death at age 7 years. In comparison, subject 
UW 36-3 carried the same homozygous CC2D2A c.3364C>T (p.P1122S) mutation but no 
additional NINL variants (or rare deleterious variants in other JBTS genes) and presented 
with the “pure JBTS” phenotype, consisting only of the MTS with associated ataxia, 
developmental delay and respiratory rhythm disturbance (Figure 4j). Subject UW07-
3 carried a heterozygous NINL nonsense mutation (c.2446 G>A, p.R816X) in addition 
to causal, compound heterozygous C5ORF42 frameshift mutations (c.8726delG; 
p.A2909Qfs*4 and c.493delA, p.I165Yfs*17). This subject presented a classical Joubert 
phenotype without extra-neuronal manifestations, suggesting that the additional NINL 
frameshift had no effect on the clinical manifestations (Figure 4k). Finally, subject UW57-
3 carried a heterozygous NINL missense mutation (c.1631A>T, p.E544V), predicted to be 
deleterious by Polyphen2, along with bi-allelic causal TMEM67 mutations (c.2825T>G, 
p.F942C and c.978+3 A>G). This individual had Joubert syndrome with coloboma 
but no retinal, renal or hepatic involvement (Figure 4l). Given the known association 
between TMEM67 mutations and coloboma [34,12], this additional feature is most likely 
explained by the causal gene mutations, while the additional NINL variant appears 
to have no obvious effect on the phenotype in individual UW57-3. While it remains 
possible that additional sequence variants in non-JBTS genes also contributed to the 
enhanced phenotype in individual UW48-3 and while our findings from a large human 
cohort remain of anecdotal nature given the rarity of this highly heterogeneous genetic 
disorder, taken together with the zebrafish experiments, they suggest that NINL may act 
as a genetic modifier specifically for CC2D2A-caused Joubert syndrome.
2.5  Ninl is required for correct Rab8a localization
Previous work on the cc2d2auw38 zebrafish mutant demonstrated that loss of Cc2d2a 
leads to abnormal Rab8a localization in retinal photoreceptors [25]. Given the opsin 
mislocalization and vesicle accumulation phenotypes observed in ninl morphants, the 
known role of Rab8a in opsin trafficking [27,35,36] and the interaction with cc2d2a 
demonstrated here, we next determined whether loss of Ninl function also had an 
effect on Rab8a localization. For this purpose, we used a transgenic construct that 
drives expression of mCherry-tagged Rab8a in wild-type zebrafish photoreceptors in a 
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Figure 4. Genetic interaction between ninl and cc2d2a. 
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(a-c) Partial ninl knockdown enhances the cystic kidney phenotype of cc2d2a mutants. (a-c) Glomerulus and 
proximal pronephric tubules highlighted in the transgenic line Tg(wt1b-EGFP). (a) Injection of a low dose of 
ninl atgMO (0.75 ng/nl) causes no cysts in wild-type larvae. (b) cc2d2a-/- larvae display small dilatations of 
the proximal tubules (arrow) in ~40% of cases. (c) Injection of this low dose of ninl atgMO in the cc2d2a-/- 
background leads to large dilatations of the proximal tubules and glomerular space (arrow) in 89% of 
mutants.  g glomerulus, p pancreas (d) Quantification of the glomerular + proximal tubular area displayed as a 
scatter plot, demonstrating a significant increase in proximal pronephric area in cc2d2a-/- larvae injected with 
low-dose ninl atgMO. The bars represent the mean and standard error of the mean (SEM) for each treatment 
group and each datapoint is an individual fish. (e-g’) Immunohistochemistry with anti-opsin antibody (4D2, 
green) on retinal cryosections of 4dpf cc2d2a-/- uninjected larvae (f-f’’) and cc2d2a-/- larvae injected with 
subphenotypic doses of ninl MO (g’g’’’), that cause no mislocalization in wild-type fish (e-e’), demonstrates 
that partial ninl knockdown increases the mislocalization of opsins (e’-g’). (h) Quantification of the mean 
intracellular fluorescence displayed as a scatter plot shows significant increase in intracellular fluorescence 
in cc2d2a-/- larvae injected with low dose of ninl atgMO. The bars represent the mean and standard 
error of the mean (SEM) for each treatment group and each datapoint represents the mean intracellular 
fluorescence from 10 photoreceptors in one individual fish. Cell membrane and outer segments are stained 
with bodipy (red in e-g). Nuclei are counterstained with DAPI. Scale bars are 100 µm in (a-c) and 4 µm in 
(e-g’). (i) Pedigree of a consanguineous family with one affected boy (UW48-3) and 4 unaffected siblings. 
UW48-3 carried a homozygous missense CC2D2A mutation as well as a frameshift mutation in NINL leading 
to premature truncation. (j) Pedigree of a family where the affected individual (UW36-3) carries the same 
homozygous CC2D2A mutation as in (i) but no additional rare deleterious variants. (k) Pedigree of a family 
where the affected individual (UW07-3) carries compound heterozygous C5ORF42 frameshift mutations 
and a nonsense mutation in NINL. (l) Pedigree of a family where the affected individual (UW57-3) carries 
compound heterozygous TMEM67 mutations and a missense NINL mutation. The phenotype of the affected 
individuals is detailed in italic on each pedigree under the corresponding mutations. MTS Molar Tooth Sign, 
DD Developmental Delay, ESRF End-Stage Renal Failure.
punctate manner [25]. When expressed in ninl morphants (atgMO), mCherry-tagged 
Rab8a localized in significantly fewer puncta than when expressed in controls (42% of 
expressing photoreceptors displayed Rab8 puncta in ninl morphants (n=38/87 from 14 
larvae) compared to 73% in uninjected controls (n=48/66 from 13 larvae), p=0.0005, 
two-tailed Fisher’s exact test; Figure 5a-c). Instead, expression of the transgene was 
mostly diffuse throughout the photoreceptor cell body of ninl morphants. A similar 
result was obtained using an anti-Rab8a antibody that recognizes endogenous small 
Rab8a puncta, which are found throughout the cell body, concentrated at the synapse 
and in the inner and outer segments in controls (Figure 5 d-d’). In ninl-knockdown larvae, 
the number of endogenous Rab8a puncta was significantly reduced (Figure 5e-e’ and 
quantification in f: the average number of puncta per µm2 was reduced to 0.04 +/- 0.01 
(or 1 puncta per 25 µm2) in ninl morphants as compared to 0.09 +/- 0.01 (or 1 puncta per 
11 µm2) in uninjected wild-type, P=0.01, unpaired Student’s t-test), supporting a role for 
Ninl in Rab8 localization.
94 | Chapter 2.2
0 20 40 60 80 100
punctate
diffuse
Tg(Rh-ch-Rab8)
uninjected
Tg(Rh-ch-Rab8)
+ ninlMO
**
% photoreceptors
n=66
n=87
Tg(Rhod:cherry-
Rab8a)
Tg(Rhod:mcherry-
Rab8a)
a a’
B
b’’b
control control
ninlMO ninlMO
Tg(Rhod:mcherry-
Rab8a)
Tg(Rhod:cherry-
Rab8a)
wi
ld-
typ
e
nin
lM
O
n 
R
ab
8 
pu
nc
ta
 p
er
 u
m
2 *
0.00
0.05
0.10
0.15
0.2
c
anti-Rab8a 
d d’
e e’
OS
control control
ninlMO ninlMO
anti-Rab8a 
bodipy 
anti-Rab8a 
bodipy 
anti-Rab8a 
f
Figure 5. Ninl is required for correct Rab8A localization. 
(a-a’) Expression of a rhodopsin-promoter driven cherry-tagged Rab8a in wild-type photoreceptors is mostly 
concentrated in one or several puncta (arrows a-a’) whereas it is diffuse in the majority of ninl morphant 
photoreceptors (b-b’). (c) Proportion of Rab8a-cherry expressing photoreceptors with punctate expression 
versus diffuse expression (bars represent 95% confidence interval; ** P<0.001, Fisher’s exact test). (d-d’) 
Endogenous Rab8a localization as seen by immunohistochemistry using an anti-Rab8a antibody (green) 
displays similar puncta (arrowheads) in wild-type photoreceptors, while the number of puncta is decreased 
in ninl morphant photoreceptors (e-e’). (f) Quantification of the number of Rab8a puncta displayed in the 
form of a scatter plot indicating that significantly fewer endogenous Rab8 puncta per µm2 are present in 
ninl morphants compared to uninjected controls (*P=0.01, unpaired Student’s t-test; bars represent standard 
error of the mean). Scoring was performed blinded as to injection status for (c) and (f). Outer segments are 
counterstained with bodipy in (d-e). Nuclei are counterstained with DAPI. All images are cryosections of 4 dpf 
larvae. Scale bars are 4 µm in all panels.
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2.6  MICAL3 associates with NINL and is mislocalized in NINL and CC2D2A-
depleted cells 
In order to unravel the underlying molecular cause of the observed vesicle accumulation 
and to identify proteins that interact with NINL, we next generated N-terminal Strep/
FLAG-tagged fusion proteins of NINL isoA and isoB. A single-step affinity purification 
combined with quantification by stable isotope labeling of amino acids in cell culture 
(SILAC) and tandem affinity purification (TAP) [37] were applied to isolate the protein 
complexes in their native functional states from human embryonic kidney 293T 
(HEK293T) cells. The complexes were subsequently analyzed by liquid chromatography 
coupled with tandem mass spectrometry (LC-MS/MS). The identified interactome 
consisted of 174 unique proteins (Figure 6a, Supplementary table 1). An important 
association was found with multiple subunits of the cytoplasmic dynein 1-dynactin 
motor complex (DYNC1H1, DYNC1LI1, DYNC1LI2, DYNCI2, DYNLRB1, DCTN1-4, and 
DCTN6) which is involved in minus end–directed microtubule-associated transport. In 
addition, six actin-binding proteins (ARP1, ARP1B, ARP10, CAPZA1, CAPZA2 and CAPZB) 
and three subunits of Ca2+/calmodulin-dependent protein kinase II (CaMKII) (CAMK2A, 
CAMK2D, and CAMK2G), involved in non-canonical Wnt5a signaling, synaptic plasticity 
and kidney development [38], were found to associate with NINL. An additional 
relevant NINL interaction partner identified was MICAL3 (Microtubule-associated 
Monooxygenase, Calponin and LIM domain containing 3 protein), which is known to 
participate in a protein complex with RAB6 and RAB8 that is involved in the fusion of 
exocytotic vesicles [39], a process that appears to be deficient in the retina of cc2d2a 
mutants and ninl morphants. We validated the interaction between NINLisoB and MICAL3 
by reciprocal co-immunoprecipitations (Figure 6b) and confirmed that endogenously 
expressed MICAL3 is present at the photoreceptor connecting cilium in rat retina (P20), 
partially overlapping with the cilium and basal body marker polyglutamylated tubulin 
(Figure 7b-d’). In hTERT-RPE1 cells, mRFP-tagged NINLisoB (Figure 7e-e’’) and eCFP-tagged 
CC2D2A (Figure 7f-f’’) partially overlapped with tagged MICAL3.
To evaluate the role of NINL and CC2D2A in MICAL3 localization, we silenced the 
expression of NINL and CC2D2A in ciliated hTERT-RPE1 cells using siRNA, which was 
quantified by qPCR analysis (Figure 7j-k). Subsequent immunohistochemical stainings 
showed predominant MICAL3 localization at the ciliary base in non-targeting siRNA-
treated cells (Figure 7g) whereas silencing of NINL expression resulted in a dispersed 
distribution of MICAL3 throughout the cell body (Figure 7h). Downregulation of CC2D2A 
expression in hTERT-RPE1 cells had a less pronounced effect on MICAL3 localization, 
resulting in partial mislocalization to the cell body (Figure 7i). These findings support 
a link between CC2D2A and MICAL3-RAB8-mediated vesicle trafficking/fusion through 
NINL.
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Figure 6. NINL interactome screen identifies MICAL3. 
(a) Strep-SILAC and TAP (tandem affinity purification) experiments show that NINL interacts specifically 
with MICAL3 (Yellow). The solid line between NINL and MICAL3 symbolizes a direct interaction, whereas 
the dashed lines indicate interactions determined by IP. (b) Co-immunoprecipitation of eGFP-MICAL3 with 
FLAG-NINLisoB, but not with FLAG-STRAD. The immunoblot (IB) in the top panel shows that eGFP-tagged 
MICAL3 co-immunoprecipitated with FLAG -tagged NINL (lane 2), whereas FLAG-tagged STRAD used as a 
negative control (lane 3) did not. The anti-GFP immunoprecipitates are shown in the middle panel; protein 
input is shown in the bottom panel. Reciprocal IP experiments using anti-FLAG antibodies confirmed the co-
immunoprecipitation of eGFP-tagged MICAL3 with FLAG-tagged NINLisoB (lane 2) and not with STRAD (lane 
3) shown in the top panel. The anti-FLAG immunoprecipitations are shown in the middle panel; protein input 
is shown in the bottom panel. A co-immunoprecipitation experiment using untagged eGFP as a negative 
control (right panel) showed that eGFP-tagged MICAL3 immunoprecipitates with FLAG-tagged NINLisoB but 
not with untagged eGFP.
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Figure 7. NINL and CC2D2A co-localize with MICAL3 and are required for correct MICAL3 
localization. 
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(a) Schematic of a photoreceptor for orientation. (b-d’) Co-localization of endogenous MICAL3 (green 
signal; b) and polyglutamylated tubulin (red signal; c) in rat retina (P20) by co-immunostaining radial cryo-
sections. The yellow signal in the merged image (d’) indicates co-localization at the base of the photoreceptor 
connecting cilium. (b’-d’) are high magnification images of the boxed areas in (b-d). (e-f’’) Centrosomal 
co-localization of NINLisoB, CC2D2A and MICAL3 in hTERT-RPE1 cells. mRFP-NINLisoB (red signal, e) localizes to 
the basal body of the cilia marked with polyglutamylated tubulin (cyanid signal; e) and overlaps with GFP-
tagged MICAL3 (green signal, e’) at the ciliary base when co-expressed (yellow signal, e’’). Co-expression of 
eCFP-CC2D2A (green signal, f) and mRFP-MICAL3 (red signal, f’) resulted in partial overlap at the base of the 
cilia (yellow signal, f’’). (g) Endogenous MICAL3 (green signal) detected by immunostaining clusters at the 
ciliary base (white arrows; cilium marked with anti-acetylated tubulin in red) of hTERT-RPE1 cells treated with 
non-targeting siRNA. (h, i) Knockdown of NINL (h) or CC2D2A (i) expression by siRNA results in dispersed 
distribution of MICAL3 throughout the cell body (brackets) with retention of some MICAL3 puncta at the 
ciliary base (arrows). qPCR analysis of NINL (j) and CC2D2A (k) siRNA treated hTERT-RPE1 cells. Cells were 
transfected with 10nM siRNA and all qPCR data were normalized against GUSB levels. Bar and error bars refer 
to mean and standard deviation, respectively (n=3, on two biologicial replicates). *: P<0.05; **: P<0.01 versus 
non targeting siRNA (NT) (student’s t-test). Nuclei are counter stained with DAPI in all panels (blue signal). 
Scale bars: are 5 µm in d, 1 µm in d’ and 10 µm in e-i.
3. DISCUSSION
Dysfunction of transition zone proteins causes several ciliopathies such as Joubert 
syndrome, Meckel syndrome, nephronophthisis or Usher syndrome [16,21,40–43]. 
Previous work suggests that transition zone proteins in general, and CC2D2A in 
particular, are required for correct localization of transmembrane proteins to the ciliary 
membrane [7,25],. The mechanism by which transition zone proteins exert this function 
and the link to upstream ciliary-directed vesicular trafficking mechanisms remain 
however largely unknown. In this work, we identify NINL as a novel physical interaction 
partner for the transition zone protein CC2D2A and propose a model linking CC2D2A to 
RAB8A-controlled vesicle trafficking through a dual role for NINL in microtubule-based 
vesicle transport (Figure 8). The association of NINL with both the cytoplasmic dynein 
1-dynactin motor complex (Dona et al, co-submitted manuscript) and MICAL3 supports 
a role for NINL in the initial transport of trans-Golgi network-derived RAB8A-MICAL3 
coated vesicles towards the base of the photoreceptor cilium, while the association of 
NINL with CC2D2A provides a docking point for these incoming vesicles at the entrance 
of the ciliary compartment.
Ciliary transmembrane proteins are synthesized in the cell body and travel from the 
Golgi towards the cilium in vesicles which move along microtubules using a cytoplasmic 
dynein motor [44]. Once at the entrance of the ciliary compartment, these vesicles 
must dock and fuse with the periciliary membrane to deliver their cargo into the ciliary 
membrane [45]. This path has been particularly well studied in photoreceptors, where 
large quantities of opsins and membrane continuously have to replenish the discs which 
constitute this photo-sensitive structure [26,46,35]. Opsin trafficking is severely affected 
in both zebrafish cc2d2a mutants and ninl morphants, suggesting that both proteins 
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play an important role in this transport which is crucial for the correct morphogenesis 
and homeostasis of the outer segments. Their co-localization at the base of the 
photoreceptor cilium could suggest that Cc2d2a and Ninl play a similar or combined 
role in opsin transport or that one protein is required to localize the other. However, 
since we found that each protein localizes independently of the other, and that ninl 
knockdown enhances the cc2d2a null mutant phenotype, the relationship between 
them is likely more complex than a simple linear pathway. At the ultrastructural level, 
the loss of function phenotypes of these two proteins also slightly diverge from each 
other: although vesicles accumulate in both cases in the affected photoreceptors, small 
vesiculo-tubular structures accumulate mostly apically around the connecting cilium in 
cc2d2a mutants [25], while this work shows that small vesicles and larger vacuoles are 
also present more basally and closer to an abnormal Golgi apparatus in ninl morphants. 
This suggests that both proteins are important for vesicular trafficking but play different 
roles in this process.
rab8ninl
cc2d2a
mical3
32
1
rhodopsin
Figure 8. Proposed model for CC2D2A and NINL function in trafficking, docking and fusion of 
rhodopsin-carrier vesicles. 
1) CC2D2A binds NINL and thus provides a docking point at the base of the connecting cilium for incoming 
vesicles. 2) NINL binds MICAL3 which in turn binds RAB8 that is coating the rhodopsin-carrier vesicles. Since 
NINL also associates with the cytoplasmic dynein1 motor complex, it provides a link between the carrier 
vesicles and the motor generating the movement along the microtubules. 3). MICAL3 subsequently interacts 
with ELKS and its redox activity promotes remodeling of the docking complex resulting in fusion of the vesicle 
at the periciliary region.
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NINL has been previously shown to bind several other ciliopathy proteins present at the 
base of cilia, specifically LCA5 and USH2A [31], suggesting that it may play a more pivotal 
role in vesicular trafficking in photoreceptors than CC2D2A. Given that the zebrafish ninl 
morphant phenotype is more severe than the cc2d2a mutant phenotype, this further 
suggests a more central role for Ninl than for Cc2d2a in cilium-directed trafficking. This 
hypothesis is also supported by the lack of bi-allelic NINL mutations in a large human 
cohort of Joubert syndrome. Indeed, this may be interpreted as lack of tolerance to loss-
of-function mutations in NINL, as these would lead to more severe phenotypes or early 
embryonic lethality. The direct interaction between NINL and the dynein 1-dynactin 
complex [47] which we confirmed and expanded in the associated study by Dona et al, 
suggests that NINL might be involved in minus end–directed microtubule-associated 
transport of organelles and cargo towards the base of the cilium. An appealing model 
would thus propose that NINL functions both more upstream in ciliary-directed 
vesicular trafficking than CC2D2A as well as at the base of the cilium where it interacts 
with several different proteins including CC2D2A.
While no bi-allelic rare deleterious NINL variants were identified in our JBTS cohort, 
we did find heterozygous NINL mutations in individuals with Joubert syndrome. 
Interestingly, only the individual with causal bi-allelic CC2D2A mutations and a 
heterozygous truncating NINL mutation had a severe phenotype with retinal and 
terminal renal disease. In comparison, the individuals with causal mutations in other 
JBTS genes and a heterozygous deleterious NINL mutation (or with the same causal 
CC2D2A mutation alone) had the classical “pure Joubert” phenotype without retinal or 
renal involvement. While bi-allelic CC2D2A mutations can result in a wide range of JBTS-
associated phenotypes, the majority of individuals with causal CC2D2A mutations and 
JBTS display the “pure JBTS” phenotype [22]. The more severe phenotype only of the 
individual carrying causal CC2D2A mutations and an additional NINL truncating variant 
suggest that deleterious variants in NINL may act as genetic modifiers specifically of 
CC2D2A-caused ciliopathies such as Joubert syndrome. Unfortunately, the rarity of 
this disorder and its prominent genetic heterogeneity with over 27 associated genes 
prevent identification of multiple individuals sharing the same combination of causal 
and additional genetic variants, precluding identification of a statistically significant 
effect of rare variants as genetic modifiers using human genetics alone. Our findings 
from a large Joubert cohort therefore remain of anecdotal nature. However, the physical 
and genetic interaction in zebrafish identified in this work substantially strengthen the 
significance of this finding and suggest that deleterious variants in NINL may indeed 
enhance the retinal and renal phenotype in individuals with CC2D2A-associated Joubert 
syndrome. The effect on the retinal phenotype may be explained by the importance 
of NINL function in photoreceptors as highlighted in the present study. Enhancement 
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of the renal phenotype by the additional NINL mutation may be explained by the 
association identified in this study between NINL and the PKD2-target CaMKII, which is 
important for renal development [38].
The identification of MICAL3 as an interaction partner for NINL is of particular relevance 
in the context of vesicular trafficking given that MICAL3 binds RAB8A and plays a role 
in exocytotic vesicle fusion [39]. MICAL3 is part of the MICAL family of flavoprotein 
monooxygenases which regulate the actin cytoskeleton by disassembling the actin 
filaments. The redox function of MICAL3 is required to promote vesicle fusion, possibly 
by destabilizing protein complexes and remodeling the docking-fusion complexes 
in which it is engaged [39]. The role of RAB8A in vesicle fusion at the ciliary base has 
been abundantly documented in various cell types including photoreceptors [27,28]. 
While RAB8A was found to bind several ciliopathy proteins directly including CEP290 
and RGPR [48,49], no direct interaction has been demonstrated between CC2D2A and 
RAB8A, despite a functional interaction in zebrafish photoreceptors and a requirement 
for CC2D2A in RAB8A localization in mouse embryonic fibroblasts [25,24]. Our findings 
now provide a model explaining the link between CC2D2A and RAB8A (Figure 8): RAB8A-
coated vesicles destined to the ciliary compartment are bound by MICAL3 which in turn 
binds NINL that is associated to the cytoplasmic dynein 1 motor complex (Dona et al, 
co-submitted manuscript), allowing the movement along the microtubules. Once at the 
base of the cilium, NINL interacts with CC2D2A, providing the specificity of the docking 
point at the entrance to the ciliary compartment. Finally, the redox activity of MICAL3 
promotes remodeling of the complex allowing fusion of the vesicle and release of cargo 
into the peri-ciliary membrane.
A role for CC2D2A in promoting the assembly of ciliary subdistal appendages was 
recently suggested whereby CC2D2A would be required for docking of transport vesicles 
[24]. This is compatible with our model which also provides a possible mechanism 
to explain how transition zone proteins may regulate ciliary protein composition by 
providing specific docking points at the entry to the ciliary compartment. Dysfunction of 
transition zone proteins can lead to a variety of ciliopathies and it is likely that abnormal 
ciliary protein composition is at least in part responsible for the observed disease 
phenotypes even in the absence of ciliogenesis defects. This provides an opportunity 
for the development of pathway-specific therapies aiming at modulating trafficking 
routes and restoring normal ciliary protein content. In this perspective, unraveling the 
cell biological function of disease genes such as CC2D2A as presented in the current 
study is a prerequisite for the future development of pharmacological treatments for 
patients with ciliopathies.
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4.  MATERIAL AND METHODS 
4.1  Zebrafish 
Zebrafish (Danio Rerio) were maintained as described [50]. The cc2d2aw38/sentinel 
mutant (referred to as cc2d2a mutant or cc2d2a-/-) was previously described [25,51,52]. 
The transgenic Tg(wt1b:EGFP) line was previously described [53]. Embryos were raised 
at 28°C in embryo medium and pigment development was inhibited by phenylthiourea 
as described in Westerfield [50].  ninl translation-blocking (5’-CATCCTCGTCCATCCCAC
CACATAC-3’) morpholino (MO) and splice blocking (5’-CCCAACACTAAAGAGATACACCA
AT-3’) morpholinos were designed by Gene Tools Inc. (USA) and 1nl was injected into 
zebrafish embryos at the one-cell stage. After a titration curve, we established that 
2ng/nl was the optimal phenotypic dose consistently causing the major phenotypes 
without significant cell death, while at the low dose of 0.75ng/nl, no phenotypes were 
observed (therefore called the “sub-phenotypic dose”). For the splice morpholino, the 
optimal phenotypic dose was 4ng/nl. For rescue experiments, cDNA encoding full 
length human NINL isoform B was cloned into a pCS2+ vector made compatible with 
the Gateway system (Invitrogen, USA), pCS2+/DEST, and subsequently transcribed with 
the SP6 Message Machine kit (Ambion, USA) according to manufacturer’s instructions. 
The cherry-Rab8a construct was previously described [25]. All quantifications were 
performed blinded as to injection status. All animal protocols were in compliance with 
internationally recognized guidelines for the use of fish in biomedical research and 
experiments and were approved by the local authorities (Veterinäramt Zürich TV4206).
4.2  Plasmids 
pDONR201 vectors containing cDNA encoding human NINL isoform A and B as well 
as aa 1-998, aa 433-637, aa 992-1177 of human CC2D2A were previously described 
[31,52]. Using Gateway cloning technology, cDNA fragments encoding aa 992-1620 
and aa 1171-1620 of human CC2D2A (NM_001080522) were cloned in pDONR201 
according to manufacturer’s instructions. pEGFP-C1-MICAL3 was kindly provided by Dr. 
A. Akhmanova (Utrecht University, The Netherlands).
4.3  Yeast two-hybrid interaction assay
The direct interaction between CC2D2A and other ciliary proteins was tested using 
a GAL4-based yeast two-hybrid system (Hybrizap, Stratagene, USA) as previously 
described [30]. The DNA binding domain (GAL4-BD) fused to full length CC2D2A was 
used as a bait to test the interaction with previously described ciliopathy and cilium-
associated proteins fused to an activation domain (GAL4-AD). Constructs encoding 
GAL4-BD and GAL4-AD fusion proteins were co-transformed in yeast strain PJ69-4A. The 
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direct interaction between baits and preys induced the activation of the reporter genes, 
resulting in the growth of yeast colonies on selective media (deficient of histidine and 
adenine) and induction of α-galactosidase and β-galactosidase colorimetric reactions 
[54].
4.4  Affinity purification of protein complexes
HEK293T cells transiently expressing the SF-TAP tagged NINLisoB were grown in 
SILAC DMEM (PAA) supplemented with 3 mM l-glutamine (PAA), 10% dialyzed fetal 
bovine serum (PAA), 0.55 mM lysine, and 0.4 mM arginine. Light SILAC medium was 
supplemented with 12C6,
14N2 lysine and 
12C6,
14N4 arginine. Heavy SILAC medium was 
supplemented with either 13C6 lysine and 
13C6,
15N4 arginine or 
13C6,
15N2 lysine and 
13C6,
15N4 
arginine. 0.5 mM proline was added to all SILAC media to prevent arginine-to-proline 
conversion [55]. All amino acids were purchased from Silantes. For one-step Strep 
purifications, SF-TAP–tagged proteins and associated protein complexes were purified 
essentially as described previously [37,56]. HEK293T cells transiently expressing the SF-
TAP tagged constructs were lysed in lysis buffer containing 0.5% Nonidet-P40, protease 
inhibitor cocktail (Roche), and phosphatase inhibitor cocktails I and II (Sigma-Aldrich) in 
TBS (30 mM Tris-HCl, pH 7.4, and 150 mM NaCl) for 20 minutes at 4°C. After sedimentation 
of nuclei at 10,000 g for 10 minutes, the cleared lysates were transferred to Strep-Tactin-
Superflow beads (IBA) and incubated for 1 hour before the resin was washed 3 times with 
wash buffer (TBS containing 0.1% NP-40 and phosphatase inhibitor cocktails I and II). 
The protein complexes were eluted by incubation for 10 minutes in Strep-elution buffer 
(IBA). After purification, the samples were precipitated with chloroform and methanol 
and subjected to in-solution tryptic cleavage as described previously [57]. LC-MS/MS 
analysis was performed on an Ultimate3000 nano HPLC system (Dionex) coupled to a 
LTQ OrbitrapXL mass spectrometer (Thermo Fisher Scientific) by a nanospray ion source. 
The raw data were analyzed using Sequest (Thermo Fisher Scientific) or Mascot and 
Scaffold (Proteome Software) as described previously [57]. Proteins were considered to 
be specific protein complex components if they were not detected in the control and 
were detected at least twice with two or more peptides (peptide probability >80%) in 
three experiments. The protein probability threshold was set to 99%. 
4.5  Knockdown of NINL and CC2D2A in cultured hTERT-RPE1 cells by RNAi
Three Silencer Select siRNAs targeting NINL and CC2D2A were purchased from Life 
Technologies (targeting sequences are listed in Supplementary Table 2). For transfection, 
a pool of three siRNAs per gene (45 nM final concentration) were plated in MW12 plates 
with or without glass slides. Lipofectamine RNAiMax (LifeTechnologies) and Opti-
MEM (LifeTechnologies) were added to the duplexes and incubated for 10-20 minutes 
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according to manufacturer’s protocol to allow the formation of transfection complexes. 
Human telomerase reverse transcriptase-transformed retinal pigment epithelium 
(hTERT-RPE1) cells from American Type Culture Collection (ATCC) were then plated 
in MW12 plates. Per plate, non-targeting Silencer Select duplexes (LifeTechnologies) 
were included as negative controls. After 24 hours of transfection, cells were serum-
starved to induce ciliogenesis. After 72 hours of transfection, knockdown-efficiency 
was determined by isolating total RNA from one 12-well with Trizol (Invitrogen, USA), 
followed by first-strand cDNA synthesis (iScript; Bio-Rad, USA). Quantitative PCRs using 
GoTaq (Promega), with validated NINL-, CC2D2A- and GUSB-specific primers (sequences 
are listed in Supplementary Table 3), were performed as previously described [31]. The 
second 12-well of cells were fixed with 2% paraformaldehyde, permeabilized with 1% 
Triton-X-100/PBS and stained with anti-MICAL3 antibodies (kindly provided by Dr. A. 
Akhmanova). Images were taken with an Axioplan2 Imaging fluorescence microscope 
(Zeiss, Germany) equipped with a DC350FX camera (Zeiss, Germany). 
4.6  Co-immunoprecipitation in HEK293T cells
HA-tagged NINL isoform B was expressed by using the mammalian expression vector 
pcDNA3-HA/DEST, FLAG-tagged CC2D2A, LRRK2 and STRAD by using p3xFLAG-CMV/
DEST and strep-FLAG-tagged NINL isoform B by using pNTAPe5/DEST from the Gateway 
cloning system (Invitrogen, USA). eGFP and eGFP-tagged MICAL3 were expressed from 
pEGFP-C1 (Clontech, USA). All plasmids contain a CMV promoter. HEK293T cells were 
co-transfected using Effectene (Qiagen, USA) according to manufacturer’s instructions. 
Twenty-four hours after transfection cells were washed with PBS and subsequently lysed 
on ice in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1% Triton-X-100 supplemented 
with complete protease inhibitor cocktail (Roche, Germany)). HA-tagged NINL isoform B 
was immunoprecipitated from cleared lysates overnight at 4°C by using rat monoclonal 
anti-HA-beads (Roche, Germany), while FLAG-tagged CC2D2A, LRRK2, STRAD and NINL 
isoform B were immunoprecipitated by using monoclonal anti-FLAG M2 Agarose beads 
(Sigma, Germany) and eGFP-tagged MICAL3 was immunoprecipitated using anti-GFP 
polyclonal antibodies (Abcam) coupled to ProtA/G beads (Santa Cruz, USA). After 4 
washes in lysis buffer, the protein complexes were analyzed on immunoblots using the 
Odyssey Infrared Imaging System (LI-COR, USA). Tagged molecules were detected by 
anti-HA, anti-FLAG or anti-GFP mono- or polyclonal antibodies. As secondary antibody 
IRDye800 goat-anti-mouse IgG (Rockland Antibodies and Assays) and Alexa Fluor 680 
goat-anti-rabbit IgG (Life Technologies) were used.
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4.7  Immunohisto- and immunocytochemistry
Zebrafish larvae were fixed in 4% paraformaldehyde (PFA) overnight at 4°C, embedded 
in OCT and cryosectioned following standard protocols. Sections were blocked using 
PBDT (PBS, 1% DMSO, 0.1% Triton X, 2mg/ml BSA) with 10% goat serum for 30 minutes 
at RT before incubation with primary antibodies overnight. Primary antibodies were 
mouse monoclonal anti-acetylated alpha tubulin (1:500, clone 6-11B-1, Sigma), mouse 
monoclonal anti-polyglutamylated tubulin GT335 (1:500, gift from C. Janke, Institut 
Curie, France), mouse anti-zebrafish Cc2d2a (1:20, [25]), rabbit anti-NINL (1:100; LSBio 
Cat# LS-C201509), mouse anti-pan centrin 20H5 (1:200, clone 20H5 Millipore), mouse 
anti-Rab8a (1:100, clone 3G1 Novus Biologicals), mouse anti-opsin 4D2 (1:100, gift from 
R. Molday, University of British Columbia) and rabbit anti-Ift88 (gift from B. Perkins [58], 
Cleveland Clinic), mouse monoclonal anti-FLAG (1:1000, Sigma), rabbit polyclonal anti-
human MICAL3 [39]. Secondary antibodies were Alexa Fluor goat anti-rabbit or goat 
anti-mouse IgG (Life Technologies) used at 1:300. Bodipy (1:300, Invitrogen) was applied 
for 20 minutes after the secondary antibodies and nuclei were counterstained with 
DAPI. Rab8 puncta detected by immuno-staining using the mouse anti-Rab8 antibody 
were analyzed blinded as to injection status in ImageJ. A region of interest was manually 
determined on single confocal sections and was thresholded (always with the same 
parameters); the “analyze particles” function of ImageJ was then used to determine the 
number of puncta per µm2. For quantification of intracellular fluorescence after 4D2 
(opsin) immuno-staining, a region of interest including 10-15 photoreceptor cell bodies 
was determined on single confocal sections using ImageJ and the mean grey value was 
measured. For quantification of the proximal pronephric area, the fluorescent region 
corresponding to the glomerulus and the proximal tubules up to the curved part of 
the tubule was outlined manually in ImageJ and the “measure” function was used to 
determine the area of the outlined region. All quantifications were performed blinded 
as to injection status. Confocal imaging was performed on a Leica HCS LSI.
4.8  Paraffin sections and Transmission Electron Microscopy
For paraffin sections, 4 dpf old ninl morphant larvae were fixed in 4% PFA overnight at 
4°C, embedded in paraffin and sectioned following standard protocols. For Transmission 
Electron Microsopy, ninl morphant and control larvae were fixed overnight at 4°C in 
a freshly prepared mixture of 2,5 % glutaraldehyde and 2% paraformaldehyde in 
0.1 M sodiumcacodylate buffer (pH 7.4). After rinsing in buffer, specimens were 
post-fixed in a freshly prepared mixture, containing 1% osmiumtetroxide and 1% 
potassiumferrocyanide in 0.1 M sodiumcacodylate buffer (pH 7.4), during 2 h at room 
temperature. After rinsing, tissues were dehydrated through a graded series of ethanol 
and embedded in epon. Ultrathin (rostrocaudally) sections (70nm), comprising zebrafish 
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eyes at the optic nerve level, were collected on formvar coated grids, subsequently 
stained with 2% uranyl acetate and Reynold’s lead citrate, and examined with a Jeol1010 
electron microscope.
4.9 Sequencing of NINL in a cohort of Joubert syndrome patients
346 individuals (from 291 families) with Joubert syndrome (JBTS) from the University 
of Washington Joubert Research Center were examined for mutations in NINL. 
Minimal enrollment criteria included clinical findings of JBTS (intellectual impairment, 
hypotonia, ataxia) and diagnostic or supportive brain imaging findings, or presence of 
a sibling with JBTS along with supportive clinical or imaging features. Procedures were 
approved by the Institutional Review Boards at the UW and Seattle Children’s Hospital, 
and all participants or their legal representatives provided written informed consent. 
Genomic DNA from peripheral blood or saliva was extracted and all NINL exons were 
captured by Molecular Inversion Probes (MIPS) [33]. Captured DNA was PCR amplified 
and sequenced on either the Illumina HiSeq or MiSeq platform. Sequence reads were 
mapped using the Burrows-Wheeler Aligner (BWA v.0.5.9). Variants were called using 
the Genome Analysis Tookit (GATK v2.5-2) and annotated with SeattleSeq (http://snp.
gs.washington.edu/SeattleSeqAnnotation138/). Minimal quality criteria for analyzed 
variants were DP (Depth) ≥ 8, QD (Quality by Depth) > 5, and ABHet (Heterozygous Allele 
Balance) <0.8. The variant list was then filtered for rare and deleterious variants. Only 
variants with minor allele frequency of <1% were considered given the rarity of JBTS 
(estimated prevalence 1/80’000 [11]). All non-sense, frameshift and canonical splice-
site variants, as well as missense variants with Polyphen2 scores >0.8 were considered 
deleterious. Selected variants were Sanger confirmed.
4.10  Statistical Analyses
For all quantifications of zebrafish experiments, the Graphpad Prism6 software (http://
www.graphpad.com/scientific-software/prism/) was employed to generate scatter 
plots, calculate mean values and SEM values, and perform statistical tests. Continuous 
data was analyzed using two-tailed, unpaired Student’s t-test and categorical data was 
analyzed using Fisher’s exact test.
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Figure S1. Cloning and characterization of zebrafish ninl. 
(a) Schematic representation of the protein structure of human NINLisoA and NINLisoB (H.s. NINLisoA and H.s. 
NINLisoB) and zebrafish ninl (D.r. ninl) as predicted by using the Pfam homepage (http://pfam.xfam.org/). (b) 
Ninl expression during zebrafish development by whole mount RNA in situ hybridization. Specific expression 
was found in the following structures as indicated by numbers and arrows: (a) 14 somite stage: otic placode 
(1); developing eye (2); neural tube (spinal cord) (3); (b) 18 somite stage: neural tube (3); pronephros (4); (c) 18 
somite stage: inner ear (1); optic nerve (5). (d) At 6 dpf, expression was observed in the tectum (6), the heart 
(7) and in the eye (2), predominantly in the photoreceptor cell layer. H.s.: homo sapiens; D.r.: danio rerio; CC: 
coiled-coil; som: somites; dpf: days post-fertilization.
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Figure S2. Specificity of the anti-Ninl antibody. 
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(a) Indirect immunohistochemical staining using anti-Ninl antibody on 4 dpf retinal cryosections of control 
MO-injected larvae (green signal) shows punctate staining, partially overlapping with the ciliary marker anti-
polyglutamylated tubulin (a’, a’’, red signal). (b) Indirect immunohistochemical staining using anti-Ninl antibody 
on 4 dpf retinal cryosections of ninl atgMO-injected larvae (b, green signal) along with the ciliary marker anti-
polyglutamylated tubulin (b’, b’’, red signal). Specific Ninl-immunofluorescence is largely abolished in ninl 
morphants, whereas the polyglutamylated tubulin signal is still detected. (c) Indirect immunohistochemical 
staining of anti-Ninl on 4 dpf retinal cryosections of ninl ex15 spMO-injected larvae (green signal) along with 
the ciliary marker anti-polyglutamylated tubulin (c’, c’’, red signal). Specific Ninl-immunofluorescence was 
still detected but at a diminished level in ninl morphants whereas the polyglutamylated tubulin signal was 
unaltered. Nuclei are stained with DAPI (blue signal). Scale bars: 4 µm. (d) Western blot analysis using protein 
extracts obtained from 100 zebrafish larvae injected with either control MO (6ng), ninl atgMO (2ng) or ninl 
ex15 spMO (4ng). A specific product was detected with a molecular weight of ~80kDa in control MO-injected 
larvae (left panel). This band was almost completely abolished in the ninl atgMO-treated larvae, but was still 
detected in ninl spMO-injected larvae although with a slightly diminished intensity. Anti-actin antibodies 
were used as a loading control (right panel). (e) Immunoprecipitation from bovine retinal extracts with anti-
human NINL antibody detects 3 bands, the strongest being of the same size as the band found on Western 
blot of zebrafish lysates (~80 kDa). 
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Figure S3. Phenotypes of the ninl atgMO. 
(a) Representative clutch of zebrafish larvae at 2dpf injected with the phenotypic dose of ninl atgMO (2ng/
nl). (b) Titration curve for the ninl atgMO illustrating the distribution of phenotypes in 2dpf larvae at two 
different concentrations: at 1ng/nl, a minority of injected larvae present a curved body shape (10%) and/
or ventriculomegaly (20%) (n=19). At ~2ng/nl, on average 66% of injected larvae present a curved body 
shape and ~40% present ventriculomegaly and/or pronephric cysts (n=84). 95% Confidence Interval bars are 
shown. (c) Representative 2dpf-old ninl atg-morphant displaying curved body shape, ventriculomegaly and 
pronephric cyst (arrow). (d-e) Dorsal view of 2dpf larvae showing the normal morphology of the brain folds in 
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wild-type (d) and the enlarged ventricle in morphants (e). (f-g) Transgenic Tg(wt1b:EGFP) zebrafish line used 
to highlight the larval pronephros, shows the morphology of the fused glomerulus and proximal tubules in 
wild-type (f) and the dilatation of the region in ninl morphants (“kidney cysts”, white arrow in g). (h) A clutch 
of ninl morphants at 4dpf. (i-j) TUNEL assay on 4dpf cryosections through retinas from ninl morphants shows 
the range of cell death detected (curved larvae in (h) were sectioned for the TUNEL assay). Note the absence 
of TUNEL-positive cells in the photoreceptor (PR) cell layer in the morphants. The ift88-/- retina is used as a 
positive control, given the known death of photoreceptors in this mutant at 4dpf. (l) Cryosection through a 
4dpf brain in a morphant larva displaying a dilated brain ventricle (v) shows no significant neuronal cell death. 
Scale bars represent 500 µm in (a) and (h), 100 µm in (c-g), 10 µm in (i-k) and 30 µm in (l). PR PhotoReceptors, 
INL Inner Nuclear Layer.
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Figure S4. Rescue of the morphant phenotype supports its specificity. 
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(a-d) Co-injection of 2 ng/nl ninl atgMO with 150 pg capped MO-resistant mRNA encoding human NINL 
isoform B reduced the incidence of body curvature defects from 71% in ninl atgMO injected larvae (n=207) 
to 36% in ninl atgMO + NINL mRNA injected larvae (n=203) (P<0.0001, two-tailed Fisher’s exact). A subset of 
these larvae were sectioned and a perfect correlation was observed in rescue between body curvature defects 
and defects in photoreceptor outer segment formation (a’-c’). (e) Quantification of the rescue of retinal outer 
segment length showing that mean OS length was rescued from 1.6 +/- 0.26 µm in ninl morphants to 3.8 +/- 
0.25 µm with co-injection of NINL mRNA (P<0.0001, unpaired Student’s t-test).
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Figure S5. Recapitulation of phenotype by a ninl ex15 spMO (4 dpf ). 
(a-b) Injection of 4ng ninl ex15 spMO (n>100) results in heart edema and small eyes. No defects in body 
curvature were observed in comparison to control MO-injected larvae. (a’, b’) Analyses of bodipy-stained 
retinas of ninl ex15 spMO-injected larvae (n=10) revealed defects in photoreceptor outer segment formation 
(10 of 10) similar to those observed in ninl atgMO-treated larvae, whereas stained retinas of control MO-
injected larvae (n=10) appeared normal (10 of 10). Scale bars represent 500µm (a-b) and 5µm (a’-b’). (c) 
RT-PCR analysis on RNA isolated from 25 larvae that were either uninjected, injected with control MO (6ng) 
or injected with various amounts of ninl ex15 spMO (2, 4, 6ng), collected at two different time points after 
injection (2 dpf and 4 dpf ). One PCR product of the expected length (~500bp) was obtained from RNA from 
uninjected and control MO-injected larvae. Sequence analysis revealed that this was the predicted transcript 
including exons 13-16. RT-PCR analysis on RNA obtained from the morphant larvae resulted in two products: 
Sequence analysis of both fragments revealed that the shorter product is the predicted wild-type transcript 
(ex13-16) and that the longer transcript in addition includes the entire intron14 (85 bp), resulting in premature 
termination of translation already after two codons in intron14. This aberrant splicing persists at 4dpf.
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Supplementary Table 1. TAP-data and SILAC data SF-TAP analysis with over-expressed 
N-terminally SF-TAP-tagged NINL in HEK293T cells. 
Shown are the number of unique identified peptides as well as the sequence coverage for each protein 
detected by mass spectrometry. Proteins identified in the SF-TAP analysis of empty vector control experiments 
were removed. SILAC analysis with over-expressed N-terminally SF-TAP-tagged NINL in HEK293T cells. Shown 
are the ratios and significance value for WT/SF-control experiments.
https://doi.org/10.1371/journal.pgen.1005575.s006
Supplementary Table 2. siRNA sequences
RefSeq 
Accession 
Number
Gene 
Symbol
Gene 
ID
siRNA 
ID
Sense 
siRNA Sequence
Antisense 
siRNA Sequence
NM_025176 NINL 22981 s22764 GGAGCAUCGUGUGACCAUUtt AAUGGUCACACGAUGCUCCtc
NM_025176 NINL 22981 s22763 GCCUGAAUCAGGAACAUCAtt UGAUGUUCCUGAUUCAGGCat
NM_025176 NINL 22981 s22765 CAGUGAGUAUAGAAACGGAtt UCCGUUUCUAUACUCACUGga
XM_940346 CC2D2A 57545 s33278 GCCUAUUCCUGAGACUACUtt AGUAGUCUCAGGAAUAGGCag
XM_940346 CC2D2A 57545 s33277 GAAUCAGUGAUAAAUCGUUtt AACGAUUUAUCACUGAUUCtc
XM_940346 CC2D2A 57545 s33279 CCAUGAUUCUGCACGAAAAtt UUUUCGUGCAGAAUCAUGGaa
Supplementary Table 3. Primer sequences
Name Fw Primer sequence (5’-3’) Rv primer sequence (5’-3’)
NINL#1 GGAAGGTTTTGTGGCTGTG AGGCAGCTGATTCCAAAG
NINL#2 CTGGGACAGGAGGCTTCTAC ATTTGGTCACTCTGCTGCTG
CC2D2A#1 AGGAAGCGTAACACCCAATG CCTGGACACCTCCTTGTTG
CC2D2A#2 AGGGTCCAACTGCCTATGTG ACAGCCCACATTTTTCAAGG
GUSB AGAGTGGTGCTGAGGATTGG CCCTCATGCTCTAGCGTGTC
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ABSTRACT
Mutations in USH2A are the most frequent cause of Usher syndrome and autosomal 
recessive nonsyndromic retinitis pigmentosa. To unravel the pathogenic mechanisms 
underlying USH2A-associated retinal degeneration and to evaluate future therapeutic 
strategies that could potentially halt the progression of this devastating disorder, an 
animal model is needed. The available Ush2a knock-out mouse model does not mimic 
the human phenotype, because it presents with only a mild and late-onset retinal 
degeneration. Using CRISPR/Cas9-technology, we introduced protein-truncating 
germline lesions into the zebrafish ush2a gene (ush2armc1: c.2337_2342delinsAC; 
p.Cys780GlnfsTer32 and ush2ab1245: c.15520_15523delinsTG; p.Ala5174fsTer). 
Homozygous mutants were viable and displayed no obvious morphological or 
developmental defects. Immunohistochemical analyses with antibodies recognizing the 
N- or C-terminal region of the ush2a-encoded protein, usherin, demonstrated complete 
absence of usherin in photoreceptors of ush2armc1, but presence of the ectodomain of 
usherin at the periciliary membrane of ush2ab1245-derived photoreceptors. Furthermore, 
defects of usherin led to a reduction in localization of USH2 complex members, whirlin 
and Adgrv1, at the photoreceptor periciliary membrane of both mutants. Significantly 
elevated levels of apoptotic photoreceptors could be observed in both mutants 
when kept under constant bright illumination for three days. Electroretinogram (ERG) 
recordings revealed a significant and similar decrease in both a- and b-wave amplitudes 
in ush2armc1 as well as ush2ab1245 larvae as compared to strain- and age-matched wild-
type larvae. In conclusion, this study shows that mutant ush2a zebrafish models present 
with early-onset retinal dysfunction that is exacerbated by light exposure. These models 
provide a better understanding of the pathophysiology underlying USH2A-associated 
RP and a unique opportunity to evaluate future therapeutic strategies.
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1.  INTRODUCTION
Usher syndrome is a rare genetic condition characterized by hearing impairment and 
a progressive loss of visual function as a consequence of Retinitis Pigmentosa (RP). The 
latter often results in legal blindness by the sixth decade of life 1. Currently there are 
no treatments for retinal degeneration in patients with Usher syndrome, although they 
benefit from hearing aids or cochlear implants. Usher syndrome is classified into three 
types (USH1, USH2 and USH3), varying in severity of hearing impairment, age at which 
RP is diagnosed, and presence or absence of vestibular dysfunction 2. Approximately 
two-thirds of USH patients present with USH2 3, up to 85% of whom can be explained 
by mutations in USH2A 4,5. Mutations in USH2A are also the most frequent cause of 
autosomal recessive RP (arRP), accounting for 7-23% of arRP cases 4. Approximately 600 
different, mostly private, mutations are evenly distributed over the gene and include 
point-nonsense, frame-shift, splice-modulating, and missense variants 6. However, there 
are a number of mutations that originate from a common ancestor and are therefore 
observed more frequently 6-8. The two most commonly found USH2A mutations are 
c.2299delG; p.Glu767fs and c.2276G>T; p.Cys759Phe, both residing in exon 13. Bi-alellic 
truncating defects of USH2A (nonsense mutations, frameshift mutations, or mutations 
that affect splicing), most often result in USH2, whereas the presence of at least one 
hypomorphic USH2A allele generally results in non-syndromic arRP 9. The distribution 
of known mutations and neutral variants from the LOVD database for USH2A does 
not reveal a particular mutation tolerant or intolerant region of the gene that could 
pinpoint particularly important functional domains 7. Despite ongoing efforts, little is 
known about either the physiological role(s) of the usherin protein in photoreceptors or 
the pathophysiological mechanism underlying USH2A-associated RP 4,10.
The USH2A transcript in retina consists of 72 exons and encodes a protein of 5,202 amino 
acids (usherin) 11,12. Moreover, a cochlea-specific exon has been identified between exons 
70 and 71 that encodes 24 additional amino acids 11. Usherin contains an N-terminal 
signal peptide, a Lam-G like domain, a LamNT domain, 10 EGF-lam domains, 4 FN3 
domains, two laminin G (LamG) domains, 28 FN3 domains, a transmembrane domain, 
and a short intracellular region with a C-terminal class I PDZ-binding motif. It is generally 
thought that usherin has a structural role at the periciliary region of the photoreceptor, 
where it is held in place via its interactions with harmonin (USH1C encoded), SANS 
(USH1G encoded) and whirlin (WHRN encoded, USH2d) 13-18. At the periciliary region, 
usherin possibly stabilizes the photoreceptor connecting cilium by an extracellular 
interaction with Adhesion G protein-coupled receptor V1 (ADGRV1; previously known 
as GPR98 or VLGR1) 11,19-21.
Understanding the molecular mechanisms underlying photoreceptor dysfunction in 
USH2A-associated RP and the development of treatment strategies have been severely 
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hampered by the absence of suitable cellular or animal models mimicking the human 
phenotype. Although mutant mouse models are commonly used to study RP and test 
therapeutic strategies, for USH and several other types of RP the retinal phenotypes in 
mouse models do not mimic that of patients with defects in the orthologous genes 
22. In contrast, retinal dysfunction from a very young age is observed in zebrafish 
USH1 gene mutants 23. Zebrafish larvae lacking Myo7aa (USH1b), harmonin (USH1c) 
or Pcdh15b (USH1f) function show reduced electroretinogram (ERG) traces by 5 to 7 
days post fertilization (dpf ) 24-26. Additionally, photoreceptor-specific degeneration has 
been shown to occur in ush2a depleted morphant larvae 27, as well as in myo7aa mutant 
larvae exposed to elevated light levels 26.
In this study, we generated and characterized two ush2a mutant zebrafish 
models (ush2armc1: c.2337_2342delinsAC; p.Cys780GlnfsTer32 and ush2ab1245: 
c.15520_15523delinsTG; p.Ala5174fsTer) to study usherin function in the retina. 
Subsequent functional analyses showed that usherin is absent from photoreceptors 
in ush2armc1, but that the extracellular domain of usherin can still be detected at the 
periciliary membrane of ush2ab1245-derived photoreceptors. The levels of usherin 
interaction partners Whrna and Whrnb (whirlin) are reduced at the photoreceptor 
periciliary membrane of homozygous ush2armc1 larvae, whereas in homozygous 
ush2ab1245 larvae only the level of Whrna is affected. Furthermore, mutant zebrafish 
display elevated levels of apoptotic cells in the outer retina as compared to strain and 
age-matched wild-type zebrafish upon constant light rearing. We further found that 
ERG traces are notably attenuated in both mutants, indicating impaired outer retinal 
function. These mutants are the first genetic animal models for ush2a that present with 
early-onset retinal dysfunction.
2. MATERIAL AND METHODS
2.1  Zebrafish maintenance and husbandry
Experimental procedures were conducted in accordance with international and 
institutional guidelines (Dutch guidelines, protocol #RU-DEC 2012-301; Swiss guidelines, 
Veterinäramt Zürich TV4206 and University of Oregon IACUC guidelines). Wild type 
adult Tupfel Long fin (TLF) or Oregon AB* zebrafish were used. The zebrafish eggs were 
obtained from natural spawning of wild-type or mutant breeding fish. Larvae were 
maintained and raised by standard methods 28.
2.2  CRISPR/Cas9 design and microinjection
For the ush2armc1 allele, oligos for generating guide RNAs were designed using the 
ZiFiT targeter software 29. Oligos were subsequently ordered from Integrated DNA 
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Technologies. Annealing of oligos was performed in a buffer (1 M NaCl, 10 mM EDTA 
and 100 mM Tris-HCl pH7.5) by incubation at 90°C for four minutes, followed by a ten 
minute-incubation step at 70°C and gradual cooling (5°C per two minutes) to 16°C. 
The annealed oligos were immediately ligated into the a BsaI (New England Biolabs, 
#R0535S) linearized pDR271 vector (Addgene plasmid #42250) using T4 ligase (New 
England Biolabs, #M0202). The oligo and surrounding sequences were excised from 
the pDR274 vector using DraI (New England Bioloabs, #R0129S). The excised DNA band 
(284 basepairs) was subsequently used as a template for in vitro transcription using 
the MAXIscript® T7 Transcription Kit (Ambion life technologies, #AM1314) according 
the manufacturer’s protocol. Obtained transcripts were purified using the MEGAclear™ 
Transcription Clean-Up Kit (Ambion life technologies, #AM1908). For the ush2ab1245 
allele, gene specific oligos were designed by flanking the 20 bp target sequence with T7 
promoter and gRNA sequence: 5`-AATTAATACGACTCACTATA-[20 bp Target Sequence]-
GTTTTAGAGCTAGAAATAGC-3`. The templates for gRNA syntheses were PCR amplified 
using the gene specific oligo with a gRNA scaffolding primer: 5`-GATCCGCACCGACTC
GGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAA
AC-3`. As input 13.4 µl water, 4ul 5x Phusion DNA polymerase buffer, 0.4 µl dNTPs (10 
µM), 1 µl of gene specific oligo (10 µM), 1 µl of gRNA scaffold oligo (10 µM), 0.2 µl Phusion 
DNA polymerase. The cycling conditions were as follows: 98°C 30 seconds, 40 cycles of 
98°C 10 seconds, 60°C 10 seconds, 72°C 15 seconds and 72°C 10 minutes. PCR products 
were column purified and used to prepare gRNA with the Ambion T7 megascript 
kit (AM1344) as per manufacturer’s instructions. A zebrafish codon-optimized Cas9 
containing vector (pT3TS-nCas9n; Addgene plasmid #46757) was used to generate Cas9 
mRNA. The vector was linearized using XbaI (NEB, #R0145S) and used as a template for 
an in vitro transcription reaction using the mMESSAGE mMACHINE® T3 Transcription 
Kit (Ambion life technologies, #AM1348) according to manufacturer’s instructions. 
Transcripts were purified using the MEGAclear™ Transcription Clean-Up Kit (#AM1908). 
Zebrafish embryos at a 1-cell stage were injected with 1 nl of a mixture containing gRNA 
(6 ng/µl), Cas9 mRNA (150 ng/µl), KCl (0.2 M) and phenol red (0.05%) using a Pneumatic 
PicoPump pv280 (World Precision Instruments) for the generation of the ush2armc1 allele. 
To generate the ush2ab1245 allele, one-cell stage zebrafish embryos were injected with 
1 nl of a mixture containing gRNA (100 ng/µl), Cas9 mRNA (150 ng/µl), KCl (0.2 M) and 
phenol red (0.05%) using an MPPI-2 Pressure Injector with a BP-15 Back Pressure Unit 
(Applied Scientific Instrumentation, Oregon USA). After injection, embryos were raised 
at 28.5°C in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM 
MgSO4), supplemented with 0.1% (v/v) methylene blue. At 2.5 days post fertilization, part 
of the injected embryos were analyzed for the presence of desired mutational events. 
When mutations could be detected, the remainder of injected embryos was raised.
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2.3  Genotyping
Genomic DNA was isolated from pools of 15 larvae after incubation in 75 µl lysis buffer 
(10 mM Tris HCl pH=8.2, 10 mM EDTA, 100 mM NaCl and 0.5 % SDS) supplemented 
with freshly added proteinase K (final concentration of 0.20 mg/ml, Invitrogen 
#25530049) at 55oC for two hours. The isolated genomic DNA was subsequently 
used as a template in a PCR. Primers used for the amplification of ush2a exon13 are 
5’-TCCACCAACAGAATCTAAATCTTTC-3’ and 5’-CTGATTTGTAAATGGTGTTGGG-3’ and 
primers used for the amplification of ush2a exon71 are 5’-CATGTTTTGGTTATCTGTT-
CTTCT-3’ and 5’-GACAGCGGAATGGTGAGATAAAC-3’. The obtained amplicons were 
cloned into a pCR®4-TOPO® vector (Invitrogen, #450030) according to manufacturer’s 
instructions. Individual clones were analyzed for the presence of mutational events 
using the ABI PRISM Big Dye Terminator Cycle Sequencing V2.0 Ready Reaction kit and 
the ABIPRISM 3730 DNA analyzer (Applied Biosystems).
2.4  Transcript analysis
Pools of 15 larvae were snap frozen in liquid nitrogen and subsequently homogenized in 
500 µl QIAzol (Qiagen, #79306) using a 25 gauge 16 mm needle. Total RNA was isolated 
using phenol:chloroform extraction and precipitated using isopropanol. Extracted total 
RNA was further purified and DNAse treated using a NucleoSpin® RNA II Isolation kit 
(Macherey-Nagel, #740955.50, Düren, Germany) according to manufacturer’s protocol. 
Subsequently, 0.5-1.0 μg of total RNA was used as a template for cDNA synthesis 
using SuperScript III RT (Life Technologies, #11755050, Carlsbad (California) - United 
States). An ush2a amplicon (1096 bp) of homozygous rmc1 larvae was amplified 
using with primers located in exon11 (5’-AGCGCTGTCGGAGTCTCTTC-3’) and exon14 
(5’-CCATCACTGACCGGTCACAG-3’). An ush2a amplicon (710 bp) of homozygous b1245 
larvae was amplified using primers located in exon68 (5’-TGGACTGGAGTGGCTCTTTC-3’) 
and exon73 (5’-GATGAGGACTTTGGAGAGACCA-3’). 
2.5  Antibodies and Immunohistochemistry 
Dissected adult eyes (12-18 mpf) and larval zebrafish (4-6 dpf ) from homozygous 
ush2armc1 and ush2ab1245 mutants and their age and strain-matched wild-type controls 
were cryoprotected with 10% sucrose in PBS for 30 minutes prior to embedding in 
OCT compound (Tissue-Tek, 4583, Sakura). After embedding, samples were slowly 
frozen down using melting isopentane. To assess retinal morphology, cryosections 
(7 µm thickness along the lens/optic nerve axis) were fixed for 10 minutes with 
paraformaldehyde (PFA) 4%, stained with hematoxylin and eosin and analysed on a Zeiss 
Axioskop light microscope. For analysis by scanning confocal microscope, embryos were 
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fixed in 4% PFA overnight at 4°C, washed 3x in PBS-T, dehydrated in 100% methanol, 
rehydrated in descending methanol series and washed several times in PBS-T before 
being cryoprotected in 30% sucrose for several hours at room temperature. Larvae were 
then embedded in molten agarose blocks, frozen, and sectioned on a cryomicrotome. 
For immunofluorescence on unfixed cryosections (7 µm thickness) were permeabilised 
for 20 minutes with 0.01% Tween20 in PBS. Sections were rinsed 3 times for 5 minutes 
with PBS and blocked for 1 hour with blocking buffer (10% normal goat serum and 2% 
bovine serum albumin in PBS). Antibodies diluted in blocking buffer were incubated 
overnight at 4 oC. Secondary antibodies were also diluted in blocking buffer and 
incubated together with DAPI (1:8000; D1306; Molecular Probes) for 1 hour. Sections 
were post fixed with PFA 4% for 10 minutes and mounted with Prolong Gold Anti-fade 
(P36930; Molecular Probes). For immunofluorescence on fixed cryosectioned tissue 
(16µm thickness), slides were hydrated 10 minutes in PBS-T, then immersed in Sodium 
Citrate solution at pH 8.5 and heated in a pressure cooker for 10 minutes. After cooling to 
37°C, slides were washed twice in PBS-T, blocked in 10% NFDM in PBS-T and incubated 
with primary antibodies. The following primary antibodies and dilutions were used: 
rabbit anti-active caspase 3 (1:500; #559565; BD Pharmingen), rabbit anti-Whrnb (1:300; 
#42690002 Cip98a; Novus Biological), rabbit anti-Whrna (1:300; #42700002 Cip98b; 
Novus Biological), rabbit anti-usherin-C (1:500; #27640002; Novus Biological), rabbit 
anti-Adgrv1 (1:1000) 27 and as marker for connecting cilium region in photoreceptor 
cells we used mouse anti-centrin (1:500; # 04-1624; Millipore) or acetylated a-tubulin 
(Sigma T7451). Secondary antibodies (Alexa Fluor 568 goat anti-rabbit (A11011), Alexa 
Fluor 488 goat anti-guinea pig (A11073) and Alexa Fluor 488 goat anti-mouse (A11029)), 
derived from Molecular Probes, were used in a 1:800 dilution. Images were taken using 
a Zeiss Axio Imager fluorescence microscope equipped with an AxioCam MRC5 camera 
(Zeiss) or a Zeiss LSM5 Confocal. The intensity of Whrna and Whrnb immunofluorescence 
was measured in FIJI version 1.47v 58 . First, the outer segment layer was isolated based 
on the centrin immunostaining. Subsequently, a mask was made based on the centrin 
staining using the “Find Maxima” option (noise=50), and dilated five times. To find 
the exact location of Whrna or Whrnb staining, the centrin mask and Whrn layer were 
combined. Find Maxima (noise=10) was used to identify the Whrn staining within the 
Centrin mask. The resulting mask was dilated three times and touching objects were 
separated using the watershed option. Subsequently, the maximum gray value of the 
identified regions was measured on the original image of Whrn immunofluorescence 
(Analyze Particles option; size=0-50, pixel circularity=0.00-1.00). Active caspase-3 
labeled cells were analyzed on a Zeiss fluorescence microscope by manually counting 
positively stained cells in the ONL. 
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2.6  Constant light rearing
For constant light treatment, embryos were raised in transparent 10-cm petri dishes 
under normal conditions and were placed under constant light from 5-8 dpf. From 5 dpf 
onwards, ush2armc1 larvae were either maintained in facility conditions of 300 lux white 
light in a 14/10h day/night rhythm or were exposed to continuous white light with an 
intensity of 3000 lux, using a 150 W LED light source (Zeiss). ush2ab1245 larvae were either 
maintained in facility conditions of 300 lux white light in a 14/10h day/night rhythm 
or were exposed to continuous white light with an intensity of 3000 lux using two LED 
strips (Westek) mounted in parallel. Light input: 12V DC, transformer input 120V ~60Hz, 
transformer output 12V DC, 6W max. Light intensities were measured at water level 
using a lumino meter (Testo 540, Lenzkirch, Germany or Advanced Light Meter 840022, 
Sper Scientific, Arizona, USA).
2.7  Fixation and pre-embedding labeling for immunoelectron 
microscopy 
For immunoelectron microscopy of adult zebrafish retinas, we followed the previously 
published protocol for pre-embedding labeling 20,30,31. In brief, rabbit anti-usherin C 
(1:500; #27640002; Novus Biological) was applied on vibratome sections of pre-fixed (4% 
PFA) murine eye-cups, followed by incubation with biotinylated secondary antibodies. 
Antibody reactions were visualized by a Vectastain ABC-Kit (Vector Laboratories) and 
0.01% hydrogen peroxide to 0.05 M diaminobenzidine (DAB) solution was added. Stained 
retinas were ﬁxed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4), followed 
by silver enhancement of DAB precipitates and post-ﬁxation in cacodylate buffered 
0.5% OsO4 on ice. Dehydrated specimens were ﬂat-mounted between two sheaths 
of ACLAR-ﬁlms (Ted Pella Inc., Redding, USA) in Araldite resin. Ultrathin sections were 
made using a Reichert Ultracut S ultramicrotome (Leica), collected on Formvar-coated 
copper or nickel grids and counterstained with 2% uranyl acetate in 50% ethanol aund 
aq. 2% lead citrate. Ultrathin sections were analysed in a Tecnai 12 BioTwin transmission 
electron microscope (FEI, Eindhoven, The Netherlands). Images were obtained with a 
CCD camera (charge-coupled-device camera; SIS MegaView3; Surface Imaging Systems, 
Herzogenrath, Germany) and processed with Adobe Photoshop CS (Adobe Systems).
2.8  Electroretinogram (ERG) recordings
ERG recordings were performed on isolated larval eyes (5-7 dpf ) as previously described 32. 
Larvae were dark-adapted for a minimum of 30 min prior to the measurements and 
subsequently handled under dim red illumination. The isolated eye was positioned to 
face the light source. Under visual control via a standard microscope equipped with 
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red illumination (Stemi 2000C, Zeiss, Oberkochen, Germany), the recording electrode 
with an opening of approximately 20 μm at the tip was positioned at the center of the 
cornea. This electrode was filled with E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 
mM CaCl, and 0.33 mM MgSO4). The electrode was positioned using a micromanipulator 
(M330R, World Precision Instruments Inc., Sarasota, USA). A custom-made stimulator 
was invoked to provide light pulses of 100 ms duration, with a light intensity of 6000 lux. 
It uses a ZEISS XBO 75W light source and a fast shutter (Uni-Blitz Model D122, Vincent 
Associates, Rochester, NY, USA) driven by a delay unit interfaced to the main ERG 
recording setup. Electronic signals were amplified 1000 times by a pre-amplifier (P55 
A.C. Preamplifier, Astro-Med. Inc, Grass Technology) with a band pass between 0.1 and 
100 Hz, digitized by DAQ Board NI PCI-6035E (National Instruments) via NI BNC-2090 
accessories and displayed via a self-developed NI Labview program 33. Statistical analysis 
was performed using SPSS Statistics 22 (IBM All the experiments were performed at 
room temperature (~22°C).
2.9  Statistical analyses
The Graphpad Prism software (version 5.03 for Windows, GraphPad Software, La Jolla 
California USA, www.graphpad.com) was used to generate scatter plots, calculate mean 
values, and perform statistical analysis using two-tailed unpaired Student’s t-tests or 
two-tailed Mann-Whitney tests. 
3.  RESULTS
3.1  Zebrafish and human usherin are highly conserved
Bioinformatic analyses of the zebrafish and human usherin protein sequence revealed 
that the proteins have a high degree of sequence similarity (52% identity; 68% 
similarity) and share a similar protein domain architecture (Fig. 1). We characterized 
the subcellular localization of usherin in the zebrafish retina with an antibody directed 
against the intracellular C-terminal region of usherin (anti-usherin-C). In adult zebrafish 
retina, usherin is not only present at the periciliary membrane of both cones and rods, 
but also apical to the cone connecting cilium (Fig. 2A, B and C; Fig. S1). Subsequent 
immunoelectron microscopy identified these structures as cone accessory outer 
segments (AOS) (Fig. 2D and E). AOS are structures that run along the photoreceptor 
outer segment and are predominantly found in cone photoreceptors of adult frogs and 
teleost fish 34. 
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Figure 1. Schematic presentation of zebrafi sh usherin. 
Motif alignment of human and zebrafi sh usherin. Both proteins have an identical predicted domain 
architecture. EGF-lam, laminin-type epidermal growth factor-like domain; LamG, laminin G domain; LamG-
like, LamG-like jellyroll fold domain; LamNT, laminin N-terminal domain; FN3, fi bronectin type 3 domain. 
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Figure 2. Usherin localizes at the periciliary membrane and accessory outer segments of adult 
zebrafi sh photoreceptor cells. 
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(A) Retinal sections of wild-type adult zebrafish are labeled for usherin (green signal) and the connecting 
cilium marker centrin (magenta signal). (B) Usherin labeling at the periciliary region of rod photoreceptors 
is present adjacent to the connecting cilium marked by centrin (indicated by an arrow head). (C) In cones, 
usherin is also detected at the periciliary region (arrow heads) as well as apical to the connecting cilium 
marked by centrin labeling (arrows). Nuclei were stained with DAPI (blue signal). (D, E) Electron microscopy 
images of adult zebrafish retinas show that usherin localizes at the periciliary membrane (arrowheads) as well 
as in the accessory outer segments (AOS; arrow) of cone photoreceptors. Scale bars in A: 10 µm; B: 3 µm; C: 
3 µm; D: 1 µm E: 0.1 µm. CC: connecting cilium, COS: cone outer segment, CP: calyceal processes, ONL: outer 
nuclear layer, OS: outer segment, ROS: rod outer segment, RPE: retinal pigment epithelium.
3.2  Generation of zebrafish ush2armc1 and ush2ab1245 mutants
Using CRISPR/Cas9 technology, we generated two ush2a mutant alleles (sequences in 
Fig. S3). ush2armc1 contains a frameshift mutation in ush2a exon13 (c.2337_2344delinsAC; 
p.Cys780GlnfsTer32), that is predicted to result in the premature termination of 
translation of usherin (Fig. 3A). ush2ab1245 harbors a frameshift mutation in ush2a exon71 
(ENSDART00000086201.4; c.15520_15523delinsTG; p.Ala5174fsTer), predicted to encode 
an usherin protein that retains the transmembrane domain but lacks the C-terminal 62 
amino acids of the intracellular region including the class I PDZ binding motif. This allele 
provides an opportunity to assess the functional importance of the intracellular region, 
including the PDZ-binding motif, relative to the ectodomain of usherin (Fig. 3A). Both 
homozygous mutants were viable and no abnormalities in morphology, development, 
or swimming behavior were observed.
3.3  ush2armc1 and ush2ab1245 do not affect ush2a pre-mRNA splicing
In patient-derived fibroblasts, the USH2A c.2299delG mutation results in skipping of 
USH2A exon12 and exon13 in some transcripts, or in skipping of exon13 only 35. Recent 
studies showed that CRISPR/Cas9-induced exonic lesions could also induce an (in-
frame) skipping of the targeted exon thereby preventing generation of a functional 
knock-out model 36. If the lesion introduced in the ush2armc1 mutant causes an in-frame 
skipping of exon 13, this could potentially result in expression of a shortened usherin 
with residual function. Similarly, the c.15520_15523delinsTG (ush2ab1245) mutation is 
predicted to disrupt an exonic splice enhancer site and potentially induce skipping of 
exon71, thereby also leaving the ush2a open reading frame intact. We, thus, analyzed 
ush2a transcripts in homozygous ush2armc1 and ush2ab1245 larvae to assess whether 
the introduced lesions would result in alternative ush2a pre-mRNA splicing events. 
Amplicons spanning exon13 or exon71 and their surrounding exons were amplified by 
RT-PCR. Because no alternatively spliced ush2a transcripts were amplified from cDNA 
derived from homozygous ush2armc1 or ush2ab1245 larvae (Fig. 3B and C), we expect that 
the introduced mutations in the rmc1 and b1245 alleles result in premature termination 
of usherin translation.
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Figure 3. ush2a transcript analyses in homozygous ush2armc1 and ush2ab1245 mutant zebrafish. 
(A) The locations of the mutations in ush2armc1 and ush2ab1245 are schematically depicted. (B) RT-PCR analyses 
of ush2a transcripts derived from homozygous ush2armc1 or (C) homozygous ush2ab1245 larvae (5 dpf ) provided 
no indications for an effect of the introduced lesions on pre-mRNA splicing. WT: wild-type, Mut: homozygous 
mutant, mQ: milliQ water.
3.4  ush2armc1 leads to absence of usherin, whereas ush2ab1245 results in 
truncated usherin at the periciliary region
Using zebrafish-specific anti-usherin antibodies directed against the N- or C-terminus of 
the protein, we evaluated the presence of usherin in the retina of homozygous ush2armc1 
and ush2ab1245 larvae and strain-matched (TLF or AB*, respectively) wild-type larvae at 5 
dpf. Anti-usherin-N is directed against an amino acid sequence present at the N-terminus 
of usherin. In wild-type larvae, both antibodies detected usherin adjacent to the basal 
body and connecting cilium marker, centrin (Fig. 4). In contrast, no usherin signal was 
detected in the retina of ush2armc1 mutant larvae using either anti-usherin antibody. 
Also in the retina of ush2ab1245 larvae, no signal was detected when using anti-usherin-C 
antibodies (Fig. 4A and B). However, a signal at the photoreceptor periciliary region 
of homozygous ush2ab1245 larvae was obtained when using anti-usherin-N antibodies. 
These results suggest that the truncated usherin protein still localizes appropriately 
at the membrane even though it lacks the C-terminal intracellular region and the PDZ 
binding motif (Fig. 4A and B). We conclude that ush2armc1 mutants completely lack 
usherin at the photoreceptor periciliary region and the mutation should be considered 
a true null allele, whereas ush2ab1245 should be considered a hypomorphic allele with 
potential residual function. 
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Figure 4. Localization of usherin in frontal cryosections of wild-type and mutant zebrafish retinas 
(5 dpf ). 
Zebrafish-specific anti-usherin-C (A) or anti-usherin-N (B) antibodies are employed (red signal). (A) In 
ush2armc1 as well as ush2ab1245 homozygous mutant larvae no signal was detected with the anti-usherin-C 
antibody, whereas in both TLF and AB* wild-type controls usherin was present adjacent to the connecting 
cilium marked by centrin (green signal). (B) No signal was detected in the retina of homozygous ush2armc1 
mutants using the anti-usherin-N antibody, however, a signal at the photoreceptor periciliary region was 
observed in the retina of homozygous ush2ab1245 larvae when this antibody was used. In wild-type controls, 
the anti-usherin-N antibody also detected usherin at the photoreceptor periciliary region. (n= 35 larvae, from 
5 biological replicates with TLF and ush2armc1 larvae, n= 64, from 8 biological replicates with AB* and ush2ab1245 
larvae). Nuclei are stained with DAPI (blue signal). Scale bars: 10 μm.
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3.5  Ablation of usherin affects the localization of Whrna and Whrnb in 
the retina 
Human Usherin was previously shown to interact directly with whirlin in vitro 16. The 
biological relevance of this interaction was confirmed by the absence of whirlin at the 
photoreceptor periciliary membrane of Ush2a knock-out mice 17. Here, we determined 
whether or not whirlin localization was also affected in the retina of homozygous ush2armc1 
and ush2ab1245 zebrafish larvae (5 dpf ). The zebrafish genome harbors two whirlin-
encoding orthologs. whrna (previously known as dfnb31a (ENSDARG00000075362)) 
encodes Whrna and whrnb (previously known as dfnb31b (ENSDARG00000068166)) 
encodes Whrnb. Whrna was found to be located at the photoreceptor periciliary region in 
wild-type larvae (Fig. 5A, Fig. S2). Reduced intensity of the Whrna signal was observed in 
the retinas of homozygous larvae of both ush2a mutants, which was further confirmed by 
quantification of fluorescence signal intensities (Fig. 5A). The same results were observed 
in homozygous ush2armc1 larvae when an anti-Whrnb antibody was employed (Fig. 5B, 
Fig. S2). In contrast, the intensity of the Whrnb signal was unaltered in photoreceptors 
of homozygous ush2ab1245 larvae as compared to AB* wild-type larvae (Fig. 5B).
3.6  Zebrafish ush2a mutants exhibit elevated levels of photoreceptor 
apoptosis
Based on the assumption that usherin is required for long-term maintenance of 
photoreceptor cells, we assessed whether absence of usherin in the zebrafish retina would 
lead to increased levels of apoptosis in the outer nuclear layer (ONL). Larvae were raised 
under a 14/10 hours light/dark cycle until 5 dpf. After 5 dpf, they were either raised for an 
additional 72 hours in regular facility conditions of 300 lux light intensity of a 14hr/10hr 
light/dark cycle, or exposed to constant light with an intensity of 3000 lux for 72 hours. A 
slight but significant increase in the amount of apoptotic photoreceptor cells was observed 
in 8 dpf ush2armc1 larvae raised in normal facility conditions (Fig. 6A). These results were 
consistent with our previously reported data on photoreceptor degeneration in larvae 
treated with a morpholino targeting an early splice junction in ush2a 27. Subsequently, 
we assessed the number of apoptotic events in ush2ab1245 mutant larvae. No significantly 
elevated levels of cell death in the ONL were observed when these larvae were raised 
under normal facility conditions (Fig. 6B). Constant light rearing with an elevated light 
intensity of 3000 lux significantly increased the amount of apoptotic cells in the ONL 
of both mutant alleles as compared to their strain-matched wild-type controls (Fig. 6A 
and B). Variations in the genetic backgrounds of the rmc1 and b1245 alleles, variances 
in the light sources used in the elevated light exposure assay, and other environmental 
differences between the two facilities where these experiments were conducted 
could contribute to the observed difference in the absolute number of apoptotic cells. 
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Figure 5. Ablation of usherin affects the localization of Whrna and Whrnb in the zebrafish retina 
(5 dpf ). 
(A) Intensity of Whrna labeling was significantly reduced in both ush2armc1 and ush2ab1245 mutants as compared 
to corresponding wild-types (n=35 larvae from 5 biological replicates with ush2armc1 mutant larvae and TLF 
larvae, and n=54 larvae from 7 biological replicates with ush2ab1245 mutant larvae and AB* larvae). Intensities of 
fluorescence using antibodies directed against Whrna (red signal) were quantified and plotted as scatter plots 
next to the corresponding images. Each dot represents the average grey-value per eye (n=5 ush2armc1 eyes and 
n=6 TLF larvae eyes, p<0.05 and n=10 ush2ab1245 and n=9 AB* eyes, p=<0.01, two-tailed unpaired Student’s 
t-test). (B) Whrnb labeling was reduced in ush2armc1 mutants, but unaltered in ush2ab1245 mutants compared 
to corresponding wild-types (n=35 larvae from 5 biological replicates with ush2armc1 mutant larvae and TLF 
larvae, and n=54 larvae from 7 biological replicates with ush2ab1245 mutant larvae and AB* larvae). Intensity 
of Whrnb labeling (red signal) was significantly reduced in ush2armc1 larvae as compared to wild-type (TLF) 
larvae (n=5 ush2armc1 eyes and n=6 TLF eyes, p<0.01, two-tailed unpaired Student’s t-test). In ush2ab1245 larvae, 
the intensity of Whrnb labeling appeared unaltered as compared to wild-type (AB*) larvae (n=27 eyes for 
both ush2ab1245 and AB* wild-type; p=0.57, two-tailed unpaired Student’s t-test). Nuclei were stained with DAPI 
(blue signal) and anti-centrin (green signal) was used as a marker for the connecting cilium. Scale bars: 10 μm, 
dpf: days post fertilization, a.u.: arbitrary units, * indicates p<0.05, ** indicates p<0.01, and ns: not significant.
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Figure 6. Quantification of apoptotic events in the ONL of zebrafish ush2a mutants (8 dpf ). 
Homozygous ush2armc1 and ush2ab1245 larvae were exposed either to 300 lux in a (14/10h) day/night rhythm or 
to continuous light at 3000 lux from 5-8 dpf. Individual dots represent the number of apoptotic cells in the 
ONL per eye. Strain matched wild-type TLF or AB* zebrafish were used as controls. (A) TLF and ush2armc1 larvae 
kept at 300 lux with a day/night cycle showed on average 0.2 (± 0.1; 30 eyes) and 0.8 (± 0.2; 28 eyes) apoptotic 
cells per eye, respectively (p<0.05). When kept under 3000 lux of continuous light, 1.7 (± 2.0; 34 eyes) and 
5.1 (± 4.5; 28 eyes) apoptotic cells per eye were observed in TLF and ush2armc1, respectively (p<0.01). (B) AB* 
and ush2ab1245  larvae maintained at 300 lux with a day/night cycle showed on average 2.5 (± 1.9; 28 eyes) 
versus 3.8 (± 2.3; 16 eyes) apototic cells per eye, respectively (n.s.). When kept under 3000 lux of continuous 
light, on average 4.2 (± 1.7; 23 eyes) versus 24.8 (± 7.9; 18 eyes) apoptotic cells per eye were observed in AB* 
and ush2ab1245, respectively (p<0.0001). Each point represents the number of apoptotic cells in the ONL per 
eye and the standard error of the mean are given as error bars.  * indicates p<0.05, ** indicates p<0.01, *** 
indicates p<0.0001, n.s.: not significant (two-tailed Mann-Whitney test); ONL: outer nuclear layer; dpf: days 
post fertilization.
Because significantly elevated levels of apoptotic events were seen in the ONL of 
ush2armc1 mutant larvae when kept at facility conditions, we examined whether retinal 
degeneration was progressive under these conditions. Retinal histology was analyzed 
for both homozygous ush2a mutants at 5 dpf and at 18 months of age, which revealed 
that cellular organization and retinal lamination in mutants was indistinguishable from 
those in wild-type controls. Moreover, photoreceptor outer segments of both ush2a 
mutants had a normal morphology (Fig. S4). The observed lack of progressive retinal 
degeneration in these mutants suggests that the rate of photoreceptor apoptosis might 
be compensated by the rate of photoreceptor regeneration when fish are raised in low-
intensity light.
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Figure 7. ush2a mutants show reduced retinal function. 
Average ERG traces from a cohort of homozygous ush2armc1 and ush2ab1245 larvae (5 dpf ) with age- and strain-
matched wild-type controls are depicted. Averages of the maximum ERG amplitudes are plotted as bar 
graphs ± standard deviation. (A-D) Normalized b-wave amplitudes recorded in both mutants are significantly 
reduced compared to ERG-traces from wild-type controls (n=72 TLF and n=75 ush2armc1, from 3 biological 
replicates, p<0.001, two-tailed unpaired Student’s t-test, and n=20 ush2ab1245 larvae and n=18 wild-type larvae, 
from 3 biological replicates, p<0.01, two-tailed unpaired Student’s t-test). (E-H) In both ush2a mutants, the 
a-wave amplitudes are significantly reduced as compared to strain-matched wild-type controls (n=10 for TLF 
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and ush2armc1, from 2 biological replicates, p<0.05, two-tailed unpaired Student’s t-test, and n=19 for AB* and 
n=23 for ush2ab1245, from 2 biological replicates, p<0.001, two-tailed unpaired Student’s t-test). * indicates 
p<0.05, ** indicates p<0.01 and *** indicates p<0.001.
3.7 ush2a mutants show reduced visual function 
To assess whether absence of usherin has implications for visual function in the ush2armc1 
and ush2ab1245 mutants, electroretinograms (ERGs) were recorded in 5 dpf ush2a 
mutant larvae and strain- and age-matched wild-type controls that were raised under 
normal facility conditions. In the zebrafish retina, a small negative a-wave generated 
by photoreceptor hyperpolarization is immediately followed by a large positive 
b-wave, generated largely by the depolarization of second-order ON-bipolar cells in 
response to photoreceptor hyperpolarization 37. The ERG maximum b-wave amplitudes 
were significantly reduced in homozygous ush2armc1 larvae as compared to age- and 
strain-matched wild-type controls (Fig. 7A and 7B). The same result was observed 
in homozygous ush2ab1245 larvae (5 dpf ) (Fig. 7C and 7D). To investigate whether the 
decreased inner retinal function was primarily mediated by a decrease in photoreceptor 
function, we recorded pharmacologically isolated a-waves by abolishing b-waves with 
glutamate receptor antagonists t-APB and TBOA. Maximum a-wave amplitudes in 
homozygous ush2armc1 larvae were significantly reduced compared to wild-type larvae 
(Fig. 7E and 7F). Again, a similar defect was detected in homozygous ush2ab1245 larvae, 
in which the maximum a-wave amplitudes were also significantly decreased compared 
to wild-type controls (Fig. 7G and 7H). Despite the absence of detectable retinal 
morphological defects, early-onset retinal photoreceptor dysfunction was recorded in 
both ush2a mutants.
4.  DISCUSSION
In this study we generated and characterized two zebrafish ush2a mutant models, 
ush2armc1 and ush2ab1245, in which different domains of usherin were ablated. No signal 
was detected in photoreceptors of either ush2armc1 or ush2ab1245 larvae when using an 
antibody targeting the intracellular C-terminal region. In contrast, truncated usherin 
was detected at the photoreceptor periciliary region of homozygous ush2ab1245 larvae 
when using an N-terminal usherin antibody, but not in ush2armc1. Absence of full length 
usherin resulted in reduced whirlin levels at the photoreceptor periciliary region. 
Furthermore, the rmc1 allele showed mild levels of photoreceptor degeneration at 8 dpf 
raised under normal facility conditions, whereas constant light rearing from 5-8 dpf with 
a light intensity of 3000 lux exacerbated photoreceptor degeneration in both mutants. 
Finally, both models presented with early-onset retinal dysfunction, as evidenced by 
significantly reduced ERG a- and b-wave responses recorded at 5 dpf. After complete 
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phenotypic evaluation of both alleles we conclude that the intracellular region of 
usherin is the most critical region in usherin required for visual function in zebrafish 
larvae.
Prior to this study, several USH mouse models were generated, which all presented with 
early-onset hearing defects, with or without vestibular dysfunction, closely resembling 
human inner ear USH defects 38. These models have contributed significantly to 
understanding the molecular pathology underlying USH-associated hearing loss 
17,39,40. Unfortunately, these mouse models only sporadically recapitulated retinal 
degeneration seen in USH patients. A spontaneous mutant mouse model, Kunming, was 
described for Usher syndrome type IIa 41. This model shows a rapid, early-onset retinal 
degeneration, but contains mutations in two genes known to be involved in inherited 
retinal dystrophies: Ush2a and Pde6b. A targeted Ush2a knock-out mouse demonstrates 
only mild retinal degeneration with late age of onset 19. A likely explanation for the 
discrepancy in phenotypic outcome between mice and humans lies within the 
anatomical differences between human and mouse photoreceptor cells. The most 
prominent subcellular locations in human photoreceptor cells where USH1 and USH2 
proteins have been found are the calyceal processes and the periciliary membrane 
15,20,42,43. In rodents, photoreceptor calyceal processes and periciliary membranes are 
absent or underdeveloped, respectively, compared to humans. In contrast, these 
structures are well-developed and present in frogs and teleost fish 22. Zebrafish mutants 
or morphants for USH1-associated genes myo7aa 26,44, cdh23 45,46, pcdh15 25 and ush1c 
24,47 have been described in the literature, most of them showing early-onset retinal 
dysfunction 23. Furthermore, we showed that morpholino-induced knock-down of 
ush2a expression induces photoreceptor cell death in zebrafish larvae 27. In this study 
we generated and characterized two zebrafish mutant models that will allow us to 
continue to investigate the molecular pathology underlying ush2a-associated retinal 
dysfunction and future therapeutic strategies.
Although the anatomical similarities between human and zebrafish photoreceptor 
cells are numerous, some differences have also been noted. Cone photoreceptors of 
adult teleost fish contain a cilium-like structure with a 9+0 arrangement of microtubule-
doublets. This structure, the accessory outer segment (AOS), protrudes from the 
connecting cilium and projects apically alongside the outer segment, eventually 
associating with the retinal pigment epithelium (RPE) 48. The function of the AOS is still 
unclear, but previous reports have suggested that the AOS provides structural support 
to the outer segment 49 and that it is involved in exchange of metabolites between 
RPE and cones 48-50. Moreover, in response to changes in ambient light conditions and 
to circadian signals during light-to-dark adaptation of the teleost retina, reversible 
retinomotor movements take place that result in contraction and elongation of rods 
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and cones to expose the outer segment optimally to incoming light 51,52. It has been 
postulated that by anchoring the cones to the pigment epithelium, the AOS may 
preserve the highly organized arrangement of the various types of cones in the fish 
retina 49. Previous experiments showed that the USH1b protein, myosin VIIa, is localized 
in the cone AOS 48, and we now discovered that usherin is present in these structures as 
well. It has been shown that myosin VIIa and usherin, together with Adgrv1 and whirlin, 
physically interact to form the ankle-link complex in cochlear hair cells 53. It is therefore 
tempting to speculate that within the AOS, myosin VIIa and usherin also form a complex 
that could be of importance for alignment and connection of the AOS to cone outer 
segments.
In humans, usherin and the other known USH2 proteins, whirlin and ADGRV1, form a 
dynamic protein complex that is mainly mediated by PDZ-PBM-based interactions 16,17. 
Previous research using knockout mice showed that usherin, whirlin, and Adgrv1 are 
mutually dependent on each other for their localization at the photoreceptor periciliary 
membrane 13,17. Whereas ush2a and adgrv1 are present as single copy genes, there are 
two zebrafish whirlin orthologs (whrna and whrnb). In larvae of the ush2armc1 allele, in 
which no usherin could be detected, we observed reduced levels of both Whrna and 
Whrnb at the periciliary membrane. In ush2ab1245 larvae, however, Whrna is significantly 
reduced at the periciliary membrane, whereas Whrnb appears unaffected. These 
observations fit a model in which the ectodomains of usherin and Adgrv1 interact 
while the intracellular regions of both proteins are anchored by whirlin (Fig. 8), as was 
previously proposed by Maerker and co-workers 15,20. Based on the results of the current 
study, Whrna seems to bind the intracellular region of usherin preferentially, whereas 
Whrnb predominantly associates with the intracellular region of Adgrv1. Complete 
absence of usherin (rmc1 allele) results in absence of both Whrna and Whrnb at the 
periciliary membrane and probably the complete USH2 complex including Adgrv1, 
similar to what was observed in the Ush2a knockout mouse 17. Immunohistochemical 
analyses using anti-Adgrv1 antibodies corroborated this hypothesis (Fig. S5). Absence 
of the C-terminal cytoplasmic region of usherin (b1245 allele) apparently affects the 
association with only the intracellular binding partner Whrna, leaving the remainder of 
the USH2 complex (Adgrv1 and Whrnb) intact (Fig. 8; Fig. S5). Thus, absence of zebrafish 
usherin affects localization of interaction partner whirlin. The observed differences in 
localization of both whirlin co-orthologs in the rmc1 and b1245 alleles suggest that 
Whrna and Whrnb have high binding-affinities for usherin and Adgrv1, respectively, and 
that they most probably have acquired divergent functions during evolution, consistent 
with the subfunctionalization hypothesis 54.
The presence of usherin at the periciliary region suggests a role in providing the 
connecting cilium with structural support. It has been proposed that the periciliary 
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membrane is physically connected to the connecting cilium by means of interactions 
between the ectodomains of usherin and Adgrv1 (Fig. 8) 15,20. The photoreceptor apical 
inner segment and periciliary region are also thought to be involved in docking of 
trans-Golgi-derived vesicles that contain cargo essential for outer segment formation, 
maintenance, and function 55. The USH protein complex, including usherin, has been 
proposed to play a role in this process 20. Based on our functional and immunohistochemical 
data, we propose a dual role for usherin in zebrafi sh photoreceptors: providing the 
connecting cilium with (ectodomain-mediated) structural support and participating 
in vesicle docking and/or signaling mediated by the intracellular region. Moreover, 
reduced retinal function and increased cell death in the retinal outer nuclear layer 
combined with the localization of truncated usherin at the periciliary membrane of the 
ush2ab1245 mutant, point towards a critical role for the intracellular region of usherin in 
retinal function, a signifi cant fi nding for future therapeutic interventions.
Whrna
Whrnb
Whrnb
Whrna
usherin
Adgrv1
wild-type
OS
CC
IS
Whrnb
Whrna
Whrna
ush2ab1245
ush2armc1
Whrnb
usherin
Adgrv1
PBM
TM
usherin...
... Adgrv1
Figure 8
Figure 8. Schematic model of molecular consequences for other USH2 proteins in ush2a mutants. 
The ectodomain of wild-type usherin associates with the ectodomain of Adgrv1 (indicated by dashed lines). 
Whrna and Whrnb bind via a PDZ-PBM-mediated interaction to usherin and Adgrv1, respectively. The ush2armc1 
allele results in the complete absence of usherin at the periciliary region. As a consequence, localization 
of Adgrv1, Whrna and Whrnb at the periciliary membrane is also aff ected. The ush2ab1245 allele, however, 
generates a truncated usherin protein that lacks only the C-terminal 62 amino acids and that is still located at 
the proper subcellular location in the photoreceptor cell. Because Whrna is mislocalized in this mutant and 
Whrnb localization is largely unaff ected, we propose a model in which Whrna has a higher binding affi  nity 
for usherin, and Whrnb a higher binding affi  nity for Adgrv1. IS: inner segment, OS: outer segment, PBM: PDZ-
binding motif.
The fi rst clinical sign of retinal dysfunction in patients with Usher syndrome is typically 
night blindness, indicative of rod dysfunction. In zebrafi sh, rod photoreceptors 
contribute little to visual function before about 14 dpf 56,57. In both ush2a mutants, 
however, we observed impaired ERGs at 5 dpf, which is suggestive of early-onset cone 
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dysfunction. Although ERG data of pre-symptomatic patients are typically not available, 
a recent study demonstrated markedly reduced ERG responses for both rods and cones 
in adolescent Usher syndrome type 2a patients 58, consistent with our observations of 
cone defects by the onset of vision in zebrafish ush2a mutants. Furthermore, USH2A-
associated retinal degeneration in humans has a slow, progressive pathology. Zebrafish, 
unlike humans, have the ability to regenerate retinal cells lost to injury or disease. 
Steady cell proliferation from stem-like populations in the ciliary marginal zone persists 
throughout adult stages 59. Acute damage to the retina triggers the reprogramming of 
Müller glial cells into retinal progenitor cells that are able to differentiate into all major 
types of retinal neurons including photoreceptors 60. Either or both of these regenerative 
pathways could explain the finding that ush2a mutants showed no progressive loss of 
retinal photoreceptor cells (Fig. S4) under normal light conditions, although increased 
levels of photoreceptor apoptosis and impaired visual function were observed within 
the first week of life when larvae were challenged by exposure to constant illumination 
with 3000 lux of white light. These observations suggest that sustained exposure to 
higher light levels throughout life might disrupt the homeostasis between slow 
degeneration and steady repopulation by regeneration in these mutants. Importantly 
these observations may have significant implications for light exposure and the use of 
sunglasses or high-energy wavelength filtering lenses as treatments in Usher syndrome 
patients. In conclusion, we have shown that zebrafish ush2a mutants show an early 
onset retinal dysfunction, mainly in the absence of photoreceptor degeneration. Not 
only will these mutants avail our studies of the retinal function of usherin, but the 
quantified phenotypes of USH2 protein mislocalization, defects in visual function and 
increased photoreceptor degeneration in elevated light conditions in ush2a mutants 
can all be used as measures for evaluation of therapeutic strategies that are currently 
being developed for the future treatment of USH2A-associated retinal degeneration.
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SUPPLEMENTAL FIGURES
Supplemental Figure 1. Specific organization of usherin within wild-type photoreceptors is 
revealed by scanning confocal microscopy. 
(A,B) Anti-usherin antibody localizes in a flattened disc pattern spanning the photoreceptor periciliary region 
in cross sections of 6dpf wild-type retinas. Tissue co-labeled sequentially with anti-centrin (A) to mark the 
basal body or acetylated α-tubulin to mark the connecting cilium (B) further defines the region of usherin 
enrichment between these two structures. (C,D) Transverse sections through the 6dpf larval retina (dotted 
line on schematic) reveal the usherin localization pattern as a ring at the periciliary region (cilia labeled green 
in panel D). (E,F) Cross sections of adult retinas labeled for usherin and centrin (F only) show the persistance 
of the ring structure superior to the basal body in addition to the localization within the accessory outer 
segments of cone photoreceptors. Scale bars: 5µm.
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Supplemental Figure 2. Zebrafish USH2 proteins encircle the base of the connecting cilium. 
(A-D) Transverse sections through the inner-outer segment boundary of 6dpf larval photoreceptors shows 
whirlin proteins (red; WhrnA: A, B, WhrnB: C, D) at the periciliary region. Centrin marks the basal body/
connecting cilium in green. (E-H) In transverse sections of 6dpf larval retinas, Adgrv1 (red) organizes into 
a concentric ring (E, F) surrounding the connecting cilium (acetylated α-tubulin, green in F); Adgrv1 (red) 
and usherin (green) localization overlaps in this region (G, H). Scale bars: 5µm. Plane of sectioning shown in 
schematics.
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ush2armc1 (c.2337_2342delinsAC; p.Cys780GlnfsTer32)
wt:  ACTGGACAGTGTGAGTGCAAAGCTGGTGTGCGGG
mut: ACTGGACAGTGTGA    ACAGCTGGTGTGCGGG
wild-type
ush2ab1245
ush2ab1245 (c.15520_15523delinsTG; p.Ala5174fsTer)
wt:  GCCAGCTGAGCCATGCCTACTCCCAGAATTCC
mut: GCCAGCTGAGCCAT  TGACTCCCAGAATTCC
A C T G G A C A G T G T G A - - - - A C A G C T G G T G T G C G G G
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Supplemental Figure 3. DNA sequence traces of homozygous ush2armc1 and ush2ab1245 alleles. 
(A) The ush2armc1 allele contains a six basepair deletion (‘GTGCAA’) and a two basepair insertion (‘AC’) in 
ush2a exon13 (c.2337_2342delinsAC; p.Cys780GlnfsTer32). Lower sequence traces are derived from larvae 
homozygous for the ush2armc1 allele, whereas the upper sequence traces are derived from strain-matched wild-
type larvae. (B) Zebrafish homozygous for the ush2ab1245 allele have a four basepair-deletion (‘GCCT’) and a two 
basepair insertion (‘TG’) in ush2a exon71, creating an instant TGA termination codon (c.15520_15523delinsTG; 
p.Ala5174fsTer). Lower sequence traces are derived from larvae homozygous for the ush2ab1245 allele, whereas 
the upper sequence traces are derived from strain-matched wild-type larvae.
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ush2armc1 ush2ab1245
Larval retinas (5 dpf)
Adult retinas (18 mpf)
wild-type
(TLF)
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GCL
IPL
ONL
OPL
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wild-type 
(AB*)
ush2armc1 ush2ab1245wild-type
(TLF)
wild-type 
(AB*)
Supplemental Figure 4. Histological examination of ush2armc1 and ush2ab1245 zebrafish retinas. 
Light microscopy of retinal sections from larval (5 dpf ) and adult (18 mpf) zebrafish stained with hematoxylin 
and eosin. Retinas of wild-type and both mutant alleles are morphologically indistinguishable from wild-type 
retinas at both ages. (n=7 larvae and n=4 adult eyes (18 mpf) with ush2armc1 mutant, ush2ab1245 mutant, TLF 
and AB* fish). Dpf: days post fertilization, mpf: months post fertilization, GCL: ganglion cell layer, IPL: inner 
plexiform layer, OPL: outer plexiform layer, ONL: outer nuclear layer, RPE: retinal pigment epithelium. Scale 
bars: 10 μm.
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Supplemental Figure 5. Ablation of usherin aff ects the localization of Adgrv1 in the zebrafi sh 
retina (5 dpf ). 
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ABSTRACT
Mutations in USH2A are among the most frequent causes of recessively inherited 
syndromic and non-syndromic retinitis pigmentosa, for which no treatment options are 
available. The absence of a suitable cellular or animal model that mimics the USH2A-
associated retinal phenotype for long hampered the development and evaluation 
of novel therapeutic strategies. Recently, the first ush2a knock-out zebrafish models 
were generated that presented with early-onset retinal dysfunction. Another critical 
roadblock in the development of a genetic therapy for USH2A is the size of the coding 
sequence, which by far exceeds the packaging capacities of the currently available viral 
vectors for gene delivery. In this study we report the identification and characterization 
of two human miniUSH2A genes that are amenable to viral delivery and improve 
retinal function of the ush2armc1 zebrafish mutant when expressed. For this purpose, 
Tol2-based transgenic ush2armc1 zebrafish lines that stably express miniUSH2A-1 or -2 
under the control of a photoreceptor-specific promoter were generated. Expression of 
either miniUSH2A rescued the levels of interaction partner Whrna at the photoreceptor 
periciliary region. Furthermore, electroretinogram (ERG) traces and visual motor 
responses (VMR) were fully restored after expression of miniUSH2A-1 and significantly 
improved after expression of miniUSH2A-2. In conclusion, this study shows the potential 
of using shortened USH2A genes for the future treatment of USH2A-associated retinitis 
pigmentosa.
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1.  INTRODUCTION
The USH2A gene is mutated in patients with Usher syndrome type ΙΙa (USH2a). Patients 
suffer from congenital hearing impairment and a progressive loss of visual function, 
as a consequence of retinitis pigmentosa (RP) 1,2. Besides causing USH2a, mutations in 
USH2A are also  among the most common cause of autosomal recessively inherited non-
syndromic RP 2,3. USH2A-associated RP is generally diagnosed after puberty. The initial 
clinical sign is often night blindness, which is followed by a progressive loss of peripheral 
vision that often results in legal blindness in the sixth or seventh decade of life 4. While 
hearing loss can be partially compensated by providing patients with hearing aids or 
cochlear implants 5, currently no treatment options are available to compensate for the 
progressive loss of visual function.
Up to now, two protein-encoding USH2A transcripts have been identified in the retina. A 
transcript encoding usherinisoA consists of 21 exons and encodes a presumably secreted 
protein of 1,551 amino acids 6. The  transcript encoding usherinisoB is built up by 51 
additional exons, and encodes a transmembrane protein of 5,202 amino acids 7. UsherinisoB 
has been proposed to be the predominant isoform in murine and zebrafish retina and 
is required for long-term maintenance of photoreceptor cells  8. It has been proposed to 
fulfil a structural role at the periciliary membrane of the photoreceptor and to possibly 
function in vesicle docking and/or outside-in signalling 9,10. Together with other known 
USH proteins, harmonin (USH1C), whirlin (USH2D), SANS (USH1G) and ADhesion G 
protein-coupled Receptor V1 (ADGRV1), usherin forms a dynamic protein complex that is 
mainly mediated by highly conserved PDZ domain-PDZ binding motif-based interactions 
9,11-19. However, the exact function of this complex and the molecular mechanism 
underlying photoreceptor dysfunction in USH2A-associated RP remains elusive.
Until recently, no suitable animal model was available to study the function of usherin 
in the retina. The major reason was that the retinal phenotype of patients with USH 
was not faithfully mimicked in the available Ush2a knock-out mouse models for Usher 
syndrome. The Ush2a knock-out mouse only manifests a mild retinal degeneration 
with a very late age of onset 18. Recently, zebrafish models having mutations in Usher 
syndrome-associated genes, such as  myo7aa (USH1b), ush1c (USH1c) and pcdh15b 
(USH1f), have been shown to exhibit early-onset retinal dysfunction 20-22. More recently, 
we generated and characterized the first known ush2a knock-out zebrafish models that 
presented with early-onset retinal dysfunction 8. These zebrafish mutants therefore 
provide an excellent opportunity to study the pathogenic mechanism underlying 
USH2A-associated retinal degeneration in vivo and to evaluate the potential of future 
therapeutic strategies.
Several pre-clinical therapeutic strategies have already been explored to restore or 
overcome the consequences of USH2A mutations. Antisense oligonucleotides (AONs) 
156 | Chapter 4
have been successfully used in vitro to correct aberrant splicing as a consequence 
of deep-intronic USH2A mutations 23,24. Using CRISPR/Cas9 technology in patient-
derived fibroblasts, the frequently found c.2299delG mutations could be repaired 25. 
Furthermore, translational read-through inducing drugs (TRIDs) were demonstrated to 
lead to read-through of the common nonsense mutation p.Arg3955Ter mutation in vitro 
26. AON-based splice modulation, CRISPR/Cas9-based genome editing and translational 
read-through are largely mutation-specific approaches 23. As more than 600 different 
USH2A mutations have been identified, which are mostly private and evenly distributed 
over the gene and include many nonsense, frame-shift inducing, splice-modulating, 
and missense variants 27, a mutation-independent therapeutic approach would be 
preferred. 
A promising mutation-independent strategy is gene augmentation using viral vectors 
for delivery. Initially, lentiviral (LV) vectors were often used because of their relatively 
high packaging capacity of ~8.5 kb. Subretinal injections of LV vectors expressing the 
USH1b gene, Myo7a, in the shaker1 mouse model rescued the mutant phenotype by 
restoring the α-transducin translocation in photoreceptors and decreasing the level of 
photoreceptor apoptosis 28,29. These results showed the potential of a LV-based delivery 
of transgenes for the future treatment of retinal dystrophies. However, biosafety poses 
a concern due to the integrative nature of LV vectors potentially leading to insertional 
mutagenesis. In contrast, adeno-associated virus (AAV)-based gene therapy vectors 
form episomal concatemers in the host cell nucleus, which have been shown to be 
stable in terminally differentiated (photoreceptor) cells 30. More importantly, the AAV-
mediated delivery of a transgene into the subretinal space has proven to be safe and 
effective in treating photoreceptor degenerative diseases 28,31-35. However, AAVs have 
a limited cargo packaging capacity of ~4.8 kb 36, which hampered the progress in the 
development of gene augmentation therapies for large genes such as USH2A. Recent 
studies have focused on developing methods that enable the delivery of large genes, 
such as MYO7A (USH1b) and ABCA4 (Stargardt disease), to retinal cells 37. Augmentation 
of these genes using dual AAVs resulted in, albeit with low efficiencies, the rescue of 
the retinal phenotype in the corresponding mouse and pig models 30,38-42.  However, the 
length of the USH2A coding sequence (~15.6 kb) exceeds also the capacity of a dual AAV 
approach 18. 
A potential solution for this critical roadblock is to engineer AAV-amenable minigenes 
that encode proteins capable of preventing or delaying the clinical symptoms seen in 
patients. This method has been successfully employed for the CEP290  and dystrophin 
genes 43-46. AAV-mediated delivery of a miniCEP290 gene was proven to be effective 
in slowing down the severe progression of retinal degeneration in the Cep290rd16 
mouse model for Leber Congenital Amaurosis (LCA) 44. In addition, reduced muscle 
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degeneration was observed after the delivery of a mini-dystrophin gene using dual AAV 
vectors in a canine model for Duchenne Muscular Dystrophy (DMD) 45. Moreover, for 
patients with Duchenne muscular dystrophy, a phase Ι/ΙΙa is started with rAAV2.5-CMV-
mini-Dystrophin gene vector (www.clinicaltrials.gov). 
In this study, we generated two different Tol2-based transgenic zebrafish lines that 
express human miniUSH2A genes in the ush2armc1 background. We show that expression 
of either miniUSH2A gene resulted in significant rescue of the retinal phenotype 
observed in ush2armc1 larvae, thereby demonstrating the potential of using miniUSH2A 
genes for the future treatment of USH2A-associated RP.
2.  MATERIAL AND METHODS
2.1  Zebrafish maintenance and husbandry
Experimental procedures were conducted in accordance with international and 
institutional guidelines (Dutch guidelines, protocol #RU-DEC 2012-301 and #RU-DEC 
2016-0091). Wild type adult Tupfel Long fin (TLF) zebrafish and the previously described 
ush2armc1 mutants were used 8. The zebrafish eggs were obtained from natural spawning 
of Tuebingen Long-Fin (TLF) breeding fish. Larvae were maintained and raised by 
standard methods 47. 
2.2  Plasmid constructs
Fragments encoding human usherinisoB amino acid residues (aa) 1-744, aa 1682-1871, 
aa 2912-3955 and aa 4919-5202 (miniUSH2A-1) or usherinisoB aa 1-47, aa 2912-3955 and 
aa 4919-5202 (miniUSH2A-2) were amplified from Human Retina Marathon®-Ready 
cDNA (Clontech, #639349) using Phusion® High-Fidelity DNA polymerase (New England 
Biolabs, #E0553), assembled and cloned in pUC19L using the GeneArt™ Seamless Cloning 
and Assembly Enzyme Mix (Thermo Fisher, #A14606) according to manufacturer’s 
instructions (primers are listed in Supplemental Table 1). Using Gateway® cloning 
technology the 3xPRE-ZOP promoter (kindly provided by Dr. Breandán Kennedy 48) 
was cloned in the pDONR™P4-P1r vector in order to generate a p5’E vector. MiniUSH2A 
-1 and -2 were cloned in pDONR™221 in order to generate a pME vector. The p5’E-
3xPRE-ZOP, pME-miniUSH2A-1 or -2 and p3’E-IRES-EGFPpA (Multisite Tol2kit clone 389; 
generously provided by Prof. Dr. Koichi Kawakami 49) were cloned in the pDestTol2CG2 
(Multisite Tol2kit clone 395) vector using the MultiSite Gateway® Three-Fragment Vector 
Construction Kit  (Thermo Fisher, #12537-023), according to manufacturer’s instruction 
and sequence verified. 
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2.3  Generation of Tol2 transposase mRNA
Transposase mRNA was generated using the pCS2FA-transposase plasmid as a template. 
After a phenol:chloroform extraction, the vector was linearized using NotI (NEB, #R0189S), 
and subsequently purified with DNA clean & ConcentratorTM 5-kit (Zymo Research, 
#D4003T). Capped RNA synthesis was performed using the mMESSAGE mMACHINETM 
SP6 Transcription Kit (ThermoFisher, #AM1340) according to manufacturer’s protocol. 
Obtained transcripts were purified using the NucleoSpin® RNA  kit (MACHEREY-NAGEL, 
#740955.250). 
2.4  Micro-injections
Zebrafish eggs were obtained from natural spawning. 1 nl of a mixture containing 
Tol2 transposase mRNA (250ng/ul), miniUSH2A expression construct (250ng/ul), KCL 
(0.2 M) and phenol red (0.05%) was injected into 1-cell-stage embryos of the ush2armc1 
line using a Pneumatic PicoPump pv280 (World Precision Instruments). After injection, 
embryos were raised at 28°C in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM 
CaCl2, 0.33 mM MgSO4) supplemented with 0.1 % v/v methylene blue. At 4 days post 
fertilization (dpf ), embryos were selected for heart-specific EGFP expression. EGFP-
positive larvae were raised and subsequently outcrossed with homozygous ush2armc1 
mutants to determine germline transmission of the miniUSH2A gene. 
2.5  Genotyping transgenic miniUSH2A zebrafish 
Genomic DNA was isolated from 5 pooled EGFP-positive larvae after a two hour incubation 
step at  55 oC  in lysis buffer (10 mM Tris-HCl pH 8.2, 10 mM EDTA, 100 mM NaCl, 0.5 % 
SDS) supplemented with freshly added proteinase K to a final concentration of 0.20 mg/
ml (Invitrogen, #25530049). Isolated genomic DNA (40 ng) was used as input in a PCR to 
detect miniUSH2A-1 and -2.  For this purpose, the Phusion® High-Fidelity PCR Kit (New 
England Biolabs, E0553) with forward primer 5’-AGACACTCTGCAGTATTCAC-3’ (3xPRE-
ZOP promoter) and reverse primer 5’-CAGAACTGAATACTTTCAGC-3’ (miniUSH2A-1) or 
5’-GAGTCGTTTGAGGTAGCAGA-3’ (miniUSH2A-2) were employed. The cycling conditions 
were as follows: 98°C 60 seconds, 30 cycles of 98°C 10 seconds, 56°C 30 seconds, and 
72°C 30 seconds and a final 72°C 5 minutes. Amplified fragments were gel-extracted 
using the NucleoSpin® Gel and PCR Clean-up kit (MACHERY-NAGEL, #740609.250) and 
sequence verified.
2.6  Immunohistochemistry
Zebrafish larvae (4-6 dpf ) were positioned (ventral side downwards) in Tissue-Tek (4583, 
Sakura), frozen in melting isopentane and cryosectioned following standard protocols 
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(7 μm thickness along the lens/optic nerve axis). Sections were permeabilized using 
0.01% Tween-20 in PBS followed by a blocking step using blocking solution (10% normal 
goat serum, 2% BSA in PBS).  Primary antibodies diluted in blocking solution were 
incubated overnight at 4 °C. The following primary antibodies were used: rabbit anti-
zebrafish Whrna (1:300; Novus Biological, #42700002), rabbit anti-zebrafish usherin-C 
(1:500; Novus Biological, #27640002), and mouse anti-centrin (1:500; Novus Biological, 
#2712468/2677126). The secondary antibodies were goat anti-mouse Alexa Fluor 488 
and goat anti-rabbit Alexa Fluor 568 (1:600, Molecular Probes-Invitrogen Carlsbad, CA, 
USA), diluted in blocking buffer supplemented with DAPI (1:8000) and incubated for 1 
hour. Sections were post-fixed in 4% PFA for 5-10 minutes and embedded with Prolong 
Gold Anti-fade (Thermo Fisher). For the immunofluorescence analyses using rabbit anti-
human usherin-C (1:500, kindly provided by Prof. Dr. D. Cosgrove 50), two adaptations 
to the protocol were made. The sections were permeabilized in PBS with 0.1% Triton-X 
for 20 minutes and the used blocking solution consisted of 10% normal goat serum, 
2% BSA, 0.1% Triton-X-100 in PBS. Images were taken with an Axioplan2 Imaging 
fluorescence microscope (Zeiss) equipped with a DC350FX camera (Zeiss, Germany). For 
quantification of fluorescence after anti-Whrnb and anti-usherin labelings, microscope 
sections were analyzed using ImageJ. The region of interest was determined in the Alexa 
Fluor 488 (anti-centrin signal) channel using the “find maxima” option. The 488 channel 
layer was projected onto the Alexa Fluor 568 (anti-Whrnb or anti-usherin signal) channel 
after using the ‘substract background’ function. Next, the ‘set measurements’, ‘analyze 
particles’ and ‘measure’ tools were used in the Alexa Fluor 568 channel, respectively, to 
determine the mean gray intensity. P-values were calculated using a two-tailed unpaired 
Student’s t-test.
2.7  Genomic qPCR analysis 
Genomic DNA was isolated from single larvae or adult zebrafish finclips using the 
QIAamp DNA Mini Kit (Qiagen, #51304) following the manufacturer’s protocol. Genomic 
qPCRs were performed to quantify copy numbers of miniUSH2A-1 and -2 using 6ng 
genomic DNA as input. Specific primers were designed with Primer3Plus (fwd= 5’- 
TGCCTCGTTTCTTCACAGTC-3’ and rev= 5’- GAGCCCAATGAAAGAACTGG -3’) covering 
the transition between the opsin promoter and the start of both miniUSH2A-1 and -2. As 
an internal reference gene gusb (ENSDART00000091932.5) was employed using fwd= 
5’-GTCGTCCCGTCACATTTATTAC-3’ and rev= 5’- ATCATGCAGTCCTACTCTGACAC-3’. All 
reaction mixtures were prepared with the GoTaq qPCR Master Mix (Promega A6001) in 
accordance with the manufacturer’s protocol. All reactions were performed in triplicate 
with the Applied Biosystems Fast 7900 system. MiniUSH2A/gusb ratios were calculated 
using the ΔCt method to obtain relative miniUSH2A copy numbers.
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2.8  Adaptor-Ligation PCR
To determine the genomic integration sites of miniUSH2A-1 and -2 and validate the 
number of genomic insertions an adaptor-ligation PCR strategy was used, as previously 
described 51. As input ~150 ng of genomic DNA extracted from single larvae was used. 
Amplified fragments were gel-extracted using the NucleoSpin® Gel and PCR Clean-up 
kit (MACHERY-NAGEL, #740609.250) and sequence verified.
2.9  GST pull-down
In order to produce GST (glutathione S-transferase) fusion proteins,  Escherichia coli 
BL21-DE3 was transformed with plasmid pDEST15-usherin_icd (aa 5064-5202). After 
induction with IPTG, GST fusion proteins were isolated as described before 11. HA-
tagged Whrna was produced by transfecting HEK293T cells with pcDNA3-HA-Whrna, 
using the transfection reagent polyethylenimine (PEI, PolySciences), according to the 
manufacturer’s instructions. Twenty-four hours after transfection, cells were washed 
with PBS and subsequently lysed on ice using lysisbuffer (50 mM Tris-HCL pH7.5, 150 
mM NaCl, 0.5% Triton-X-100) supplemented with Complete protease inhibitor cocktail 
(Roche, Germany).  GST pull-down assays were performed as described previously 11. 
Proteins were resolved on 4-12% NuPage gradient gels (Thermo Fisher #NP0321BOX) 
and analyzed on immunoblots. Bands were visualized by using the Odyssey Infrared 
Imaging System (LI-COR, USA). HA-tagged Whrna was detected by anti-HA monoclonal 
antibodies (Sigma, #H9658). As secondary antibody, Alexa Fluor 680 goat-anti-rabbit 
IgG was used (Molecular Probes, USA).
2.10  Visual Motor Response assay (VMR)
Locomotor activity was tracked and analyzed using EthoVision XT 11.0 software (Noldus 
Information Technology BV, Wageningen, The Netherlands), as previously described 
8,52. Larvae (5dpf) were individually positioned into a 48-wells plate, containing 200µl 
of E3 medium per well. The 48-wells plate was placed in the observation chamber of 
the DanioVision™ tracking system (Noldus Information Technology BV, Wageningen, 
The Netherlands). After 20 minutes of dark adaption, the larvae were exposed to 3 
cycles of 10 minutes dark/10 minutes light. In all experiments, larvae were subjected 
to locomotion analyses between 13:00-18:00 in a sound- and temperature-controlled 
(28 °C) behavioral testing room. 
2.11  Electroretinograms (ERG)
ERG measurements were performed on isolated larval eyes (5-7 dpf ) as previously 
described 53. Larvae were dark-adapted for a minimum of 30 min prior to the 
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measurements and subsequently handled under dim red illumination. Isolated eyes 
were positioned to face the light source. Under visual control via a standard microscope 
equipped with red illumination (Stemi 2000C, Zeiss, Oberkochen, Germany), the 
recording electrode with an opening of approximately 20  μm at the tip was placed 
against the center of the cornea. This electrode was filled with E3 medium (5 mM NaCl, 
0.17 mM KCl, 0.33 mM CaCl2, and 0.33 mM MgSO4). The electrode was moved with a 
micromanipulator (M330R, World Precision Instruments Inc., Sarasota, USA). A custom-
made stimulator was invoked to provide light pulses of 100 ms duration, with a light 
intensity of 6000 lux. For the light pulses a ZEISS XBO 75W light source was employed 
and a fast shutter (Uni-Blitz Model D122, Vincent Associates, Rochester, NY, USA) 
driven by a delay unit interfaced to the main ERG recording setup. Electronic signals 
were amplified 1000 times by a pre-amplifier (P55 A.C. Preamplifier, Astro-Med. Inc, 
Grass Technology) with a band pass between 0.1 and 100 Hz, digitized by DAQ Board 
NI PCI-6035E (National Instruments) via NI BNC-2090 accessories and displayed via a 
self-developed NI Labview program 54. Statistical analyses were performed using SPSS 
Statistics 22 (IBM), and graphs were generated in Excel (Microsoft). Statistical significance 
was set at p < 0.05. All experiments were performed at room temperature (22°C).
3.  RESULTS
3.1  Design and construction of miniUSH2A genes 
Human usherin is predicted to contain multiple copies of the Laminin-type EGF-like 
(EGF Lam) domain, the Laminin G (LamG) domain and the Fibronectin type 3 (FN3) 
domain. To decide which domains of those should be included in the miniUSH2A genes, 
we examined which ones were evolutionary best conserved and therewith likely most 
critical to the proteins’ function. Analysis of the Treefam database (http://www.treefam.
org) showed that full length orthologs or usherin, with identical domain composition, 
arose early in metazoan evolution and can also be found in prebilaterian metazoa like 
sponges and anemones. We determined the conservation per residue using consurf 55 
based on a sequence alignment 56 created from the metazoan orthologs available in 
2012. Subsequently averaging the conservation per domain did not reveal any domains 
with significantly higher scores than the other domains in that family (Suppl. Fig. 1). 
We therefore decided that to construct the miniUSH2A genes,   there was, based on 
sequence conservation, no reason not to include the domain combination that was 
most practical from a cloning point of view.
Considering the transgene packaging capacity of the conventional LV and AAV vectors 
30, we constructed two human USH2A minigenes (Fig. 1A). MiniUSH2A-1 (~6.8 kb) 
encodes a polypeptide of 2,262 amino acids containing the signal sequence (S), the 
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laminin G-like domain (LamGL), the laminin N-terminal domain (LamNT), four EGF 
Lam domains, one LamG domain, the cysteine-rich region fl anked by two and fi ve FN3 
domains at the N- and C-terminal side respectively, the transmembrane domain (TM) 
and the intracellular region containing the class I PDZ-binding motif (PBM). MiniUSH2A- 
2 (~4.1 kb) encodes a polypeptide of 1,375 amino acids that contains the usherin signal 
sequence (S), two FN3 domains, the cysteine-rich region, fi ve additional FN3 domains, 
the transmembrane domain (TM) and the intracellular region containing the class I PDZ-
binding motif (PBM). We cloned the coding sequences of miniUSH2A-1 and miniUSH2A-2 
in the Tol2 transposon vector pDestTol2CG2, between an enhanced zebrafi sh opsin 
promoter and the internal ribosomal entry site (IRES) EGFP. This vector further contains 
the coding sequences of EGFP under the control of a heart-specifi c cmcl2 promoter (Fig. 
1B and C). The complete expression cassette was fl anked by Tol2 sites. 
13316 bp
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IRES-EGFP
EGFP
opsin promoter
Tol2 3' TIR
Tol 2 5' TIR
cmlc2 promoter
15977 bp
miniUSH2A-1 insert
IRES-EGFP
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Tol2 3' TIR
Tol 2 5' TIR
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Figure 1. Construction of miniUSH2A fragments and generation of Tg(3xPRE-1_-1.2ZOP:Hsa.
miniUSH2A-1 and -2,  EGFP, cmcl2:EGFP);ush2armc1. 
(A) Schematic presentation of the domain architecture of human usherinisoB, miniUSH2A-1 and miniUSH2A-2. 
The fragments of usherinisoB that are encoded in the miniUSH2A genes are boxed. Tol2-based vectors containing 
an enhanced zebrafi sh opsin promoter (3xPRE-1_-1.2ZOP) driving the expression of miniUSH2A-1 (6786 bp) 
(B),  miniUSH2A-2 (4125 bp) (C) and IRES-EGFP in zebrafi sh photoreceptors, were generated. The vector further 
contains the heart-specifi c cmcl2 promoter driving the expression of EGFP. (D-E) The miniUSH2A-containing 
plasmids were co-injected with Tol2 transposase mRNA into one-cell staged ush2armc1 embryos. At 4 dpf, 
heart-specifi c EGFP expression could be observed for which the larvae were selected. 
MiniUSH2A genes restore visual function in zebrafish larvae | 163
4
3.2  MiniUSH2A-1 and miniUSH2A-2 insertion into the genome of ush2armc1 
zebrafish
We injected the minigene-containing vectors together with Tol2 transposase mRNA 
into homozygous one-cell staged ush2armc1 embryos (Fig. 1D and E). ush2armc1 mutants 
contain a frameshift-inducing mutation in ush2a exon 13 (c.2337_2344delinsAC; 
p.Cys780GlnfsTer32) that leads to a premature termination of translation and, as a 
consequence, absence of zebrafish usherin. Injected larvae (F0) that were positive for 
heart-specific EGFP expression at 4 dpf were raised and outcrossed with homozygous 
ush2armc1 fish in order to test for germline transmission of the miniUSH2A expression 
cassettes. Again, larvae (F1) with heart-specific EGFP expression were selected. Tol2 
transposase induces a random integration of (multiple) transposable elements into the 
genome. Therefore we performed a genomic qPCR analysis to determine the number of 
miniUSH2A copies that were integrated in the genome of the transgenic F1 larvae. This 
revealed that for both USH2A minigenes multiple copies were present in the genomes 
of F1 larvae. The same analyses were performed after a second outcross with ush2armc1 
mutants. F2 larvae contained either one or two copies of the miniUSH2A-1 gene, whereas 
for miniUSH2A-2 only larvae were identified with a single copy insertion (Suppl. Fig. 2). 
This was corroborated by an adaptor ligation assay. This assay also revealed the exact 
genomic position of minigene insertions. Single copies of miniUSH2A-1 were found to 
be integrated at two distinct genomic loci: approximately 70 bp upstream of the zinc-
finger CCCH-type containing 4 (zc3h4) gene at chromosome 15 (Fig. 2A; Suppl. Fig. 
3) and in an intergenic region at chromosome 18, approximately 800 bp upstream of 
lsm14ab (Fig. 2A; Suppl. Fig. 4). So far, ZC3H4 mutations have not been associated with 
a human disease and also no animal models for ZC3H4 are available. Deletion of ZC3H4 
in patients with the 19q13.32 microdeletion syndrome has also not been reported to 
be associated with retinal dysfunction 57. A single copy of miniUSH2A-2 was found to be 
integrated  within the 5’-UTR of the zgc:154061 gene at chromosome 17 (Fig. 2B; Suppl. 
Fig. 5). Mutations of C15ORF41, the human orthologue of zgc:154061, are associated 
with congenital dyserythropoietic anemia (OMIM: 615631), an inherited disorder that 
affects the development of red blood cells. Although no retinal phenotype has been 
described to be associated with C15ORF41 or ZC3H4 mutations, we questioned whether 
disruption of these genes due to the integration of an USH2A minigene would affect 
retinal morphology. 
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Figure 2. Analysis of Tol2-based miniUSH2A-1 and -2 genomic insertions in transgenic F2 larvae. 
(A) Genomic DNA of transgenic F2 larvae was fragmented and adaptor-ligated. Nested PCR and Sanger 
sequencing revealed that miniUSH2A-1 is incorporated in chromosome 15 (larvae 2 and 3, ~250 bp fragment), 
in chromosome 18 (larva 4, ~1.1 kb fragment), or at both genomic loci (larvae 1 and 5). (B) A single copy of 
miniUSH2A-2 was incorporated in chromosome 17 (~300 bp fragment). 
3.3  MiniUSH2A- 1 and -2 are expressed and localize to the photoreceptor 
periciliary region 
We first determined whether the USH2A minigenes are expressed in photoreceptor 
cells and whether miniUSH2A-1 and -2 localize to the photoreceptor periciliary region 
in  transgenic zebrafish larvae. For this purpose, we performed immunofluorescence 
assays with an antibody that specifically recognizes the intracellular region of human 
usherin. As expected, no anti-usherin signal was observed in retina of wild-type and 
ush2armc1 larvae (Fig. 3D and 3E). In the retina of transgenic larvae, miniUSH2A-1 and 
-2 were detected adjacent to the connecting cilium/basal body marker centrin (Fig. 
3B and 3C). We next assessed whether the expression of the miniUSH2A genes had an 
adverse effect on retinal morphology. Histological analysis of transgenic fish expressing 
miniUSH2A-1 or -2 showed a normal retinal lamination and cellular organization 
in both larvae and adults as compared to wild-type controls (5 dpf: n=21; 5 months 
post fertilization (mpf) n=2; Suppl. Fig. 6). Also, no other abnormalities in overall 
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body morphology or swimming behavior were observed. Therefore, we conclude that 
the genomic integration and expression of miniUSH2A-1 or -2 has no gross negative 
consequences for zebrafish development and function of adult fish in the presented 
transgenic zebrafish lines.
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Figure 3. Localization of miniUSH2A-1 and -2 in the retina of transgenic zebrafish (5 dpf ). 
(A) Schematic presentation of a cone photoreceptor cell with the expected localization of centrin and 
miniUSH2A. (B-C) In the transgenic zebrafish larvae, miniUSH2A-1 or -2 is detected using an anti-human 
usherin antibody (red signal), while in wild-type larvae (D) and ush2armc1 mutants (E) no signal is observed. 
(n=14 for all groups, from 2 biological replicates). In all images the nuclei are stained with DAPI (blue signal) 
and anti-centrin is used as a marker for the connecting cilium and basal body (green signal). Scale bars: 5μm. 
3.4 Expression of miniUSH2A restores Whrna levels at the photoreceptor 
periciliary region 
Usherin and whirlin interact and are mutually dependent on each other for their 
localization at the photoreceptor periciliary membrane 11,8,15. Therefore, we questioned 
whether the expression of miniUSH2A-1 or -2 would result in the restoration of 
Whrna localization in ush2armc1 zebrafish photoreceptor cells. We first confirmed that 
the intracellular region of human usherin and zebrafish Whrna indeed interact. In 
a glutathione S-transferase (GST) pull-down assay, full length HA-tagged Whrna was 
pulled down from HEK293T cell lysates by GST-fused usherin aa 5064-5202 but not by 
GST alone (Fig. 4C). Subsequently, we performed immunohistochemistry using anti-
Whrna antibodies. Anti-centrin antibodies were employed as a marker for the basal 
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Figure 4. Association of miniUSH2A-1 and -2 with Whrna. 
(A) Whrna labeling (red signal) at the photoreceptor periciliary region was significantly decreased in 
ush2armc1 larvae as compared to wild-type larvae (5 dpf ). In transgenic larvae expressing miniUSH2A-1 and 
miniUSH2A-2, Whrna labeling at the periciliary region was restored (5 dpf ) ( n= 14 larvae for each group from 
2 biological replicates). Nuclei are counterstained with DAPI (blue signal), and anti-centrin (green signal) was 
used as a basal body and connecting cilium marker. Scale bars: 10 μm. (B) Quantification of Whrna localization 
(red signal) at the photoreceptor periciliary region in both transgenic zebrafish lines as compared to wild-
type and ush2armc1 larvae. Each single datapoint in the scatter graph displays the averaged mean grey value 
from the eye of one larva. The mean value and the Standard Error of the Mean (SEM) are displayed as bars. 
Expression of either miniUSH2A leads to a significant increase of fluorescence intensity compared to ush2armc1 
mutants. (* indicates P<0.05, two-tailed unpaired Student’s t-test). (C) GST pull down assay, showing that HA-
tagged zebrafish Whrna was efficiently pulled down by GST-fused usherin (aa5064- aa5202), but not by GST 
alone. The third line shows 5% input of the protein extract.
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body and connecting cilium. In transgenic larvae expressing miniUSH2A-1 or -2, Whrna 
levels at the photoreceptor periciliary regions were signifi cantly increased as compared 
to those in ush2armc1 larvae (Fig. 4A and 4B). This demonstrates that expression of 
miniUSH2A-1 and miniUSH2A-2 leads to the formation of an USH2A-Whrna complex at the 
photoreceptor periciliary region, potentially resulting in the (partial) functional rescue.
3.5  Expression of miniUSH2A rescues the visual motor response 
The next step was to assess whether supplementing ush2armc1 zebrafi sh with human 
miniUSH2A-1 or -2 (partially) restores retinal function. As shown before, the visual 
motor response (VMR) is a semi high-throughput behavioral assay by which defects 
in visual function can be detected in a sensitive and robust way. ush2armc1 larvae have 
a decreased light-ON VMR as compared to wild-type controls (Fig. 5). Recording  the 
light-ON VMR of transgenic miniUSH2A-1 or -2 ush2armc1 larvae demonstrated that 
expression of either miniUSH2A protein restored the VMR. The maximum velocity during 
the fi rst 2 seconds after the light-ON stimulus, which is regarded to be the eye-specifi c 
response, was signifi cantly improved in ush2armc1 larvae expressing miniUSH2A-1 or -2 
as compared to ush2armc1 mutant larvae (P<0.01 for transgenic miniUSH2A-1 and P<0.05 
for miniUSH2A-2 larvae, two-tailed unpaired Student’s t-test. Furthermore, the recorded 
VMRs in transgenic miniUSH2A-1 or -2 larvae was not signifi cantly diff erent from the VMR 
recorded in age-matched wild-type larvae (P=0.39, two-tailed unpaired Student’s t-test). 
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ush2armc1             (n=70)
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Figure 5.  Visual Motor Responses in transgenic zebrafi sh expressing miniUSH2A-1 or -2 (5 dpf ). 
(A) The eye-specifi c Light-ON Visual Motor Response (VMR) presented as the maximum velocity (mm/s) is 
shown for the time frame of 30 seconds prior and after light alternation. The average Vmax of wild-type larvae 
(red line), ush2armc1 larvae (blue line), miniUSH2A-1-expressing ush2armc1 larvae (black line), miniUSH2A-2-
expressing ush2armc1 larvae (green line) is shown. A clear increase in VMR is observed in both miniUSH2A-1 and 
miniUSH2A-2-expressing ush2armc1 larvae as compared to ush2armc1 mutants (5 dpf; n=56 minimum per group; 
minimum of 2 biological replicates).
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3.6  MiniUSH2A expression enhances b-wave amplitudes of the electro-
retinogram 
We next recorded electroretinograms (ERGs) to determine the functionality of the retina 
of transgenic larvae expressing miniUSH2A-1 or -2 (5 dpf ). Average ERGs from dark-
adapted individual wild-type, ush2armc1, miniUSH2A-1 and miniUSH2A-2 larvae are shown 
in Figure 6A, together with the maximum average amplitudes plotted as bar-graphs (Fig. 
6B). Analysis of retinal function by ERG revealed a significant improvement of the b-wave 
amplitudes of the miniUSH2A-1 (37%) and -2 (57%) expressing larvae at 5dpf compared 
to the ush2armc1 larvae (Fig. 6). Statistical analyses revealed no significant differences in 
b-wave amplitudes recorded in ush2armc1 larvae expressing miniUSH2A-1 or -2. Also the 
b-wave amplitudes of wild-type control larvae and larvae expressing the miniUSH2A-1 
gene were not significantly different. Overall, our results suggest that the expression 
of miniUSH2A-1 or miniUSH2A-2 both improves retinal function of ush2armc1 larvae. 
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Figure 6. Physiological rescue potential of miniUSH2A-1 and miniUSH2A-2. 
(A) The average normalized b-wave amplitude (µV) was significantly reduced in ush2armc1 mutants as 
compared to strain-matched wild-type larvae (5dpf). B-wave amplitudes recorded in ush2armc1 larvae 
expressing miniUSH2A-1 or miniUSH2A-2 were significantly improved as compared to ush2armc1 larvae. (B) 
Statistical analysis of the maximum b wave amplitudes was performed using at least 13 larvae per experiment. 
(*P<0.05; two-tailed unpaired Student’s t-test; n=13 wild-type, n=21 ush2armc1, n=27 miniUSH2A-1 and n=13 
miniUSH2A-2 larvae, from minimal 2 biological replicates).
4.  DISCUSSION
Development of gene augmentation therapy for the future treatment of USH2A-
associated RP has been severely hampered by the enormous size of the usherin-
encoding sequence. In this study, we generated different transgenic zebrafish lines to 
evaluate the therapeutic potential of human miniUSH2A genes. We provided evidence 
for the (partial) restoration of retinal function of ush2armc1 mutants after expression of 
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two human miniUSH2A genes of different lengths. First of all, using an antibody directed 
against the intracellular C-terminal region of human usherin, miniUSH2A-1 and -2 were 
detected at the photoreceptor periciliary region of transgenic larvae. Furthermore, 
the level of Whrna at the periciliary region was increased in both transgenic lines as 
compared to ush2armc1 mutants. Finally, expression of miniUSH2A-1 leads to a complete 
restoration of visual function as determined by ERG recordings and VMR assays, while 
expression of miniUSH2A-2 partially restored visual function.
A Tol2-based strategy was adopted to generate transgenic zebrafish lines that express 
miniUSH2A. Tol2 transposase catalyzes the excision of the transposon from the donor 
plasmid, resulting in the stable integration of (multiple copies of ) the transposable 
element at random positions in the genome. As a result, the level of minigene 
expression can vary significantly between individual larvae. To minimize this variability, 
we performed all functional analyses on F2 larvae derived from a single transgenic fish 
in which a single copy of the minigene is inserted at a known position in the genome. 
Still, to better control minigene expression levels and to enable comparative analyses 
between different minigene-expressing transgenic lines, integration of a single copy 
at the same pre-determined genomic locus is preferred. The observed difference in 
rescue efficiency after expression of either miniUSH2A-1 or -2 may be the consequence 
of the composition of the minigene or can be caused by a difference in expression 
level resulting from the different genomic loci where the minigenes are integrated. 
The unknown consequence of the differential genomic integration makes comparison 
of therapeutic efficacy of different miniUSH2A genes extremely difficult. Site-directed 
zebrafish transgenesis into a single genomic landing site can be achieved with the 
phiC31 integrase system 58. A single site-specific integration of minigenes could result in 
reduced variability, however, the visual performance of transgenic zebrafish containing 
the phiC31 integrase-mediated genomic landing site still needs to be determined 59.
Prior to the application of minigenes in human subjects, more research is needed to 
determine the most efficient method of gene delivery and the optimal level of gene 
expression. Adeno-associated viruses (AAV) are currently the most frequently used 
vehicles for retinal gene delivery. So far, subretinal injections with viral vehicles such 
as AAV2, AAV8 and AAV2tYF, have been performed to transduce photoreceptor cells 
60. The major disadvantage of this method is that only cells around the injection site 
are being transduced. Recently, transduction of mouse photoreceptors after intravitreal 
injection using an AAV7m8 vector that is capable of penetrating all retinal layers was 
demonstrated 61. AAVs have a packing capacity of ~4.7 kb. However, due to the inclusion 
of necessary regulatory elements, like a promoter and polyadenylation signal, the 
practical limit for a cDNA that can be packaged in AAV is ~3 kb 60. This implicates that 
both miniUSH2A genes, respectively ~4.1 kb and ~6.8 kb in length, are still too large to 
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be incorporated into a single AAV particle. A possible solution is to use a dual or triple 
AAV approach albeit this will result in a significantly lower therapeutic potential due 
to the low recombination efficiency 42,62. Another option is the use of a lentiviral (EIAV) 
vector with a capacity of ~8.5 kb. Lentiviruses have already been successfully used for 
augmenting the Myo7a gene in the retina of the shaker1 mouse 28, and are currently 
being used as the vehicles for delivery in the UshStat® clinical trial Usher syndrome 1b 
patients. Lentivirus-mediated gene delivery is generally effective for targeting cells of 
the retinal pigment epithelium (RPE), although it may not be very efficient in transducing 
differentiated photoreceptors 63. Future studies therefore need to address whether even 
smaller miniUSH2A genes, that would fit within the range of the packaging capacity 
of AAV vectors, could also ameliorate the retinal phenotype of zebrafish ush2a mutant 
larvae. 
Extensive studies on evolutionary conservation did not identify clearly critical regions 
for usherin function. From our previous studies it is evident that ush2ab1245 larvae, which 
exclusively lack the 62 C-terminal amino acids including the class I PDZ binding motif 
(PBM), have a retinal phenotype that is comparable to the phenotype of ush2armc1 
larvae that completely lack usherin 8. Furthermore, the dynamic Usher protein complex 
consisting of Usher syndrome type 1 and 2-associated proteins, is largely mediated by 
highly conserved intracellular PDZ-PBM-based interactions. Together these data point 
into the direction that at least the presence of the intracellular region of usherinisoB is 
essential for zebrafish retinal function. 
So far, more than 200 human eyes have been injected with recombinant AAV or lentiviral 
vectors in clinical trials over the past 10 years using different strategies, vectors and 
routes of delivery 60. In general, the safety record of the published retinal gene transfer 
trials has been excellent. However, direct comparison between studies is challenging 
due to fundamental differences between the trials. As the success of each approach 
is gene specific and influenced by many factors, this will also need to be tested for the 
USH2A minigenes. Levels of gene expression and the efficiency of transduction need 
to be balanced and tested to prevent ineffective treatment or even potential toxic 
side effects. As usherin is expressed in both rods and cones 64, targeting both types of 
photoreceptor cells is preferred. Some photoreceptor-specific promoters are used in 
clinical trials, although more research is needed to determine whether or not these are 
more suitable than for example a ubiquitously active chicken beta actin (CBA) promoter 
60. Alternatively, the endogenous USH2A promoter, which is expected to express the 
right amount of usherin in the correct cells, could be used. 
For now, the ultimate goal of USH2A minigene therapy is to stop or slow down the 
progression of the retinal degeneration. As such, timing of intervention is crucial, since 
the presence of (partly) viable photoreceptors is essential for this therapeutic approach. 
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Patients with USH2A-associated RP are  born with grossly intact and functional 
photoreceptor cells and only develop the initial signs of visual dysfunction after puberty. 
The diagnosis Usher syndrome type 2a is nowadays often given before the onset of retinal 
dysfunction as these children fail the neonatal hearing test and subsequently often 
undergo genetic testing. This enables the future treatment of young individuals, and 
might prevent any irreversible disease symptoms. Patient-specific iPSC-derived retinal 
cells may be useful in unraveling the potential difference in pathogenic mechanisms 
caused by different mutations 65. Based on studies in iPSC-derived retinal progenitor cells 
of an Usher syndrome type 2A patient, it has been postulated that protein-truncating 
mutations might act via a different mechanism of action than missense mutations 65. 
Elucidation of the pathogenic mechanisms underlying RP caused by different types 
of USH2A mutations will reveal whether or not USH2A minigene augmentation will be 
beneficial for all patients with USH2A-associated RP or that it will only be suitable for 
patients with protein-truncating mutations. 
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SUPPLEMENTAL DATA
Minigene Subfragment primer name Sequence
miniUSH2A-2 pUC19L-ss_fwd 5’-AATTCGAGCTCGGTACATGAATTGCCCAGTTCT-3’
miniUSH2A-2 Ss-8xFN3_rev 5’-CGGCTCGGCTTGAAAGCTCCCACG-3’
miniUSH2A-2 Ss-8xFN3 fwd 5’-CTTTCAAGCCGAGCCGAGAAGTG-3’
miniUSH2A-2 8xFN3-TM-end rev 5’-TCGGAAGCCCACAGACTCTCCAC-3’
miniUSH2A-2 8xFN3-TM-end fwd 5’-GTCTGTGGGCTTCCGAGTGGATC-3’
miniUSH2A-2 TM-end-pUC19L rev 5’-GCCAAGCTTGCATGCCTTACAGGTGGGTGTCT-3’
miniUSH2A-2 Gateway cloning fwd 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGCCGCCGCCAT-GAATTGCCCAGTTCTTTC-3’
miniUSH2A-2 Gateway cloning rev 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCTTACAGGTGGGT-GTCTGT-3’
miniUSH2A-1 pUC19L-ss_fwd 5’-AATTCGAGCTCGGTACATGAATTGCCCAGTTCT-3’
miniUSH2A-1 Ss_4xEGF-lamG rev 5’-GGATTGTAACATCCAACATCATTAAAGC-3’
miniUSH2A-1 4xEGF-LamG fwd 5’-TTGGATGTTACAATCCGTCAGCTATTT-3’
miniUSH2A-1 LamG-8xFN3 rev 5’-CGGCTCGGACCCCGTGTAAATTTAAC-3’
miniUSH2A-1 8xFN3-TM-end fwd 5’-CACGGGGTCCGAGCCGAGAAGTG-3’
miniUSH2A-1 TM-end-pUC19L rev 5’-GCCAAGCTTGCATGCCTTACAGGTGGGTGTCT-3’
miniUSH2A-1 Gateway cloning fwd 5’-GGGGACAAGTTTGTACAAAAAAGCAGGCTTCGCCGCCGCCAT-GAATTGCCCAGTTCTTTC-3’
miniUSH2A-1 Gateway cloning rev 5’-GGGGACCACTTTGTACAAGAAAGCTGGGTCTTACAGGTGGGT-GTCTGT-3’
Supplemental Table 1. Primer sequences for the construction of miniUSH2A-1 and -2
A 
5,202 aa
Cys-rich
Human USH2A
S
1
0.5
0
-0.5
Supplemental Figure 1. Relative levels of sequence diversity among the domains and between 
domain regions in the USH2A protein. 
Sequence diversity was calculated with consurf (consurf.tau.ac.il/2016) based on a full length alignment from 
31 sequences from the deuterostomia taxon, 21 of which are from the vertebrates. Sequence variation was 
calculated per residue and then averaged per domain, or per inter-domain region, and shown for domains 
and interdomain regions that are at least 10 amino acids long. The Y-axis gives standard deviations in the 
per residue sequence variation. A low (negative) score indicates a relatively well conserved part of the 
sequence.  Among each set of domains we did not detect any particularly well (or not well) conserved domain 
that should be included in the construct (or left out).
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Supplemental Figure 2. Genomic qPCR for F2 larvae. 
The relative amount of integrated miniUSH2A copies was determined by genomic qPCR analyses for larvae 
of the F2 generation. Transgenic miniUSH2A-1 larvae contained either 1 or 2 copies of the minigene (A). 
(B) Transgenic miniUSH2A-2 larvae all contained a single copy of the USH2A minigene.
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sae1zc3h4
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Supplemental Figure 3. Integration site of miniUSH2A-1 (chromosome 15). 
(A) One copy of miniUSH2A-1 was integrated approximately 70 nucleotides upstream of the zinc-finger CCCH-
type containing 4 (zc3h4) gene at chromosome 15. (B) Chromatogram of the boundary between miniUSH2A-1 
and the zc3h4 locus. The Tol2 5’-TIR site (black solid line) and the 8 nucleotide duplication of the Tol2 target 
site (red dotted line) are boxed.
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Supplemental Figure 4. Integration site of miniUSH2A-1 (chromosome 18). 
(A) One copy of miniUSH2A-1 was integrated approximately 800 nucleotides upstream of the lsm14ab gene at 
chromosome 18. (B) Chromatogram of the boundary between miniUSH2A-1 and the lsm14ab locus. The Tol2 
5’-TIR site (black solid line) and the 8 nucleotide duplication of the Tol2 target site (red dotted line) are boxed.
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A
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Tol2 3’-TIR miniUSH2A-2zgc:154061 duplication
C
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Supplemental Figure 5. Integration site of miniUSH2A-2 (chromosome 17). 
(A) MiniUSH2A-2 was integrated within the 5’-UTR of the zgc:154061 gene at chromosome 17. (B,C) 
Chromatogram of the boundaries between miniUSH2A-1 and the zgc:154061 locus. The Tol2 3’ and 5’-TIR sites 
(black solid line) and the 8 nucleotide duplication of the Tol2 target site (red dotted line) are boxed.
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Supplemental Figure 6. Histological examination of miniUSH2A-1 and -2 zebrafish retinas. 
Light microscopy of retinal sections from larval (5 dpf ) and adult (5 mpf) zebrafish stained with hematoxylin 
and eosin. Retinas of wild-type and both miniUSH2A larvae are morphologically indistinguishable from wild-
type retinas at both ages. (n=7 larvae and n=2 adult eyes (5mpf) with miniUSH2A-1, miniUSH2A-2 and TLF 
fish). Dpf: days post fertilization, mpf: months post fertilization, GCL: ganglion cell layer, IPL: inner plexiform 
layer, OPL: outer plexiform layer, ONL: outer nuclear layer, RPE: retinal pigment epithelium. Scale bars: 10 μm. 
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Clinicians and geneticists have collectively spent approximately 140 years of research 
before the first mutations in the MYO7A gene were identified as the underlying cause 
of USH1b. Hereafter, the hunt for pathogenic mutations that could help to explain the 
genetic etiology of Usher syndrome started. Although mutations in USH2A are the most 
frequent cause of Usher syndrome and non-syndromic autosomal recessive RP in man 
1-3, surprisingly little is known about the function of the USH2A-encoded protein usherin 
in the eye. Based on prevalence numbers it is estimated that worldwide approximately 
170,000 Usher syndrome patients and 250,000 patients with non-syndromic, autosomal 
recessively inherited RP can be explained by mutations in the USH2A gene. For the 
progressive and irreversible loss of visual function caused by mutations in USH2A, 
currently no treatment options are available. Therefore, the main aim of the research 
described in this thesis was to develop and evaluate therapeutic options for the future 
treatment of USH2A-associated retinal degeneration. On this road towards therapy for 
USH2A-associated RP, several stages can be distinguished: the design phase, the pre-
clinical phase and finally the clinical trials (Phase 0 – ΙV). This chapter reviews our main 
discoveries and achievements, and addresses future challenges.
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1. THE DESIGN PHASE
1.1. Strategy
Several therapeutic strategies have already been (pre-)clinically explored to restore or 
overcome the consequences of specific mutations in Usher syndrome-associated genes. 
Translational read-through inducing drugs (TRIDs) have been shown to be effective in 
the read-through of nonsense mutations in USH1G in vitro 4, and USH1C in vitro and in 
vivo 5. Also splice correction strategies using antisense oligonucleotides (AONs) have 
been explored. AONs were shown to have great potential in in vitro correction of 
aberrant USH2A pre-mRNA splicing as a consequence of deep-intronic mutations 6,7. 
Furthermore, treatment of neonatal mice with a single systemic dose of AONs partially 
corrects Ush1c pre-mRNA splicing in an Ush1c c.216G>A knock-in model. As a result, 
stereocilia organization in the cochlea was improved leading to a rescue of cochlear hair 
cells, vestibular function and low-frequency hearing in mice 8. In addition, CRISPR/Cas9-
based genome editing holds great potential for treating inherited eye diseases, however 
development of precise reagents that specifically target desired genomic loci, while 
inducing no or minimal off target modifications is still an important step that needs to 
be taken before this method can move towards a clinical application 8. As more than 600 
different disease-causing mutations in USH2A have been identified, which are evenly 
distributed over the gene 9, it is not cost-effective and feasible to develop mutation-
specific treatments for all of them. Therefore, a mutation-independent approach would 
be preferred as a common treatment from which a relatively large group of patients 
could benefit. 
A promising mutation-independent strategy is gene augmentation using viral vectors 
for delivery. The virus delivers a functional copy of the gene associated with the disease 
to the light-sensitive photoreceptor cells and/or RPE cells after a subretinal injection. 
MYO7A is effectively expressed in the retina of the shaker1 mouse for USH1b after being 
packaged into a lentivirus (UshStat®) 10. Currently UshStat® is being evaluated in phase 
Ι/ΙΙ clinical trials (ClinicalTrials.gov Identifier:NCT01505062). Another strategy could be 
the use of minigenes (chapter 4a), this method has already proven its potential for the 
large genes dystrophin and CEP290 11-13. 
The presence of photoreceptors is a pre-requisite for the application of genetic 
therapies to treat USH2A-associated retina dysfunction.  Therefore slowing down the 
speed of retinal degeneration will enlarge the window of opportunity for a future 
therapeutic intervention. A possibility to slow down retinal degeneration is using a 
pharmacological approach with compounds that for instance inhibit apoptosis. In 
general, pharmacological strategies have the advantage to target common causes or 
mechanisms. The disadvantage of using exogenous pharmacological molecules is the 
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limitation of specifically targeting the retinal cells of interest after a controlled drug 
delivery 14.
In case the disease is already in a more advantaged stage and no (functional) 
photoreceptors are present anymore, alternative strategies are required. One of 
these strategies is stem cell transplantation 15. Significant progress has been made in 
experimental stem cell applications, for which the first phase Ι/ΙΙ clinical trials have been 
recently approved. The latest studies on stem cell transplantation showed that this type 
of therapeutic approach is promising in restoring visual function in patients with an 
advanced state of degenerative retinal disease 16-18.
Alternatively, patients can be provided with epiretinal prostheses. One of these 
epiretinal prostheses that has been generated by Second Sight Medical Products, Argus 
2, has already been approved for commercial use although it still requires optimization 
19. A different strategy for restoring visual function when photoreceptors have largely 
degenerated is based on optogenetics. In optogenetics for the retina viable inner retina 
cells are genetically modified to express light-sensitive ion channels. So far, optogenetics 
has not been tested yet in humans.
In this thesis, we describe the development of a minigene augmentation therapy to 
restore visual function in RP patients with mutations in the USH2A gene. In order to 
evaluate this strategy in vivo, a suitable animal model is required. 
1.2 Model systems
The availability of suitable animal models is crucial to determine the therapeutic effect of 
a certain treatment on visual function. Alternatively, iPSC-derived 3D retinal organoids 
generated from patient cells could be used. However, these organoids usually lack 
RPE cells which are essential for the proper formation, maturation and maintenance 
of fully functional photoreceptor outer segments. The presence of functional outer 
segments is essential for light capture and as such vital to determine the effect of a 
therapeutic intervention 20. So far, rodents, fruit flies and zebrafish have been used as 
model organisms to study Usher syndrome-associated retinal degeneration (Table 2, 
General introduction). In chapter 4, we demonstrated that the zebrafish is a suitable 
model to study USH2A-associated retinal dysfunction and that it can be used for the in 
vivo evaluation of therapeutic strategies. As for every model system the use of zebrafish 
has several advantages, challenges and limitations.
One advantage of the zebrafish is that the retinal laminar organization is highly 
similar to the human situation. Besides rods, zebrafish have four distinct types of cone 
photoreceptors (ultraviolet (UV), blue, red and green cones) which all have a peak 
sensitivity to a specific wavelength 21. The cone photoreceptors develop prior to the 
rods. By 24 dpf, the zebrafish retina is considered to be adult-like, with only the fine-
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tuning of the connections left to develop. It should therefore be noted that at 5 dpf, 
the developmental stage at which most of our experiments have been conducted, the 
zebrafish retina is still immature. 
Zebrafish ush2a mutant models do not mimic the progressive retinal degeneration as 
seen in man. Contrary to mammals, the zebrafish has the capacity to fully regenerate 
entire parts of the nervous system, including the retina. Following injury, zebrafish Müller 
glia cells dedifferentiate into proliferating precursor cells and subsequently differentiate 
into new (neuronal) cells, while mammalian Müller glia cells undergo reactive gliosis 22. 
A potential explanation for the lack of a progressive ush2a-associated retinal phenotype 
in fish could therefore be that the rates of photoreceptor degeneration and subsequent 
regeneration are perfectly balanced. Crossing ush2a mutants with (temperature-
sensitive) zebrafish models defective for their regenerative capabilities, like nightcap 
(ncp) or no blastema (nbl), could unveil the contribution of regeneration to the lack of 
a progressive retinal phenotype 23,24. From a different perspective, finding the switch 
to activate this remarkable regeneration pathway in man could potentially hold great 
promise for the future treatment of USH2A-associated retinal degeneration 23,25. 
Finally, the translational value of a zebrafish model for a human condition can be 
argued, although this should be considered for all types of cellular and animal models 
that are used. Zebrafish are evolutionarily quite distinct from man, but they still share a 
high degree of DNA sequence and functional homology. Although one should take into 
account that, due to an ancient genome duplication event in teleost fish, approximately 
30% of genes are duplicated in the zebrafish genome 26. Alternatively, pre-clinical proof 
of concept for a therapeutic approach could be obtained using animal models that are, 
both genetically and physiologically, more closely related to human than zebrafish (e.g. 
dogs, cats or pigs) 25. 
2. PRE-CLINICAL PHASE
In the pre-clinical phase, the generation and characterization of the model system 
derived from the design phase needs to be accomplished. Subsequently, the potential 
of the strategy selected in the design phase can be tested in the generated animal model 
in vivo.  To determine whether a therapeutic strategy is effective in restoration of visual 
function, consistent and sensitive read-outs are required. Therapeutic efficacy can be 
determined by measuring VMRs and ERG traces and by looking at bio-markers. In order 
to identify suitable bio-markers it is essential to understand the underlying molecular 
mechanisms of the retinal degeneration. The powerful combination of proteomics 
and knock-out animal models can attribute to unravel the retinal degeneration 
pathomechanisms of an USH2A mutation.
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2.1 Proteomics 
Usher syndrome-associated proteins co-function in highly dynamic protein networks 
at different subcellular locations and during different time points in development, as 
has been explained in the introduction of this thesis (chapter 1). In order to elucidate 
the cellular function of usherin and to unravel the pathogenic mechanism underlying 
USH2A-associated RP, we further investigated usherin’s “social network” of proteins 
(chapter 2a and 2b). 
Already in 2009, NINL was identified as a key usherin-interaction partner that connects 
the retinal ciliopathies Usher Syndrome and Leber congenital amaurosis at the molecular 
level 27. Using a combination of proteomics and zebrafish modelling, we identified that 
NINL plays an important role in two consecutive steps of intracellular vesicle transport. 
First of all, a module consisting of NINL and DZANK1 (chapter 2a) was identified that 
plays a crucial role in the proper assembly and folding of the intracellular cytoplasmic 
dynein 1 motor complex in photoreceptor cells. Cytoplasmic dynein 1 has been shown 
to be essential for photoreceptor outer segment formation and function. Next, a 
complex consisting of CC2D2A-NINL-MICAL3-RAB8A (chapter 2b) was identified that is 
involved in the fusion and docking of RAB8A-coated cargo vesicles at the photoreceptor 
ciliary base. Although very interesting and important, the data described in these two 
chapters did not result in the identification of the exact function of usherin in the retina.
The Cop9 signalosome associates with different members of the Usher protein network 
28. One of the eight Cop9 subunits, COPS8, directly interacts with the intracellular region 
of usherin. The Cop9 signalosome has different predicted roles in actin attachment/
polymerization 29, DNA damage response and proteasomal degradation 30. Future 
functional analyses in patient-derived cellular models or animal models will reveal 
to which extent an impaired Cop9 signalosome function contributes to the Usher 
syndrome pathogenesis. 
2.2 Animal models 
In chapter 2, the temporary downregulation of zebrafish ninl, cc2d2a and dzank1 
expression was induced by using translation or splice-blocking morpholinos (MOs) 31. 
Reported toxicity, off-target effects and non-reproducibility of results in corresponding 
mutants have led to a strong debate around the use of MOs. Recently, novel guidelines 
for the proper use of MOs in a tightly controlled setting have been released 32. However, 
to study the long-term effect of genetic modifications it is recommended to generate 
mutants by CRISPR/Cas9-based genome editing. 
The availability of ush2a mutant zebrafish models that present with early-onset retinal 
dysfunction (chapter 3a) also provides opportunities to unravel the underlying 
molecular mechanisms of USH2A-associated retinal degeneration in more detail. In 
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order to sort out the cause of photoreceptor dysfunction and apoptosis, a more in 
depth phenotyping of the mutant is recommended. For instance, Transmission Electron 
Microscopy (TEM) analyses as used in chapter 2 will provide a more detailed insight 
into potential morphological problems such as vesicle accumulation. Additional 
immunohistochemical analyses for specific photoreceptor marker proteins, such as 
opsins, at different time points could potentially reveal the underlying cause of the retinal 
dysfunction as observed in the ush2a knock-out larvae. Alternatively, similar to what has 
been observed for several other types of inherited retinal dystrophies 33, mutations in 
USH2A could affect photoreceptor proteostasis resulting in a gradual degeneration of 
photoreceptor cells. Autophagy is a protective mechanism used to recycle misfolded, 
mislocalized and/or aggregated proteins from the cytoplasm and the endoplasmic 
reticulum (ER) 22. However, a prolonged increased level of autophagy could eventually 
induce programmed cell death. As the Usher protein network associates with the 
Cop9 signalosome, a complex involved in autophagosome maturation 34, investigating 
proteostasis in the zebrafish ush2a models (chapter 3a) could provide insight into the 
underlying mechanisms of photoreceptor death.
In chapter 4 we showed the suitability of the zebrafish to model USH2A-associated 
retinal dysfunction and indicated the potential of using USH2A minigenes as a future 
treatment option for USH2A-associated RP.  Furthermore, we demonstrated that the 
presence or absence of the usherin interaction partner whirlin at the photoreceptor 
periciliary membrane could serve as a biomarker for therapeutic efficacy in zebrafish. 
3. TOWARDS CLINICAL TRIALS
Prior to entering phase I clinical trials, three major aspects still need to be addressed: the 
method of delivery, toxicological screening of the therapeutic compound and patient 
selection criteria.
3.1 Delivery methods 
Gene therapy requires a vehicle to deliver the gene of interest to the target cells. 
Methods for gene therapy can be broadly divided into viral and non-viral 24. Thus 
far, viral vectors have been the most popular vehicles for gene delivery to the retina. 
AAV-mediated delivery of a gene into the subretinal space has proven to be safe 
and effective in treating photoreceptor degenerative diseases35-40. However, AAVs 
have a limited cargo packaging capacity of ~4.8 kb 41, which hampered the progress 
in the development of gene augmentation therapies for large genes such as USH2A. 
Alternatively, lentiviral (LV) vectors, which have a relatively high packaging capacity of 
~8.5 kb, could be used. However, the integrative nature of LV vectors could potentially 
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result in insertional mutagenesis. Nanoparticles could be used as alternative non-viral 
vehicles for gene delivery. They have already been successfully applied in clinical trials 
for cystic fibrosis, and currently the use of nanoparticles as a vehicle for ocular drug 
delivery is under investigation 42,43. In contrast to the limited packaging capacity of 
AAVs, a major advantage of the use of CK30-nanoparticles is the theoretically unlimited 
plasmid size that can be loaded. Sequences with a size up to 20 kb have already been 
successfully loaded onto nanoparticles 42,43, which is well within the range of the full 
length coding sequence of human USH2A (~15.6 kb). Nanoparticles are perfectly suited 
for drug delivery due to their small size and the diversity of materials that can be used to 
generate these particles for targeted aims. They are able to penetrate biological barriers, 
can deliver drugs directly at the target site and provide a sustained release profile. A 
successful delivery of genes to different retinal cell types such as RPE, photoreceptor 
cells and ganglion cells using CK30-nanoparticles after subretinal injections has 
already been shown. However, prior to the clinical application of nanoparticles for eye 
disorders, the main obstacles such as a poor delivery via eye drops, the relatively low 
gene expression levels during a short period of time and the side effects of the delivery 
method, should first be overcome 44. Future research in cellular or animal models will 
determine which method will be most suitable for the delivery of USH2A minigenes to 
the human photoreceptor cells. 
3.2 Toxicological screening
Toxicological testing of new genetic treatments is essential in the drug development 
process. The levels of toxicity can be determined by studying the accidental exposures 
to a substance, by in vitro studies using cell lines or by in vivo exposure of animal models. 
The preclinical toxicity testing helps to calculate the “No Observed Adverse Effect Level” 
which is needed to determine the maximal dose prior to initiating the clinical evaluation 
of genetic treatments that are under development 45.
 
3.3 Patient selection criteria
Only patients with syndromic or non-syndromic RP caused by mutations in USH2A are 
potentially eligible to be included in future clinical trials. An early genetic diagnosis of 
Usher syndrome is essential since therapeutic strategies will only be effective when 
photoreceptors are still present. Based on studies in iPSC-derived retinal progenitor 
cells of an Usher syndrome type 2a (USH2a) patient, it has been postulated that the 
mechanism of disease of protein-truncating mutations could differ from the mechanism 
of disease of missense mutations 46. Elucidation of the pathogenic mechanisms caused 
by different types of USH2A mutations will reveal whether or not USH2A minigene 
augmentation will be beneficial for all patients with USH2A-associated RP or that it will 
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only be suitable for patients with protein-truncating mutations. Other selection criteria 
that will determine whether or not someone is eligible to be included in the initial 
clinical trials are the level of visual acuity (BCVA of ≤20/40), age (only adults should 
be included in the first trials due to ethical concerns and difficulties in performing 
intravitreal injections in children), absence of amblyopia and presence of photoreceptor 
(outer nuclear) and RPE layers on a standard OCT scan. Patients that underwent ocular 
surgeries or a thermal laser treatment within 6 months prior to the initiation of the 
clinical trial are typically excluded.
4.  CLINICAL TRIALS: EXPECTATIONS AND PROSPECTS 
4.1 The first clinical trial for USH2A-associated retinal degeneration: 
timeline
Taken together, the results described in chapter 4 are very promising, but the actual 
implementation of this therapeutic approach as a treatment for USH2A-associated 
retinal degeneration is still far away. Only estimates can be made on expected timelines 
when our developments will reach the clinical phase, based on studies that have 
adopted the minigene approach as a therapeutic option to treat CEP290-associated 
retinal dystrophy or Duchenne Muscular Dystrophy (DMD) 11-13,47. In 1987, mutations in 
dystrophin were identified as the underlying cause of DMD 34. Already in 1994, Rafael and 
co-workers discovered that addition of a shortened version of dystrophin could prevent 
the observed dystrophic phenotype in mdx mice 30. Thereafter, a variety of studies in 
mouse and dog were performed before the first phase Ι clinical trial was initiated in 
2006, in which six participants were supplemented with rAAV2.5-CMV-minidystrophin 
(d3990). In 2015, another phase I clinical trial was launched in which two participants 
were treated with an even shorter version of the dystrophin gene (rAAVrh74.MCK.micro-
Dystrophin). For the latter, a phase Ι/ΙΙa trial was initiated in 2017 which is currently still 
ongoing. In total, the journey from gene discovery until clinical phase ΙΙa already took 
over 30 years. Although this timeline can be highly variable between different studies, 
we expect that it will take at least multiple years before our minigene approach, if at 
all, reaches the clinical trial phase. In the coming years crucial information on timing, 
dosing and delivery methods needs to be gathered for the USH2A minigene approach. 
In the meanwhile, a lot can be learned from the first phase I/IIa clinical trial for USH2A-
associated RP using an exon-skipping approach, which is expected to advance towards 
the clinic at the end of 2018.
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4.2 Potential of genetic therapies to restore Usher syndrome-associated 
hearing loss
Although patients with Usher syndrome benefit from hearing aids and cochlear implants, 
yet no curative treatment is available. Usher syndrome-associated proteins have been 
shown to play an essential role in development of the inner ear hair bundle and 
cohesion in knock-out mice (Table 2, general introduction) 48,45,46,50,60-62. Several gene 
replacement or splice correction strategies have been proven successful in restoring 
auditory and/or vestibular function in mouse models for USH1c 49-51, USH2d 52,53 USH1g 
54 and USH3 55,56, when applied prior to the completion of murine inner ear maturation 
at postnatal day 20. As the development of the human auditory and vestibular system is 
already completed during gestation, it is expected that intervention studies in man will 
only be beneficial when applied in utero.
Ush2a knock-out mice develop moderately-severe, non-progressive hearing loss, closely 
resembling the hearing loss observed in USH2a patients 57. In the inner ear, usherin is 
part of the ankle links, a subset of lateral links that connect two adjacent stereocilia near 
their basal ends 57,58. It is speculated that the enormous size of usherin (5,202 amino 
acids) is essential for the proper spacing between two adjacent stereocilia. Therefore 
it is questionable whether USH2A minigene augmentation, even when applied at the 
most optimal time-point during development, will be effective in preventing hearing 
impairment in USH2a patients.  However, in some patients with USH2a, severe progression 
of hearing impairment is observed 59. For this group of patients the introduction of an 
USH2A minigene into the inner ear could potentially halt the progression of the disease.
5.  CONCLUDING REMARKS 
The diagnosis Usher syndrome changes the lives of patients dramatically as they are all 
of a sudden confronted with an uncertain future. Depending on the age of the patients 
and the severity of the hearing and vision loss, assistive listening devices, an epiretinal 
prosthesis, braille instructions, low-vision services, a guide dog, auditory training or 
other communication methods such as sign language can be provided to the patients. 
Proper assistance is important to enable Usher syndrome patients to carry out daily 
activities, to communicate with the outer world and to maintain their independence.
 In the Netherlands, five different patient-organizations are committed to support 
the deafblind community: Oogvereniging pg Doofblinden, Stichting Ushersyndroom, 
Stichting Klavertje 2, Contactgroep Ushersyndroom and Stichting Wetenschappelijk 
Onderzoek DoofBlindheid. The main goal of these groups is to provide support by 
stimulating contact between patients and providing information. In addition, they play 
an important role in creating societal awareness for this rare condition. Another goal of 
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these organizations is to raise funds in order to financially support scientific research 
with the ultimate aim of improving the quality of life of patients. 
In line with the goal of the patient organizations, the results described in this thesis 
hold great promise to potentially save residual vision in patients with loss-of-function 
mutations in the USH2A gene. As a next step, we provide new directions for exiting future 
experiments which should focus on the delivery and safety aspects of the described 
therapies in the retina. Altogether, the data provided in this thesis point towards 
the value of the zebrafish as a model to “fish for answers” and provide new handles 
for breaking down the remaining barriers prior to the implementation of a treatment 
option for USH2A-associated RP. 
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6.1
Usher syndrome is a genetically and clinically heterogeneous disorder characterized by 
hearing impairment from birth and a progressive loss of visual function as a consequence 
of retinitis pigmentosa (RP) (chapter 1). Usher syndrome type 2 is the most common 
type of Usher syndrome and represents around two-third of Usher syndrome cases, 
of whom 57-85% can be explained by mutations in USH2A. Also, mutations in USH2A 
are among the most frequent causes of autosomal recessively inherited nonsyndromic 
RP (arRP), accounting for 7-23% of arRP cases. Currently, no treatment options exist for 
USH2A-associated retinal degeneration. The aim of the research described in this thesis 
was to elucidate the pathogenic mechanisms underlying Usher syndrome type 2 and to 
develop a pre-clinical therapeutic strategy for USH2A-associated RP. 
Usher syndrome-associated proteins function together in a highly dynamic protein 
complex (chapter 1). So far, surprisingly little is known about the function of this 
protein complex in the retina. In chapters 2a and 2b, we aimed to unravel part of this 
function by studying key interaction partners of the USH2A-encoded protein usherin. 
NINL is thought to be an important interaction partner of usherin in the retina, since 
this protein is connecting the retinal ciliopathies Usher syndrome and Leber congenital 
amaurosis at the molecular level. Using a combination of (affinity) proteomics and 
zebrafish as a model system, we found that NINL is part of a dynamic multi-subunit 
protein complex in photoreceptor cells that plays an important role in two consecutive 
steps in transporting trans-Golgi network (TGN)-derived cargo vesicles (chapter 2). First 
of all, a direct interaction between NINL and DZANK1 was identified. NINL and DZANK1 
associate with complementary subunits of the cytoplasmic dynein 1 complex. Our results 
support a model in which the NINL-DZANK1 module plays a crucial role in the proper 
assembly of the intracellular cytoplasmic dynein 1 motor complex in photoreceptor 
cells (chapter 2a). In chapter 2b, we identified a series of physical interactions linking a 
protein complex consisting of NINL, CC2D2A and MICAL3 to vesicular trafficking. These 
data suggest a new model, in which CC2D2A provides a specific docking point for NINL-
bound transport vesicles at the entrance to the photoreceptor ciliary compartment. 
NINL is proposed to bind the vesicles through MICAL3 which in turn binds RAB8 that 
is coating TGN-derived cargo vesicles. MICAL3 subsequently promotes remodeling of a 
docking complex resulting in vesicle fusion at the periciliary membrane. Interestingly, 
a heterozygous protein truncating mutation in NINL has been identified in a Joubert 
syndrome patient in combination with a known homozygous pathogenic mutation in 
the CC2D2A gene. Phenotypically this patient presented with a much more severe form 
of Joubert syndrome than was expected based on the known homozygous CC2D2A 
mutation. Together with the genetic interaction data in zebrafish, this suggests that 
variants of NINL may act as a genetic modifiers for CC2D2A-associated Joubert Syndrome 
(chapter 2b). With the studies described in the chapters 2a and 2b, we contributed to 
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the knowledge of mechanisms by which transmembrane proteins such as usherin are 
transported from the photoreceptor inner segment towards the periciliary membrane 
(chapter 2). 
Further investigations on the potential of the zebrafish model to study USH2A-associated 
retinal degeneration are described in chapters 3 and 4. In chapter 3 the generation 
and characterization of two zebrafish ush2a mutants is described. Using CRISPR/Cas9-
technology, we introduced protein-truncating germline lesions into the zebrafish 
ush2a gene (ush2armc1: c.2337_2342delinsAC; p.Cys780GlnfsTer32 and ush2ab1245: 
c.15520_15523delinsTG; p.Ala5174fsTer). Homozygous mutants were viable and did 
not display any obvious abnormalities during early development. Immunofluorescence 
analyses using antibodies recognizing the N- or C-terminal end of usherin 
demonstrated complete absence of usherin in photoreceptors of the ush2armc1 mutant, 
but demonstrated the presence of the ectodomain of usherinisoB at the photoreceptor 
periciliary membrane of ush2ab1245 mutant larvae. Complete absence of usherin (ush2armc1) 
resulted in reduced levels of both paralogs of its interaction partner whirlin, Whrna and 
Whrnb, and of Adgrv1 at the photoreceptor periciliary membrane. In photoreceptors 
of ush2ab1245 larvae only reduced levels of Whrna were observed, whereas the levels 
of Whrnb and Adrgrv1 were largely unaffected. Based on these data, we proposed a 
model in which the ectodomains of usherin and Adgrv1 associate. We furthermore 
suggested that Whrna has a higher binding affinity for usherin, and Whrnb a higher 
binding affinity for Adgrv1. We also observed significantly elevated levels of apoptotic 
photoreceptors in both mutants when kept under constant illumination for three days. 
Electroretinogram (ERG) recordings revealed a significant and similar decrease in both 
a- and b-wave amplitudes in ush2armc1 as well as ush2ab1245 larvae as compared to strain- 
and age-matched wild-type larvae. In conclusion, this study demonstrated that mutant 
ush2a zebrafish models present with early-onset retinal dysfunction. These models are 
therefore instrumental in obtaining a better understanding of the pathophysiology 
underlying USH2A-associated RP and in evaluating future therapeutic strategies.
Chapter 4 describes the generation and subsequent evaluation of the therapeutic 
potential of two human miniUSH2A genes in improving retinal function of the ush2armc1 
zebrafish mutant. For this purpose, Tol2-based transgenic ush2armc1 zebrafish lines were 
generated that stably express miniUSH2A-1 or miniUSH2A-2 under the control of a 
photoreceptor-specific promoter. Expression of either miniUSH2A restores the levels 
of interaction partner Whrna at the photoreceptor periciliary region. Furthermore, 
ERG traces and Visual Motor Responses (VMRs) were fully restored after expression of 
miniUSH2A-1 and significantly improved after expression of miniUSH2A-2. In conclusion, 
this study shows the potential of shortened USH2A genes for the development of a 
future treatment of USH2A-associated RP.
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In conclusion, the research described in this thesis has resulted in some major steps 
forward towards the development of a future treatment for USH2A-associated RP. The 
generation of the first ush2a animal model with an early onset retinal dysfunction 
provides a unique opportunity to unravel the pathogenic mechanism(s) underlying 
USH2A-associated retinal degeneration. In addition, this zebrafish model enabled us 
to demonstrate the potential of the miniUSH2A gene approach in improving zebrafish 
larval visual function. Finally, in chapter 5 the current challenges and recommendations 
for future studies on the road towards therapy for USH2A-associated RP are provided.  
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6.2
Het Usher syndroom is een genetisch en klinisch heterogene aandoening die wordt 
gekenmerkt door gehoorverlies vanaf de geboorte en een progressief verlies van het 
gezichtsvermogen ten gevolge van retinitis pigmentosa (RP) (hoofdstuk 1). Usher 
syndroom type 2 is de meest voorkomende variant en vertegenwoordigt ongeveer 
twee derde van alle Usher syndroom gevallen, waarvan 57-85% kan worden verklaard 
door mutaties in USH2A. Ook zijn mutaties in USH2A een van de meest voorkomende 
oorzaken van autosomaal recessief overervende niet-syndromale RP (arRP). Mutaties in 
USH2A verklaren 7-23% van de arRP gevallen. Momenteel bestaat  er geen behandeling 
voor USH2A-geassocieerde netvliesdegeneratie. Het doel van het onderzoek beschreven 
in dit proefschrift was om de pathogene mechanismen die ten grondslag liggen aan 
Usher syndroom type 2 op te helderen en om een  pre-klinische behandelstrategie te 
ontwikkelen voor USH2A-geassocieerde RP.
Usher syndroom-geassocieerde eiwitten functioneren samen in een zeer dynamisch 
eiwitcomplex (hoofdstuk 1). Tot nu toe is er verrassend weinig bekend over de functie 
van dit eiwitcomplex in het netvlies. In de hoofdstukken 2a en 2b is beschreven 
hoe we hebben gepoogd om een deel van deze functie te ontrafelen door een van 
de belangrijkste interactiepartners van het door USH2A-gecodeerde eiwit usherin te 
bestuderen. Het NINL-eiwit wordt beschouwd als een belangrijke interactiepartner van 
usherin in het netvlies, omdat het de retinale ciliopathieën Usher syndroom en Leber 
congenital amaurosis op moleculair niveau met elkaar verbindt. Door gebruik te maken 
van een combinatie van proteomics en het zebravismodel, ontdekten we dat NINL deel 
uitmaakt van een dynamisch eiwitcomplex in fotoreceptorcellen dat een belangrijke 
rol speelt in twee opeenvolgende stappen in het vervoeren van transportvesikels die 
afkomstig zijn van het trans-Golgi-netwerk (TGN)  (hoofdstuk 2). Er werd een directe 
interactie tussen NINL en DZANK1 geïdentificeerd. NINL en DZANK1 associëren met 
complementaire eenheden van het cytoplasmische dyneïne 1-complex. Onze resultaten 
ondersteunen een model waarin de NINL-DZANK1 module een cruciale rol speelt bij de 
juiste assemblage van het intracellulaire cytoplasmische dyneïne 1-motorcomplex in 
fotoreceptorcellen (hoofdstuk 2a). In hoofdstuk 2b identificeerden we een reeks directe 
interacties die een eiwitcomplex bestaande uit NINL, CC2D2A en MICAL3 verbinden aan 
vesiculair transport. Deze bevindingen suggereren een nieuw inzicht, waarbij CC2D2A 
een specifiek landingspunt biedt voor NINL-gebonden transportvesikels aan de ingang 
van het ciliaire compartiment van de fotoreceptor. In dit model bindt NINL aan de vesikels 
via MICAL3, dat op zijn beurt interacteert met RAB8. RAB8 moleculen vormen een 
coating op de transportvesikels afkomstig van het TGN. MICAL3 bevordert vervolgens 
de herstructurering van het koppelingscomplex wat leidt tot de fusie van het vesikel 
met het periciliaire membraan. In een patiënt met Joubert syndroom met een bekende 
homozygote pathogene mutatie in het CC2D2A-gen hebben we een  heterozygote 
truncerende mutatie in NINL geïdentificeerd.  Het fenotype van deze patiënt was veel 
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ernstiger dan op grond van de bekende homozygote CC2D2A-mutatie kon worden 
verwacht. Deze bevinding gecombineerd met de geïdentificeerde genetische interactie 
tussen ninl en cc2d2a in de zebravis suggereert dat varianten in NINL kunnen werken 
als genetische modulator bij CC2D2A-geassocieerd Joubert syndroom (hoofdstuk 2b). 
De studies zoals beschreven in de hoofdstukken 2a en 2b hebben geresulteerd in een 
beter inzicht in de transportmachinerie waarmee transmembraaneiwitten zoals usherin 
worden vervoerd van het binnenste segment van de fotoreceptor naar de periciliaire 
membraan (hoofdstuk 2).
Hoofdstukken 3 en 4 beschrijven de experimenten waarmee de potentie van de 
zebravis als model om USH2A-geassocieerde netvliesdegeneratie te bestuderen is 
onderzocht. In hoofdstuk 3 wordt de ontwikkeling en karakterisering van twee zebravis 
ush2a-mutanten beschreven. Met behulp van CRISPR/Cas9-technologie introduceerden 
we verschillende truncerende mutaties in het ush2a gen van de zebravis (ush2armc1: 
c.2337_2342delinsAC; p.Cys780GlnfsTer32 en ush2ab1245: c.15520_15523delinsTG; 
p.Ala5174fsTer). Homozygote mutanten bleken levensvatbaar en vertoonden geen 
duidelijke morfologische afwijkingen tijdens de vroege ontwikkeling. Met behulp 
van immunohistochemie waarbij gebruik gemaakt is van antilichamen die het N- of 
C-terminale deel van usherin herkennen, is aangetoond dat usherin volledig afwezig 
is in fotoreceptoren van de ush2armc1 mutant. Echter, het ectodomein van usherinisoB is 
nog wel aanwezig aan het periciliaire membraan van fotoreceptoren in ush2ab1245 larven. 
Volledige afwezigheid van usherin (ush2armc1) resulteerde in een verlaagde hoeveelheid 
van de beide paralogen van interactiepartner whirlin, Whrna en Whrnb, en van Adgrv1 
aan het periciliare membraan van de fotoreceptor. In fotoreceptoren van ush2ab1245 
larven werd  een verlaagde hoeveelheid van Whrna waargenomen, terwijl de niveaus 
van Whrnb en Adrgrv1 grotendeels onaangetast waren. Op basis van deze gegevens 
hebben we een model voorgesteld waarin de ectodomeinen van usherin en Adgrv1 met 
elkaar interacteren. We stelden bovendien voor dat Whrna een hogere bindingsaffiniteit 
heeft voor usherin en Whrnb een hogere bindingsaffiniteit voor Adgrv1. We hebben 
ook in beide mutanten significant verhoogde aantallen apoptotische fotoreceptoren 
waargenomen ten opzichte van wild-type controles, als de larven gedurende drie 
dagen in constant licht werden gehouden. Electroretinogram (ERG) metingen lieten 
een significante en vergelijkbare afname van de amplitude van zowel de a- als b-golf 
zien in ush2armc1 en ush2ab1245 larven in vergelijking met wildtype-larven van dezelfde 
leeftijd en stam. Samenvattend heeft  deze studie aangetoond dat zebravis ush2a-
mutanten al in het larvale stadium een probleem hebben met het functioneren van hun 
netvlies. Deze mutanten kunnen daarom een belangrijke rol spelen in het ontrafelen 
van de pathofysiologie die ten grondslag ligt aan USH2A-geassocieerde RP en in het 
evalueren van toekomstige therapeutische strategieën.
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Hoofdstuk 4 beschrijft de ontwikkeling en daaropvolgende evaluatie van het 
therapeutisch potentieel van twee humane USH2A-minigenen ter verbetering van de 
visuele functie van de ush2armc1 zebravismutant. Voor dit doel werden met behulp van 
het Tol2-transposase systeem twee  transgene ush2armc1 zebravislijnen gegenereerd 
die miniUSH2A-1 of miniUSH2A-2 stabiel tot expressie brengen onder de controle van 
een fotoreceptor-specifieke promoter. Expressie van miniUSH2A-1 of -2 leidde tot een 
herstel van de hoeveelheid  Whrna in de periciliaire regio van fotoreceptoren. Daarnaast 
herstelden de ERG-amplitudes en Visuele Motor Response (VMR) volledig na expressie 
van miniUSH2A-1 en verbeterden ze significant na expressie van miniUSH2A-2. Deze 
studie laat derhalve de potentie zien van het gebruik van verkorte USH2A-genen als 
toekomstige behandelmethode voor USH2A-geassocieerde RP.
Concluderend heeft het onderzoek beschreven in dit proefschrift geresulteerd in een 
aantal belangrijke stappen in de richting van de ontwikkeling van een toekomstige 
behandeling voor USH2A-geassocieerde RP. De ontwikkeling van het eerste ush2a-
diermodel met een vroeg retina fenotype biedt een unieke mogelijkheid om 
het pathogene mechanisme dat ten grondslag ligt aan USH2A-geassocieerde 
netvliesdegeneratie te ontrafelen. Daarnaast heeft het zebravis model ons in staat 
gesteld om de potentie van het gebruik van USH2A-minigenen te onderzoeken om 
de visuele functie van deze vis te verbeteren. Tenslotte worden in hoofdstuk 5 de 
uitdagingen besproken die we op het pad van een verdere ontwikkeling van therapie 
voor USH2A-geassocieerde RP nog zullen tegenkomen, en doen we aanbevelingen om 
deze ontwikkeling te bevorderen.
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Het is zover, het moment waar ik lang naar uitgekeken heb. De rit die niet altijd even 
makkelijk ging, maar uiteindelijk toch gelukt is dankzij de hulp van velen die ik graag 
wil bedanken.
Allereerst wil ik mijn promotoren Jan en Hannie, en co-promotor Erwin bedanken. 
Dank voor deze mooie kans die mij geboden is. Na een uiterst leerzame en leuke 
stage, was ik verkocht aan de zebravisjes en het Usher onderzoek. Ik kon er echt mijn 
ei in kwijt, en was vaak niet meer te houden. Ik ben blij en trots dat ik het zebravis 
onderzoek in Nijmegen mee heb mogen opzetten, van alleen een klimaatcel met kast, 
tot een uitgebreid systeem met talloze waardevolle mutanten. Het allerleukst heb ik 
het opzetten van nieuwe assays gevonden, en dit heb ik dan ook uitgebreid mogen 
doen. Bedankt voor deze mogelijkheid en het vertrouwen. Qua resultaten is het ook 
enorm goed gegaan, ik denk dat we vooral erg trots mogen zijn dat we nu richting 
clinical trials gaan en het mooie patent van de minigenen zijn een kers op de taart na 
al het harde werk. Hannie, bedankt voor alle hulp, de altijd kritische blik en waardevolle 
schrijftips. Erwin, we zijn samen op het lab begonnen, jouw positieve kijk op de wereld 
en enthousiasme zijn zeer aanstekelijk. Han en Ad, bedankt voor al jullie hulp. Ook Henri 
Marres en Arjan Verhoeven van de KNO-afdeling wil ik graag bedanken voor de fijne 
tijd op de KNO-afdeling en de betrokkenheid bij ons mooie Usher onderzoek. Ronald 
Pennings, de altijd vrolijke, geïnteresseerde en vol met passie KNO-arts. Bedankt voor 
onze fijne gesprekken, ik waardeer je passie voor de patiënt en betrokkenheid. 
Daarnaast ben ik blij dat ik veel patiënten met het Usher syndroom heb mogen leren 
kennen, maar vooral ook de mensen achter deze ziekte heb leren kennen. Ik bewonder 
jullie doorzettingsvermogen, positiviteit en ook hoe goed jullie zijn in crowdfunding. 
Ik wil graag alle betrokken organisaties een hart onder de riem steken, jullie doen 
geweldig werk en steunen ons onderzoek enorm. In het bijzonder wil ik graag Yvonne 
Bressers bedanken, een van de drijvende krachten achter stichting Usher syndroom. 
Tijdens onze gesprekken hebben we veel gelachen, ik hou van je enthousiasme en 
dat niets je te gek of moeilijk is, je gaat er “gewoon” voor. Daarnaast natuurlijk ook de 
mensen van Stichting Wetenschappelijk Onderzoek Doofblindheid (SWODB). Frank, 
Nicole, Hedda, Erik en Linda bedankt voor de fijne samenwerking. Mijn doel om naast 
het wetenschappelijk onderzoek ook mijn steentje te kunnen bijdragen en meer te leren 
over de wensen van de mensen met Usher syndroom was een leerzame tijd voor mij. 
Door de jaren heen heb ik heel veel mensen leren kennen, met ieder heb ik een andere 
band opgebouwd, waar ik ontzettend dankbaar voor ben en vaak ook veel van geleerd 
heb. Het liefste zou ik iedereen uitgebreid persoonlijk willen bedanken, maar om 
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niemand te vergeten wil ik bij deze al mijn collega’s van Genetica (de sensory disease 
groep), Oogheelkunde, KNO, Dierfysiologie en Fysiologie bedanken. 
In het bijzonder; Lisette, Theo, Erik, Edith, Ralph, Sanne, Margrit, Jaap, Celia, Anne, 
Jeroen, Suzanne, Rob, Alex, Dyah, Lonneke, Müriel, Julio, Anita, Simon, Matthijs en 
Tamara. Bedankt voor de fijne samenwerking, alle waardevolle discussies, en ook de 
talloze grappige en leuke momenten. Ralph en Erik, de mannen van het lab, bedankt 
voor alle wetenschappelijke discussies en hulp bij de experimenten! Sanne, twee van 
onze hoogtepunten zijn zeker ons avontuur in Zürich en al onze gezellige en lekkere 
pizza-dates. Lisette, bedankt voor al je technische hulp, tips en tricks, en natuurlijk ook 
voor onze waardevolle vriendschap. Theo, bedankt dat je echt altijd voor me klaar hebt 
gestaan. Je bent de master van de histologie, wat een voorrecht om deze technieken 
en vaardigheden van je te hebben mogen leren. Ontelbare kleuringen, uurtjes (dagen) 
achter de mic, en ook de ontelbare uren droge humor waar we samen prima mee vooruit 
komen en waardoor de tijd voorbij gevlogen is. Edith, je hebt heel veel TEM en SEM 
werk gedaan, wat een ontzettend indrukwekkende technieken en wat een fantastische 
plaatjes. Bedankt voor al je hulp, de fijne samenwerking en zorgvuldigheid. 
Ook een woord van dank aan Francois. Bedankt voor je kennis en het geduld om samen 
het ERG apparaat aan de gang te krijgen. Stiekem was ik ook heel benieuwd hoe de 
broer van Tom zou zijn. Ik vond het enorm leuk je te leren kennen en dank je voor je hulp! 
Daarnaast kon ik ook altijd bij Marty terecht voor alle technische vragen, ondersteuning 
en vooral ook de oplossingen, bedankt! Dirk, je hebt altijd klaargestaan voor me wat 
betreft de elektrofysiologie wat ik erg waardeer. In het begin waren al die knopjes en 
draadjes toch maar gek en verlangde ik vooral naar de pipet. Jon-Ruben ook jij bedankt 
voor je hulp. Uiteindelijk is het allemaal gelukt,  hebben we prachtige data verkregen en 
vooral ook veel extra kennis in huis kunnen halen. Dyah, wellicht beginnen we ooit ons 
plan B met ons eigen restaurant op wielen, met jou natuurlijk als hoofd Chef. Lonneke, 
ik herinner me nog goed dat we beiden begonnen zijn als student toen we nog het lab 
deelde met de “eiwit mensen”. We hebben elkaar heel goed leren kennen en het klikte 
meteen, bedankt dat je vandaag ook mijn paranimf wil zijn. 
Wat heb ik een waanzinnig goede tijd gehad (en nog steeds) samen met de eiwitladies 
(en Stef ). Ronald, Ideke, Ka Man, Sylvia, Brooke, Machteld, Maryam, Minh, Tess and 
Cenna. Dat we naar een ander lab gegaan zijn heeft geen invloed gehad op onze 
vriendschappen. Jullie zijn een enorm hechte groep van hele fijne mensen en ik ben 
ontzettend dankbaar om daar deel van uit te maken. Een heel groot woord van dank 
voor alle hulp, groot en klein, wetenschappelijk en vooral ook de sociale ondersteuning 
en vriendschap in goede en slechte tijden, enorm bedankt. Jeroen, jij hoort natuurlijk 
ook bij deze groep, soms zaten we een beetje in hetzelfde schuitje, bedankt voor al onze 
gesprekken! De tussenburen natuurlijk ook bedankt, vooral Lilian en Eveline. Bedankt 
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voor alle gesprekken en jullie hulp als ik weer eens iets nodig had! Ook regelmatig 
een bezoekje aan de Pre-labs, even kletsen (grappen uithalen) met Jaap, Michael, Bjorn, 
Ellen, Ellen, Petra, Marloes, Marlies, Masha en Remco en de andere pre-labbers, een 
super fijne tijd met veel fijne collega’s. Jaap bedankt voor al onze fijne gesprekken, en 
ook voor alle hulp met de qPCRs. Een van de leukste dingen om te doen zijn natuurlijk 
escape-rooms en spelletjes: Alex, Bjorn, Michael, Suus, Galuh en Lonneke bedankt voor 
alle leuke avonden. Peer uiteindelijk hebben we wel een hele bijzonder band gekregen, 
wat ontzettend gaaf dat je het avontuur in Australië aangegaan bent. De plannen waren 
bijna rond om naar het WK in Adelaide te komen, wie weet komt er toch nog een mooie 
mogelijkheid.  Alex Hoischen, ik ben je eeuwig dankbaar voor de hulp die je me gegeven 
hebt. Ik bewonder je positieve instelling en je bereidwilligheid om, hoe druk je het ook 
hebt, altijd tijd voor me vrij te maken, super bedankt.
Ook mijn kamergenootjes verdienen een woord van dank, ik wil speciaal Judith, Renske, 
Theo, Ideke, Machteld, Marjolein, Euginia, Armen, Benjamin, en Ralph noemen. De 
hoeveelheid grappen die getapt zijn, zijn niet te beschrijven en als ik eraan terug denk 
lig ik uiteraard weer dubbel, bedankt voor alle gezelligheid. Arjan ook jij bedankt voor 
alle gezellige gang gesprekken. Ik denk dat sommige mensen het prima vonden dat we 
een andere kamer kregen dan was het in de gang tenminste wat stiller. 
Daarnaast een speciaal woordje van dank aan mijn studenten. Nanda, je was mijn eerste 
eigen student, en eigenlijk was je gewoon mijn maatje. Ik denk dat iedereen ons in de 
gang al van ver kon horen aankomen, wat hebben we een lol gehad en daarnaast ook 
hele mooie dingen bereikt. Ik ben heel blij voor je dat je nu je eigen PhD begonnen 
bent!! Dilys, ik denk dat je heel veel geleerd hebt bij ons in het lab. Bedankt voor alle 
hulp!
De ruggengraat van de Genetica afdeling; de dames van het secretariaat Ineke, Miranda 
en Doménique (en natuurlijk Dennis). Bedankt voor alle hulp bij al mijn vragen en 
daarnaast ook altijd een luisterend oor. Nick, de kwaliteit goeroe en daarnaast vooral 
grappentap maatje, bedankt voor al je bezoekjes aan ‘t einde van de gang en alle leuke 
grappen. Ook de dames van de celkweek, bedankt voor al jullie hulp en de leerzame 
en fijne gesprekken. Katie, ik kan en wil jou natuurlijk niet vergeten, jij bent zeker een 
van de eerlijkste mensen die ik ken. Oprecht blij en oprecht verdrietig, bedankt voor al 
je hulp en al onze gesprekken. 
Een groot woord van dank aan alle collega’s van het vissenlab. Ik heb een hele goede tijd 
gehad op het vissenlab, en vond de ontspannen sfeer erg fijn, net als de vrijdagmiddag 
borrels en de jaarlijkse triatlon. Postbode, Remi en Bokito, jullie hebben alle drie het 
goede voorbeeld laten zien hoe dat promoveren nu moet, nu ben ik uiteindelijk 
ook zelf aan de beurt. Peter, Marnix en Juriaan, bedankt voor alle wetenschappelijke 
ondersteuning, goede tips en onze gesprekken. Daisy, Wim en Jan, bedankt dat jullie 
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altijd voor me hebben klaar gestaan. Ruud bedankt voor onze mooie samenwerking, 
op naar de volgende. Antoon, Jeroen en Tom, bedankt voor al jullie inzet met het 
opzetten van de visjes en alle waardevolle tips wat betreft de visjes en daarbuiten. 
Tom, je speciale kracht om die visjes echt altijd eitjes te laten leggen is zeer waardevol, 
het lijkt me nog steeds een goed idee om een grote poster af te drukken en deze bij 
alle visjes op te hangen, succes gegarandeerd;)! Gert, ik waardeer je enorm en vond 
het een fijne samenwerking met daarbij vele mooie (levens)lessen. Het mooie is dat 
ik de afdeling niet verlaten heb, maar in de buurt gebleven ben en verder mag gaan 
werken met de visjes. Paco, we zijn nu zelfs nog directere collega’s geworden, ik zie een 
mooie samenwerking tegemoet . De zebravis wereld is voor mij echt enorm gaaf en 
vooral ook een gezellige gemeenschap waar ik me heel goed thuis voel en mijn passie 
ligt. Allereerst natuurlijk dank aan onze zebravis platform in Nijmegen. Een speciaal 
woord van dank naar de groep van Leonie, Bilge, Marco, Naomi en Julien. Dank voor 
alle wetenschappelijke en niet-wetenschappelijk discussies. Julien, during our joined 
trip to the zebrafish congress in Buda and Pestch we got to know each other very well, I 
wish you and your family all the best. Bilge en Naomie, zet ‘m op met de laatste loodjes, 
jullie kunnen het!! Leonie, ik denk dat we een hele speciale band op hebben gebouwd, 
bedankt voor alle theetjes, adviezen en fijne gesprekken. Selma, ook bedankt voor je 
hulp, uiteindelijk mag ik verder werken met de visjes die jij gemaakt hebt, hoe bijzonder.
Daarnaast ook alle samenwerkingen die ik in de loop van jaren heb mogen opbouwen. 
Wim en Maarten uit Amsterdam. Wim, bedankt dat je altijd klaar stond voor een praatje 
en al je hulp. Maarten, je bent altijd positief, rustig en vol met waardevolle tips, ik heb 
veel van je mogen leren, bedankt.  Secondly, I would greatly want to thank Stephan 
and his lab members for my really pleasant stay in your lab in Zürich. Next to the 
great atmosphere in your lab, we gathered nice data and after this collaboration I was 
able to set up our own system in Nijmegen. Jingjing, thank you so much for the daily 
supervision and Kara for taking care of the fish and all other help. Ruxandra, thanks for 
our collaboration and two really nice shared publications about the NINL complex. I 
admire the critical look and endless enthusiasm. Another great team of collaborators 
originated from Oregon: Monte and Jennifer. Thanks for the endless help about all kind 
of zebrafish related research questions and our joined effort for the zebrafish mutant 
paper. Monte, it was a great pleasure to meet you in person in Budapest. 
Je hebt vrienden die komen en gaan, en je hebt vrienden die voor eeuwig zijn. Ons 
middelbare school clubje Adrienne, Elise, Evelien, Sandra en Susette. Het maakt niet uit 
hoe ver we uit elkaar wonen, hoe verschillend onze levens(fases) soms zijn. Als er nood 
aan de vrouw is, weten we elkaar te vinden. Ik waardeer jullie steun en vriendschappen 
enorm. 
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Een van mijn grootste passies en hobbies is het hockeyen. Er zijn heel wat uurtjes 
doorgebracht op het veld. Even de frustratie eruit slaan, heerlijk dat meppen op doel 
naar (de) Muur. Ik heb vanaf het begin een klik gehad met mijn nieuwe teamgenootjes 
van Union en voelde me enorm thuis op ’t veld en daarbuiten, ik waardeer jullie enorm 
en ben blij jullie te hebben leren kennen. Daarnaast, is een van mijn grote hobbies 
het zwemmen. Wat een ontelbare uurtjes vergaderingen van spellencommissie, 
wedstrijdcommissie tot bestuur. Soms zag ik er wel eens tegenop, weer de zoveelste 
vergadering maar uiteindelijk was het altijd gezellig en zeker nuttig. Daarnaast ligt mijn 
passie natuurlijk bij het coachen/trainen, en ook om zelf te zwemmen.  Op de zaterdag 
lesgeven aan de kleintjes is toch wel een van mijn favorieten (oke behalve als het buiten 
lekker weer is;)). Eerlijkheid en openheid van de kleintjes, dat geeft me een hoop energie 
en doet me goed. Wouter en Michiel, we vormen samen een goed team, en daarbij 
nu ook de BAM‘ers maakt het compleet. Ook mijn zwemmaatjes uit Gouda wil ik niet 
vergeten. Ons avontuur op het EK in Allicante, Spanje is wel een van de hoogtepunten 
geweest. Ellis, wat was ik blij dat ik eindelijk bij die boei was, we hebben het maar mooi 
gedaan met die hoge grote golven!! Ons volgende avontuur wordt hopelijk het EK in 
Italië, op naar de kikkers! 
Een speciaal woord van dank aan Fleur, Marianne, Chantal, Janneke, Wanda, Martine, 
Frank en aan alle E10-ers. Jullie zijn erg belangrijk voor mij geweest,  nu wil ik jullie graag 
laten zien wat ik heb kunnen bereiken mede dankzij jullie. Ook een speciaal woord van 
dank aan Eveline, wat ben ik blij dat ik je heb leren kennen en gebruik mag maken van 
je diensten. Je hebt me geïnspireerd en zeker verder geholpen. Nanneke, ik ben blij je te 
leren kennen en onze nuchtere kijk op het leven te delen.
Ook een woord van dank aan de collega’s van mijn nieuwe afdeling Fysiologie, het voelt 
als thuiskomen in een warme familie. Er wordt hard gewerkt maar tegelijkertijd heerst 
er een ontspannen en gezellige sfeer. Elja en Kim, mijn groepsmaatjes, we hebben nu 
al heel veel lol, heel veel succes nog met jullie PhD. Peter en Henri, bedankt voor het 
vertrouwen in mij, hopelijk volgen er nog vele mooie resultaten en momenten.  
Ik wil graag al mijn mede-onderzoekers meegeven dat ons werk echt verschil kan 
maken. Ik hoop van harte dat alle mooie onderzoeken uiteindelijk ook de patiënt 
bereiken en we iedere keer weer een stapje verder komen en dat dit ons een extra boost 
van motivatie geeft. 
Natuurlijk ook dank aan alle vrienden en familieleden voor de nodige ontspanning en 
gezelligheid. Ronald en Doreen, bedankt voor alle steun die ik van jullie gekregen heb. 
Ronald, dankzij jou ben ik lang geleden terecht gekomen op de KNO-afdeling, bedankt 
voor de gouden tip. Ik kon en kan echt altijd op jullie rekenen waar ik echt dankbaar 
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voor ben. Natuurlijk ook mijn eigen familie, bedankt voor alle hulp en alle gezellige 
momenten. We zijn een heel sterk team en vormen een hecht gezin. Het maakt niet 
uit hoe groot of klein het probleem is, er is altijd wel een oplossing en we staan altijd 
voor elkaar klaar. Bedankt! Amine, también eres parte de la familia, estoy muy feliz de 
conocerte. Quiero agradecerte por toda tu ayuda, paciencia y cordialidad. Deseo la 
felicidad y la suerte en nuestra nueva etapa de vida.
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